Pathway,Count
MP:0000600 liver hypoplasia,59
MP:0001716 abnormal placenta labyrinth morphology,85
MP:0001698 decreased embryo size,537
MP:0001092 abnormal trigeminal ganglion morphology,36
MP:0000961 abnormal dorsal root ganglion morphology,64
MP:0000245 abnormal erythropoiesis,117
MP:0000828 abnormal fourth ventricle morphology,14
MP:0000826 abnormal third ventricle morphology,19
MP:0005039 hypoxia,29
MP:0002840 abnormal lens fiber morphology,45
MP:0005545 abnormal lens development,28
MP:0003077 abnormal cell cycle,115
MP:0003203 increased neuron apoptosis,90
MP:0003717 pallor,218
MP:0004045 abnormal cell cycle checkpoint function,45
MP:0004265 abnormal placental transport,12
MP:0009395 increased nucleated erythrocyte cell number,44
MP:0009937 abnormal neuron differentiation,116
"MP:0011098 embryonic lethality during organogenesis, complete penetrance",656
MP:0011703 increased fibroblast proliferation,39
MP:0001614 abnormal blood vessel morphology,164
MP:0000364 abnormal vascular regression,20
MP:0006093 arteriovenous malformation,16
MP:0003984 embryonic growth retardation,595
MP:0004076 abnormal vitelline vascular remodeling,61
MP:0004784 abnormal anterior cardinal vein morphology,11
MP:0004787 abnormal dorsal aorta morphology,58
MP:0008803 abnormal placental labyrinth vasculature morphology,78
"MP:0011097 embryonic lethality between somite formation and embryo turning, complete penetrance",85
MP:0012099 decreased spongiotrophoblast size,18
MP:0002084 abnormal developmental patterning,92
MP:0002151 abnormal neural tube morphology,190
MP:0001695 abnormal gastrulation,51
MP:0000913 abnormal brain development,100
MP:0002230 abnormal primitive streak formation,25
MP:0001675 abnormal ectoderm development,47
MP:0001680 abnormal mesoderm development,62
MP:0001726 abnormal allantois morphology,58
MP:0001718 abnormal visceral yolk sac morphology,88
MP:0001691 abnormal somite shape,37
MP:0001684 abnormal axial mesoderm morphology,7
MP:0002825 abnormal notochord morphology,39
MP:0009768 impaired somite development,18
MP:0011733 fused somites,11
MP:0012087 absent midbrain,7
MP:0012135 embryonic-extraembryonic boundary constriction,15
MP:0012136 absent forebrain,13
MP:0012157 rostral body truncation,19
MP:0020515 abnormal visceral yolk sac endoderm morphology,10
MP:0020516 abnormal visceral yolk sac mesenchyme morphology,6
MP:0009744 postaxial polydactyly,8
MP:0002086 abnormal extraembryonic tissue morphology,111
MP:0001711 abnormal placenta morphology,87
MP:0001713 decreased trophoblast giant cell number,31
MP:0005031 abnormal trophoblast layer morphology,56
MP:0005033 abnormal trophoblast giant cell morphology,39
MP:0002836 abnormal chorion morphology,23
MP:0003403 absent placental labyrinth,21
MP:0003988 disorganized embryonic tissue,32
MP:0009593 absent chorion,15
MP:0009657 failure of chorioallantoic fusion,60
MP:0001879 abnormal lymphatic vessel morphology,35
MP:0000238 absent pre-B cells,10
MP:0000574 abnormal foot pad morphology,21
MP:0002192 hydrops fetalis,55
MP:0002144 abnormal B cell differentiation,106
MP:0001914 hemorrhage,275
MP:0001916 intracerebral hemorrhage,25
MP:0004106 lymphatic vessel hyperplasia,6
MP:0004938 dilated vasculature,21
MP:0008778 abnormal lymphangiogenesis,13
MP:0010200 enlarged lymphatic vessel,8
"MP:0011085 postnatal lethality, complete penetrance",432
MP:0002127 abnormal cardiovascular system morphology,56
MP:0000452 abnormal mouth morphology,14
MP:0002108 abnormal muscle morphology,49
MP:0000614 absent salivary gland,6
MP:0001823 thymus hypoplasia,167
MP:0002177 abnormal outer ear morphology,31
MP:0000460 mandible hypoplasia,33
MP:0002338 abnormal pulmonary ventilation,6
MP:0000284 double outlet right ventricle,186
MP:0000273 overriding aortic valve,69
MP:0001071 abnormal facial nerve morphology,27
MP:0001065 abnormal trigeminal nerve morphology,32
MP:0002633 persistent truncus arteriosis,74
MP:0005105 abnormal middle ear ossicle morphology,36
MP:0005249 abnormal palatine bone morphology,12
MP:0005508 abnormal skeleton morphology,131
MP:0003007 ectopic thymus,6
MP:0003138 absent tympanic ring,9
MP:0003139 patent ductus arteriosus,13
MP:0003755 abnormal palate morphology,27
MP:0004110 transposition of great arteries,44
MP:0004181 abnormal carotid artery morphology,13
MP:0004204 absent stapes,11
MP:0004318 absent incus,6
MP:0008023 abnormal styloid process morphology,11
MP:0006337 abnormal first pharyngeal arch morphology,22
MP:0006344 small second pharyngeal arch,13
MP:0009524 absent submandibular gland,7
MP:0009904 tongue hypoplasia,5
MP:0010418 perimembraneous ventricular septal defect,99
"MP:0011089 perinatal lethality, complete penetrance",269
MP:0002233 abnormal nose morphology,28
MP:0001953 respiratory failure,161
MP:0001293 anophthalmia,148
MP:0000830 abnormal diencephalon morphology,35
MP:0003635 abnormal synaptic transmission,33
MP:0004100 abnormal spinal cord interneuron morphology,24
MP:0020527 small thalamus,10
MP:0000259 abnormal vascular development,79
MP:0000280 thin ventricular wall,99
MP:0002672 abnormal pharyngeal arch artery morphology,23
MP:0003229 abnormal vitelline vasculature morphology,129
MP:0003542 abnormal vascular endothelial cell development,12
MP:0003974 abnormal endocardium morphology,25
MP:0004068 dilated dorsal aorta,18
MP:0000458 abnormal mandible morphology,49
MP:0002237 abnormal nasal cavity morphology,25
MP:0002239 abnormal nasal septum morphology,17
MP:0000098 abnormal vomer bone morphology,6
MP:0005587 abnormal Meckel's cartilage morphology,24
MP:0003110 absent malleus processus brevis,5
MP:0006018 abnormal tympanic membrane morphology,9
MP:0006020 decreased tympanic ring size,14
MP:0004596 abnormal mandibular angle morphology,11
MP:0004726 abnormal nasal capsule morphology,19
MP:0009546 absent gastric milk in neonates,87
MP:0009703 decreased birth body size,166
MP:0009707 absent external auditory canal,5
"MP:0011087 neonatal lethality, complete penetrance",517
MP:0030283 small mandibular coronoid process,5
MP:0000111 cleft palate,214
MP:0000438 abnormal cranium morphology,155
MP:0002098 abnormal vibrissa morphology,63
MP:0000455 abnormal maxilla morphology,53
MP:0002152 abnormal brain morphology,187
MP:0001286 abnormal eye development,71
MP:0001785 edema,258
MP:0000157 abnormal sternum morphology,85
MP:0000116 abnormal tooth development,38
MP:0000562 polydactyly,145
MP:0000564 syndactyly,108
MP:0000914 exencephaly,236
MP:0000023 abnormal ear position,14
MP:0000928 incomplete rostral neuropore closure,70
MP:0000075 absent neurocranium,12
MP:0002764 short tibia,204
MP:0003723 abnormal long bone morphology,67
MP:0003935 abnormal craniofacial development,47
MP:0004351 short humerus,46
MP:0004355 short radius,38
MP:0004359 short ulna,44
MP:0004576 abnormal embryonic autopod plate morphology,9
MP:0004599 abnormal vertebral arch morphology,51
MP:0008160 increased diameter of humerus,7
MP:0008161 increased diameter of radius,5
MP:0008163 increased diameter of ulna,5
MP:0009003 abnormal vibrissa number,9
"MP:0011101 prenatal lethality, incomplete penetrance",351
MP:0000474 abnormal foregut morphology,26
MP:0001176 abnormal lung development,93
MP:0001178 pulmonary hypoplasia,60
MP:0005631 decreased lung weight,21
MP:0003120 abnormal tracheal cartilage morphology,23
MP:0003160 abnormal esophagus development,6
MP:0003159 abnormal esophageal smooth muscle morphology,5
MP:0003641 small lung,59
MP:0009570 abnormal right lung morphology,8
MP:0010810 increased type II pneumocyte number,13
MP:0010827 small lung saccule,7
MP:0010883 trachea stenosis,6
MP:0011143 thick lung-associated mesenchyme,18
MP:0000596 abnormal liver development,40
MP:0001577 anemia,248
MP:0001730 embryonic growth arrest,263
MP:0009266 abnormal mesendoderm development,12
MP:0011388 absent heart,11
MP:0012083 absent foregut,5
MP:0030324 abnormal anterior head development,6
MP:0000757 herniated abdominal wall,22
MP:0000109 abnormal parietal bone morphology,29
"MP:0011090 perinatal lethality, incomplete penetrance",256
MP:0000088 short mandible,65
MP:0000097 short maxilla,46
MP:0000929 open neural tube,151
MP:0000783 abnormal forebrain morphology,119
MP:0003104 acrania,12
MP:0004377 small frontal bone,10
MP:0004383 absent interparietal bone,9
MP:0004418 small parietal bone,13
MP:0004444 small supraoccipital bone,7
MP:0004449 absent presphenoid bone,9
MP:0011862 decreased cranium length,17
MP:0000603 pale liver,75
MP:0000601 small liver,88
MP:0001722 pale yolk sac,101
MP:0000229 abnormal megakaryocyte differentiation,20
MP:0001606 impaired hematopoiesis,54
MP:0004229 abnormal embryonic erythropoiesis,30
MP:0002085 abnormal embryonic tissue morphology,167
MP:0000352 decreased cell proliferation,182
MP:0003787 abnormal imprinting,17
MP:0008877 abnormal DNA methylation,38
"MP:0011092 embryonic lethality, complete penetrance",381
MP:0012131 small visceral yolk sac,7
MP:0013504 increased embryonic tissue cell apoptosis,94
MP:0002123 abnormal definitive hematopoiesis,102
MP:0000263 absent organized vascular network,8
MP:0001721 absent visceral yolk sac blood islands,14
MP:0001719 absent vitelline blood vessels,62
MP:0006138 congestive heart failure,58
MP:0013241 embryo tissue necrosis,36
MP:0002169 no abnormal phenotype detected,1944
MP:0001602 impaired myelopoiesis,13
MP:0001634 internal hemorrhage,77
MP:0005244 hemopericardium,44
MP:0005650 abnormal limb bud morphology,46
MP:0002447 abnormal erythrocyte morphology,90
MP:0002875 decreased erythrocyte cell number,204
MP:0004230 abnormal embryonic erythrocyte morphology,11
MP:0000372 irregular coat pigmentation,36
MP:0001147 small testis,357
MP:0005171 absent coat pigmentation,13
MP:0002811 macrocytic anemia,14
MP:0008871 abnormal ovarian follicle number,19
MP:0002083 premature death,997
MP:0000351 increased cell proliferation,61
MP:0002020 increased tumor incidence,130
MP:0002038 increased carcinoma incidence,35
MP:0002032 increased sarcoma incidence,49
MP:0005621 abnormal cell physiology,275
MP:0000343 altered response to myocardial infarction,48
MP:0006043 decreased apoptosis,46
MP:0003207 decreased cellular sensitivity to gamma-irradiation,18
MP:0003674 oxidative stress,104
MP:0003763 abnormal thymus physiology,9
MP:0003789 increased osteosarcoma incidence,12
MP:0004023 abnormal chromosome number,9
MP:0004228 decreased cellular sensitivity to ionizing radiation,9
MP:0008009 delayed cellular replicative senescence,10
MP:0008944 decreased sensitivity to induced cell death,45
MP:0009542 decreased thymocyte apoptosis,16
MP:0009764 decreased sensitivity to induced morbidity/mortality,45
MP:0012431 increased lymphoma incidence,107
MP:0001915 intracranial hemorrhage,67
MP:0006054 spinal hemorrhage,17
MP:0000358 abnormal cell morphology,114
MP:0002128 abnormal blood circulation,46
MP:0000267 abnormal heart development,168
MP:0001688 abnormal somite development,95
MP:0000272 abnormal aorta morphology,33
MP:0005029 abnormal amnion morphology,19
MP:0005221 abnormal rostral-caudal axis patterning,64
MP:0003091 abnormal cell migration,44
MP:0004180 failure of initiation of embryo turning,51
MP:0004261 abnormal embryonic neuroepithelium morphology,65
MP:0010656 thick myocardium,6
MP:0011257 abnormal head fold morphology,11
MP:0011260 abnormal head mesenchyme morphology,19
MP:0012104 small amniotic cavity,7
MP:0001126 abnormal ovary morphology,78
MP:0001931 abnormal oogenesis,24
MP:0002212 abnormal secondary sex determination,8
MP:0001939 secondary sex reversal,12
MP:0000520 absent kidney,66
MP:0000528 delayed kidney development,18
MP:0000715 decreased thymocyte number,113
MP:0005431 decreased oocyte number,59
MP:0003606 kidney failure,44
MP:0006361 abnormal female germ cell morphology,7
MP:0006425 absent Mullerian ducts,5
MP:0009093 oocyte degeneration,7
MP:0010984 abnormal metanephric mesenchyme morphology,19
MP:0010987 abnormal nephrogenic mesenchyme morphogenesis,5
MP:0001436 abnormal suckling behavior,97
MP:0002116 abnormal craniofacial bone morphology,59
MP:0002113 abnormal skeleton development,88
MP:0000164 abnormal cartilage development,54
MP:0000039 abnormal otic capsule morphology,12
MP:0000029 abnormal malleus morphology,25
MP:0000030 abnormal tympanic ring morphology,18
MP:0000079 abnormal basioccipital bone morphology,21
MP:0000909 abnormal facial motor nucleus morphology,9
MP:0005106 abnormal incus morphology,16
MP:0005107 abnormal stapes morphology,23
MP:0005272 abnormal temporal bone morphology,16
MP:0005579 absent outer ear,9
MP:0003168 abnormal scala vestibuli morphology,6
MP:0004423 abnormal temporal bone squamous part morphology,10
MP:0008380 abnormal gonial bone morphology,5
MP:0009890 cleft secondary palate,104
MP:0000155 asymmetric rib joints,7
MP:0000480 increased rib number,42
MP:0004615 cervical vertebral transformation,45
MP:0008277 abnormal sternum ossification,37
MP:0010082 sternebra fusion,18
MP:0000432 abnormal head morphology,58
MP:0000919 cranioschisis,11
MP:0000108 midline facial cleft,20
MP:0004574 broad limb buds,9
"MP:0011099 lethality throughout fetal growth and development, complete penetrance",220
MP:0001259 abnormal body weight,32
"MP:0011086 postnatal lethality, incomplete penetrance",643
"MP:0011088 neonatal lethality, incomplete penetrance",293
MP:0001689 incomplete somite formation,42
MP:0006042 increased apoptosis,139
MP:0003874 absent pharyngeal arches,11
MP:0003873 pharyngeal arch hypoplasia,11
MP:0000729 abnormal myogenesis,25
MP:0003054 spina bifida,52
MP:0003090 abnormal muscle precursor cell migration,7
MP:0004206 abnormal dermomyotome development,9
"MP:0011091 prenatal lethality, complete penetrance",362
MP:0001379 abnormal penile erection,5
MP:0003415 priapism,11
MP:0000598 abnormal liver morphology,233
MP:0000607 abnormal hepatocyte morphology,114
MP:0000602 enlarged liver sinusoidal spaces,44
MP:0001636 irregular heartbeat,47
MP:0000608 dissociated hepatocytes,5
MP:0009431 decreased fetal weight,66
MP:0011527 disorganized placental labyrinth,8
MP:0000153 rib bifurcation,32
MP:0004672 short ribs,30
MP:0008148 abnormal sternocostal joint morphology,36
MP:0000163 abnormal cartilage morphology,44
MP:0000558 abnormal tibia morphology,54
MP:0000556 abnormal hindlimb morphology,71
MP:0002639 micrognathia,111
MP:0003055 abnormal long bone epiphyseal plate morphology,66
MP:0003109 short femur,106
MP:0003408 increased width of hypertrophic chondrocyte zone,37
MP:0004509 abnormal pelvic girdle bone morphology,52
MP:0004694 absent patella,7
MP:0008381 absent gonial bone,5
MP:0009886 failure of palatal shelf elevation,25
MP:0000137 abnormal vertebrae morphology,132
MP:0004668 absent vertebral body,6
MP:0004683 absent intervertebral disk,9
MP:0008149 abnormal costovertebral joint morphology,9
MP:0000823 abnormal lateral ventricle morphology,25
MP:0002190 disorganized myocardium,33
MP:0000281 abnormal interventricular septum morphology,53
MP:0002652 thin myocardium,79
MP:0005312 pericardial effusion,68
MP:0005329 abnormal myocardium layer morphology,88
MP:0002824 abnormal chorioallantoic fusion,23
MP:0003057 abnormal epicardium morphology,19
MP:0004057 thin myocardium compact layer,27
MP:0004557 dilated allantois,8
MP:0001622 abnormal vasculogenesis,49
MP:0000932 absent notochord,18
MP:0003400 kinked neural tube,55
MP:0006386 absent somites,37
MP:0010117 abnormal lateral plate mesoderm morphology,11
MP:0012173 short rostral-caudal axis,15
MP:0000313 abnormal cell death,48
MP:0001701 incomplete embryo turning,66
MP:0000292 distended pericardium,53
MP:0005602 decreased angiogenesis,71
MP:0003230 abnormal umbilical artery morphology,9
MP:0011204 abnormal visceral yolk sac blood island morphology,18
MP:0012253 abnormal intersomitic vessel morphology,20
MP:0001674 abnormal germ layer development,26
MP:0001710 absent amniotic folds,7
MP:0003087 absent allantois,20
MP:0003886 abnormal embryonic epiblast morphology,37
MP:0000435 shortened head,44
MP:0000784 forebrain hypoplasia,21
MP:0003231 abnormal placenta vasculature,57
MP:0004188 delayed embryo turning,23
MP:0002110 abnormal digit morphology,99
MP:0000572 abnormal autopod morphology,68
MP:0000554 abnormal carpal bone morphology,31
MP:0005104 abnormal tarsal bone morphology,21
MP:0005306 abnormal phalanx morphology,54
MP:0005353 abnormal patella morphology,11
MP:0003073 abnormal metacarpal bone morphology,21
MP:0003072 abnormal metatarsal bone morphology,25
MP:0006280 abnormal digit development,25
MP:0004634 short metacarpal bones,13
MP:0004635 short metatarsal bones,13
MP:0004686 decreased length of long bones,97
MP:0008730 fused phalanges,19
MP:0008915 fused carpal bones,16
MP:0011261 abnormal limb mesenchyme morphology,9
MP:0002114 abnormal axial skeleton morphology,96
MP:0000955 abnormal spinal cord morphology,83
MP:0001288 abnormal lens induction,7
MP:0001292 abnormal lens vesicle development,13
MP:0002728 absent tibia,12
MP:0006069 abnormal retinal neuronal layer morphology,45
MP:0003720 abnormal neural tube closure,112
MP:0003857 abnormal hindlimb zeugopod morphology,12
MP:0006279 abnormal limb development,44
MP:0004269 abnormal optic cup morphology,40
MP:0004275 abnormal postnatal subventricular zone morphology,22
MP:0009688 abnormal spinal cord central canal morphology,8
MP:0001672 abnormal embryo development,172
MP:0002188 small heart,57
MP:0006108 abnormal hindbrain development,43
MP:0004066 abnormal primitive node morphology,19
MP:0006293 absent nasal placodes,6
MP:0006294 absent optic vesicle,8
MP:0000160 kyphosis,173
MP:0003048 abnormal cervical vertebrae morphology,53
MP:0003445 sirenomelia,6
MP:0004608 abnormal cervical axis morphology,23
"MP:0011108 embryonic lethality during organogenesis, incomplete penetrance",247
MP:0000373 belly spot,97
MP:0000371 diluted coat color,117
MP:0001177 atelectasis,75
MP:0000154 rib fusion,84
MP:0000141 abnormal vertebral body morphology,39
MP:0000078 abnormal supraoccipital bone morphology,10
MP:0000104 abnormal sphenoid bone morphology,12
MP:0000106 abnormal basisphenoid bone morphology,24
MP:0005297 spina bifida occulta,15
MP:0006030 abnormal otic vesicle development,22
MP:0003235 abnormal alisphenoid bone morphology,12
MP:0004113 abnormal aortic arch morphology,54
MP:0004157 interrupted aortic arch,44
MP:0004448 abnormal presphenoid bone morphology,11
MP:0004452 abnormal pterygoid process morphology,12
MP:0004537 abnormal palatine bone horizontal plate morphology,8
MP:0004670 small vertebral body,8
MP:0004706 short vertebral body,6
MP:0006354 abnormal fourth pharyngeal arch artery morphology,17
MP:0006356 abnormal third pharyngeal arch artery morphology,7
MP:0008271 abnormal bone ossification,87
MP:0010402 ventricular septal defect,193
MP:0010526 aortic arch coarctation,7
MP:0000885 ectopic Purkinje cell,27
MP:0000849 abnormal cerebellum morphology,113
MP:0000872 abnormal cerebellum external granule cell layer morphology,42
MP:0000864 abnormal cerebellum vermis morphology,18
MP:0004098 abnormal cerebellar granule cell morphology,26
MP:0008393 absent primordial germ cells,7
MP:0011759 absent Rathke's pouch,8
MP:0001216 abnormal epidermal layer morphology,75
MP:0000592 short tail,143
MP:0001712 abnormal placenta development,53
MP:0003861 abnormal nervous system development,45
MP:0004073 caudal body truncation,44
MP:0004712 notochord degeneration,7
MP:0008854 bleb,12
MP:0011495 abnormal head shape,37
MP:0012082 delayed heart development,18
MP:0012501 abnormal pericardial cavity morphology,13
MP:0013164 abnormal forelimb bud morphology,7
MP:0013168 absent hindlimb buds,5
MP:0004387 abnormal prechordal plate morphology,6
MP:0009331 absent primitive node,17
MP:0012740 abnormal posterior primitive streak morphology,5
MP:0000589 thin tail,6
MP:0002861 abnormal tail bud morphology,18
MP:0003050 abnormal sacral vertebrae morphology,24
MP:0003345 decreased rib number,54
MP:0004613 fusion of vertebral arches,56
MP:0012707 incomplete caudal neuropore closure,11
MP:0003135 increased erythroid progenitor cell number,43
MP:0003887 increased hepatocyte apoptosis,44
MP:0009783 abnormal melanoblast morphology,6
MP:0001324 abnormal eye pigmentation,29
MP:0001265 decreased body size,1111
MP:0002249 abnormal larynx morphology,11
MP:0000049 abnormal middle ear morphology,27
MP:0000150 abnormal rib morphology,133
MP:0000091 short premaxilla,15
MP:0002238 abnormal nasal mucosa morphology,5
MP:0000031 abnormal cochlea morphology,59
MP:0000041 absent endolymphatic duct,11
MP:0000074 abnormal neurocranium morphology,78
MP:0000102 abnormal nasal bone morphology,29
MP:0001093 small trigeminal ganglion,17
MP:0002689 abnormal molar morphology,20
MP:0005269 abnormal occipital bone morphology,20
MP:0002817 abnormal tooth mineralization,5
MP:0002820 abnormal premaxilla morphology,13
MP:0005358 abnormal incisor morphology,52
MP:0003148 decreased cochlear coiling,17
MP:0003162 decreased lateral semicircular canal size,10
MP:0003163 absent posterior semicircular canal,9
MP:0003165 absent superior semicircular canal,6
MP:0006033 abnormal external auditory canal morphology,14
MP:0003651 abnormal axon extension,57
MP:0003932 abnormal molar crown morphology,10
MP:0004136 abnormal tongue muscle morphology,12
MP:0004384 small interparietal bone,13
MP:0004453 abnormal pterygoid bone morphology,7
MP:0004470 small nasal bone,6
MP:0004540 small maxilla,8
MP:0004595 abnormal mandibular condyloid process morphology,6
MP:0009902 abnormal lateral nasal prominence morphology,6
MP:0013595 absent vomeronasal organ,5
MP:0013933 short Meckel's cartilage,7
MP:0020137 decreased bone mineralization,42
MP:0030089 short lower incisors,5
MP:0030090 short upper incisors,5
MP:0002566 abnormal sexual interaction,53
MP:0001399 hyperactivity,567
MP:0000026 abnormal inner ear morphology,56
MP:0001394 circling,151
MP:0001923 reduced female fertility,274
MP:0001922 reduced male fertility,268
MP:0000035 abnormal membranous labyrinth morphology,18
MP:0005307 head tossing,58
MP:0003308 abnormal cochlear sensory epithelium morphology,22
MP:0004289 abnormal bony labyrinth,9
MP:0006287 inner ear cysts,5
MP:0000926 absent floor plate,19
MP:0000822 abnormal brain ventricle morphology,19
MP:0002621 delayed neural tube closure,30
MP:0004252 abnormal direction of heart looping,37
MP:0006346 small pharyngeal arch,17
MP:0011732 decreased somite size,28
MP:0012062 small tail bud,8
MP:0000350 abnormal cell proliferation,21
MP:0000606 decreased hepatocyte number,15
MP:0000774 decreased brain size,123
MP:0000964 small dorsal root ganglion,20
MP:0004200 decreased fetal size,142
MP:0008534 enlarged fourth ventricle,8
MP:0000531 right pulmonary isomerism,29
MP:0006065 abnormal heart position or orientation,25
MP:0003686 abnormal eye muscle morphology,37
MP:0001304 cataract,255
MP:0001297 microphthalmia,278
MP:0001317 abnormal pupil morphology,14
MP:0000120 malocclusion,50
MP:0006241 abnormal placement of pupils,9
MP:0030541 misaligned incisors,10
MP:0000274 enlarged heart,367
MP:0002745 abnormal atrioventricular valve morphology,17
MP:0003105 abnormal heart atrium morphology,41
MP:0006062 abnormal vena cava morphology,10
MP:0003384 abnormal ventral body wall morphology,16
MP:0012535 abnormal optic fissure closure,6
MP:0012536 delayed optic fissure closure,5
MP:0013337 abnormal adenohypophysis development,6
MP:0013351 abnormal Rathke's pouch development,11
MP:0013352 abnormal Rathke's pouch apoptosis,6
MP:0020854 increased corneal epithelium thickness,8
MP:0000431 absent palatine bone horizontal plate,12
MP:0002989 small kidney,109
MP:0004443 absent supraoccipital bone,10
MP:0004447 small basioccipital bone,8
MP:0004476 absent palatine bone,5
MP:0004592 small mandible,30
MP:0030026 small Meckel's cartilage,7
MP:0001312 abnormal cornea morphology,107
MP:0000297 abnormal atrioventricular cushion morphology,33
MP:0002823 abnormal rib development,18
MP:0003119 abnormal digestive system development,21
MP:0006107 abnormal fetal atrioventricular canal morphology,12
MP:0006198 enophthalmos,12
MP:0004624 abnormal thoracic cage morphology,35
MP:0004673 splayed ribs,5
MP:0008726 enlarged heart left atrium,5
MP:0010406 common atrium,28
MP:0010422 heart right ventricle hypoplasia,18
MP:0010426 abnormal heart and great artery attachment,12
MP:0010607 common atrioventricular valve,15
MP:0001700 abnormal embryo turning,98
MP:0000293 absent myocardial trabeculae,13
MP:0000298 absent atrioventricular cushions,15
MP:0002884 abnormal pharyngeal arch morphology,51
MP:0004251 failure of heart looping,44
MP:0008788 abnormal fetal cardiomyocyte morphology,29
MP:0009073 absent Wolffian ducts,6
MP:0004086 absent heartbeat,22
MP:0001077 abnormal spinal nerve morphology,32
MP:0004607 abnormal cervical atlas morphology,32
MP:0008146 asymmetric sternocostal joints,31
MP:0010728 fusion of atlas and occipital bones,13
MP:0011513 abnormal vertebral artery morphology,10
MP:0003794 delayed somite formation,15
MP:0000536 hydroureter,33
MP:0003584 bifid ureter,13
MP:0003827 abnormal Wolffian duct morphology,29
MP:0004017 duplex kidney,27
MP:0008487 abnormal mesonephros morphology,10
MP:0010980 ectopic ureteric bud,7
MP:0011727 ectopic ovary,9
MP:0011797 blind ureter,8
MP:0000428 abnormal craniofacial morphology,165
MP:0002109 abnormal limb morphology,102
MP:0002111 abnormal tail morphology,124
MP:0002092 abnormal eye morphology,217
MP:0001927 abnormal estrous cycle,33
MP:0000441 increased cranium width,17
MP:0001262 decreased body weight,1471
MP:0001505 hunched posture,94
MP:0001924 infertility,125
MP:0000149 abnormal scapula morphology,27
MP:0002187 abnormal fibula morphology,24
MP:0000576 clubfoot,16
MP:0000585 kinked tail,222
MP:0000588 thick tail,18
MP:0001891 hydrocephaly,163
MP:0001935 decreased litter size,331
MP:0001926 female infertility,367
MP:0001925 male infertility,747
MP:0000107 abnormal frontal bone morphology,41
MP:0002636 delayed vaginal opening,20
MP:0002687 oligozoospermia,244
MP:0004083 polysyndactyly,17
MP:0004342 scapular bone foramen,6
MP:0004358 bowed tibia,20
MP:0004361 bowed ulna,13
MP:0004372 bowed fibula,12
MP:0004374 bowed radius,18
MP:0004650 increased lumbar vertebrae number,5
MP:0004852 decreased testis weight,258
MP:0010099 abnormal thoracic cage shape,22
MP:0030189 broad snout,16
MP:0030431 wide metopic suture,5
MP:0001706 abnormal left-right axis patterning,52
MP:0000930 wavy neural tube,34
MP:0003232 abnormal forebrain development,81
MP:0003864 abnormal midbrain development,38
MP:0004132 absent embryonic cilia,19
MP:0001303 abnormal lens morphology,218
MP:0001330 abnormal optic nerve morphology,45
MP:0001325 abnormal retina morphology,168
MP:0005193 abnormal anterior eye segment morphology,23
MP:0005201 abnormal retinal pigment epithelium morphology,95
MP:0005205 abnormal eye anterior chamber morphology,18
MP:0006000 abnormal corneal epithelium morphology,29
MP:0003237 abnormal lens epithelium morphology,21
MP:0003728 abnormal retinal photoreceptor layer morphology,32
MP:0001685 abnormal endoderm development,36
MP:0001724 abnormal extraembryonic endoderm formation,18
MP:0001683 absent mesoderm,66
"MP:0011096 embryonic lethality between implantation and somite formation, complete penetrance",282
MP:0001648 abnormal apoptosis,55
MP:0000270 abnormal heart tube morphology,33
MP:0000278 abnormal myocardial fiber morphology,107
MP:0001693 failure of primitive streak formation,36
MP:0002546 mydriasis,22
MP:0005576 decreased pulmonary ventilation,10
MP:0006243 impaired pupillary reflex,39
MP:0002784 abnormal Sertoli cell morphology,54
MP:0002199 abnormal brain commissure morphology,28
MP:0005120 decreased circulating growth hormone level,15
MP:0005236 abnormal olfactory nerve morphology,17
MP:0003425 abnormal optic vesicle formation,24
MP:0003793 abnormal submandibular gland morphology,13
MP:0008789 abnormal olfactory epithelium morphology,26
MP:0009522 submandibular gland hypoplasia,5
MP:0004559 small allantois,13
MP:0006323 abnormal extraembryonic mesoderm development,13
MP:0008786 abnormal hindgut morphology,10
MP:0001633 poor circulation,18
MP:0001082 abnormal geniculate ganglion morphology,12
MP:0001073 abnormal glossopharyngeal nerve morphology,14
MP:0001076 abnormal hypoglossal nerve morphology,9
MP:0001074 abnormal vagus nerve morphology,18
MP:0001102 small superior vagus ganglion,71
MP:0002855 abnormal cochlear ganglion morphology,26
MP:0003993 abnormal ventral spinal root morphology,19
MP:0000266 abnormal heart morphology,391
MP:0000471 abnormal stomach epithelium morphology,11
MP:0002189 abnormal myocardial trabeculae morphology,57
MP:0001081 abnormal cranial ganglia morphology,35
MP:0001944 abnormal pancreas morphology,58
MP:0002200 abnormal brain ventricular system morphology,8
MP:0000841 abnormal hindbrain morphology,48
MP:0000897 abnormal midbrain morphology,47
MP:0001045 abnormal enteric ganglia morphology,12
MP:0000820 abnormal choroid plexus morphology,38
MP:0001088 small nodose ganglion,10
MP:0001085 small petrosal ganglion,10
MP:0001107 decreased Schwann cell number,8
MP:0000880 decreased Purkinje cell number,51
MP:0000786 abnormal embryonic neuroepithelial layer differentiation,15
MP:0000851 cerebellum hypoplasia,18
MP:0005537 abnormal cerebral aqueduct morphology,16
MP:0006009 abnormal neuronal migration,85
MP:0006046 atrioventricular valve regurgitation,6
MP:0003634 abnormal glial cell morphology,15
MP:0004203 abnormal cranial flexure morphology,9
MP:0008547 abnormal neocortex morphology,29
MP:0008825 abnormal cardiac epithelial to mesenchymal transition,16
MP:0000296 absent trabeculae carneae,13
MP:0001255 decreased body height,24
MP:0000690 absent spleen,32
MP:0005227 abnormal vertebral body development,10
MP:0004173 abnormal intervertebral disk morphology,24
MP:0004610 small vertebrae,15
MP:0004704 short vertebral column,19
MP:0004733 abnormal thoracic cavity morphology,13
MP:0000445 short snout,162
MP:0001732 postnatal growth retardation,677
MP:0001300 ocular hypertelorism,27
MP:0001106 abnormal Schwann cell morphology,28
MP:0002651 abnormal sciatic nerve morphology,40
MP:0010025 decreased total body fat amount,498
MP:0001676 abnormal apical ectodermal ridge morphology,17
MP:0002264 abnormal bronchus morphology,16
MP:0002691 small stomach,25
MP:0003321 tracheoesophageal fistula,17
MP:0011024 abnormal branching involved in lung morphogenesis,17
MP:0001663 abnormal digestive system physiology,53
MP:0001146 abnormal testis morphology,155
MP:0002211 abnormal primary sex determination,11
MP:0000496 abnormal small intestine morphology,61
MP:0001940 testis hypoplasia,24
MP:0000494 abnormal cecum morphology,18
MP:0001575 cyanosis,210
MP:0002995 primary sex reversal,10
MP:0003140 dilated heart atrium,36
MP:0004109 abnormal Sertoli cell development,7
MP:0004841 abnormal small intestine crypts of Lieberkuhn morphology,15
MP:0008022 dilated heart ventricle,31
MP:0006418 abnormal testis cord formation,9
MP:0006419 disorganized testis cords,7
MP:0002089 abnormal postnatal growth/weight/body size,40
MP:0000118 arrest of tooth development,7
MP:0000282 abnormal interatrial septum morphology,24
MP:0000694 spleen hypoplasia,125
MP:0001319 irregularly shaped pupil,21
MP:0000299 failure of atrioventricular cushion closure,8
MP:0000644 dextrocardia,68
MP:0003052 omphalocele,54
MP:0006061 right atrial isomerism,18
MP:0010440 anomalous pulmonary venous connection,12
MP:0010454 abnormal truncus arteriosus septation,30
"MP:0011109 lethality throughout fetal growth and development, incomplete penetrance",191
MP:0011667 double outlet right ventricle with atrioventricular septal defect,36
MP:0008543 atrial fibrillation,9
MP:0010392 prolonged QRS complex duration,34
MP:0002073 abnormal hair growth,89
MP:0000745 tremors,355
MP:0001406 abnormal gait,448
MP:0001290 delayed eyelid opening,33
MP:0001344 blepharoptosis,20
MP:0000968 abnormal sensory neuron innervation pattern,54
MP:0001008 abnormal sympathetic ganglion morphology,13
MP:0001014 absent superior cervical ganglion,9
MP:0001015 small superior cervical ganglion,33
MP:0003043 hypoalgesia,23
MP:0006408 dorsal root ganglion hypoplasia,5
MP:0000443 abnormal snout morphology,38
MP:0001340 abnormal eyelid morphology,36
MP:0000087 absent mandible,20
MP:0002251 abnormal nasopharynx morphology,6
MP:0001299 abnormal eye distance/ position,12
MP:0002243 abnormal vomeronasal organ morphology,12
MP:0000776 abnormal inferior colliculus morphology,8
MP:0001061 abnormal oculomotor nerve morphology,11
MP:0001063 abnormal trochlear nerve morphology,5
MP:0002698 abnormal sclera morphology,8
MP:0005157 holoprosencephaly,50
MP:0005261 aniridia,5
MP:0005352 small cranium,29
MP:0003078 aphakia,31
MP:0003451 absent olfactory bulb,15
MP:0003727 abnormal retinal layer morphology,27
MP:0004163 abnormal adenohypophysis morphology,26
MP:0004463 basisphenoid bone foramen,19
MP:0004872 absent nasal septum,7
MP:0004912 absent mandibular coronoid process,9
MP:0008934 absent choroid plexus,5
MP:0009579 acephaly,6
MP:0009905 absent tongue,6
MP:0012132 abnormal midbrain-hindbrain boundary morphology,8
MP:0012703 decreased embryonic neuroepithelium thickness,15
MP:0002766 situs inversus,37
MP:0004133 heterotaxia,68
MP:0004131 abnormal motile primary cilium morphology,15
MP:0012093 absent nodal flow,7
MP:0000743 muscle spasm,31
MP:0001961 abnormal reflex,40
MP:0005296 abnormal humerus morphology,42
MP:0003047 abnormal thoracic vertebrae morphology,50
MP:0004353 abnormal deltoid tuberosity morphology,12
MP:0004617 sacral vertebral transformation,22
MP:0004618 thoracic vertebral transformation,51
MP:0004678 split xiphoid process,18
MP:0012284 increased sternebra number,7
MP:0001431 abnormal eating behavior,62
MP:0000746 weakness,94
MP:0001306 small lens,48
MP:0005301 abnormal corneal endothelium morphology,10
MP:0011962 increased cornea thickness,9
MP:0000255 vasculature congestion,17
MP:0000937 abnormal motor neuron morphology,57
MP:0001056 abnormal cranial nerve morphology,26
MP:0001096 abnormal glossopharyngeal ganglion morphology,16
MP:0001100 abnormal vagus ganglion morphology,12
MP:0000846 abnormal medulla oblongata morphology,17
MP:0003661 abnormal locus ceruleus morphology,7
MP:0003964 abnormal noradrenaline level,15
MP:0000433 microcephaly,81
MP:0000477 abnormal intestine morphology,88
MP:0000470 abnormal stomach morphology,38
MP:0001258 decreased body length,412
MP:0001890 anencephaly,22
MP:0000034 abnormal inner ear vestibule morphology,30
MP:0001328 disorganized retinal layers,21
MP:0002622 abnormal cochlear hair cell morphology,37
MP:0005220 abnormal exocrine pancreas morphology,14
MP:0002929 abnormal bile duct development,13
MP:0006089 abnormal vestibular saccule morphology,25
MP:0006090 abnormal utricle morphology,19
MP:0003934 abnormal pancreas development,14
MP:0004395 increased cochlear inner hair cell number,15
MP:0004401 increased cochlear outer hair cell number,18
MP:0006292 abnormal nasal placode morphology,8
MP:0009493 abnormal cystic duct morphology,8
MP:0012686 everted embryonic neuroepithelium,5
MP:0002882 abnormal neuron morphology,105
MP:0005547 abnormal Muller cell morphology,17
MP:0001004 abnormal retinal photoreceptor morphology,40
MP:0005253 abnormal eye physiology,65
MP:0003731 abnormal retinal outer nuclear layer morphology,42
MP:0003729 abnormal photoreceptor outer segment morphology,48
MP:0004022 abnormal cone electrophysiology,93
MP:0004021 abnormal rod electrophysiology,102
MP:0005559 increased circulating glucose level,161
MP:0003655 absent pancreas,5
MP:0003327 liver cysts,13
MP:0003675 kidney cysts,103
MP:0000552 abnormal radius morphology,22
MP:0005108 abnormal ulna morphology,26
MP:0004174 abnormal spine curvature,59
MP:0010403 atrial septal defect,56
MP:0010585 abnormal conotruncal ridge morphology,7
MP:0005192 increased motor neuron number,11
MP:0004981 decreased neuronal precursor cell number,31
MP:0008947 increased neuron number,17
MP:0000162 lordosis,36
MP:0001539 decreased caudal vertebrae number,63
MP:0000963 fused dorsal root ganglion,16
MP:0005222 abnormal somite size,8
MP:0006029 abnormal sclerotome morphology,16
MP:0004609 vertebral fusion,57
MP:0008530 abnormal rostral-caudal patterning of the somites,9
MP:0010152 abnormal brain ependyma morphology,9
MP:0012182 abnormal presomitic mesoderm morphology,5
MP:0012728 abnormal somite border morphology,6
MP:0002163 abnormal gland morphology,11
MP:0002164 abnormal gland physiology,7
MP:0001752 abnormal hypothalamus secretion,11
MP:0001746 abnormal pituitary secretion,11
MP:0000221 decreased leukocyte cell number,186
MP:0000222 decreased neutrophil cell number,136
MP:0005016 decreased lymphocyte cell number,159
MP:0002783 abnormal ovarian secretion,7
MP:0002782 abnormal testes secretion,11
MP:0005361 small pituitary gland,12
MP:0003663 abnormal thermosensation,8
MP:0006399 abnormal long bone epiphyseal ossification zone morphology,7
MP:0008321 small adenohypophysis,11
MP:0008329 decreased somatotroph cell number,13
MP:0008332 decreased lactotroph cell number,10
"MP:0011084 lethality at weaning, incomplete penetrance",45
MP:0000036 absent semicircular canals,15
MP:0005191 head tilt,53
MP:0003938 abnormal ear development,17
MP:0004249 abnormal crista ampullaris morphology,25
MP:0002950 abnormal neural crest cell migration,21
MP:0000613 abnormal salivary gland morphology,25
MP:0000440 domed cranium,94
MP:0000629 absent mammary gland,7
MP:0001181 absent lungs,11
MP:0001244 thin dermal layer,19
MP:0001231 abnormal epidermis stratum basale morphology,33
MP:0001218 thin epidermis,29
MP:0001199 thin skin,35
MP:0001201 translucent skin,15
MP:0001341 absent eyelids,10
MP:0002428 abnormal semicircular canal morphology,41
MP:0000492 abnormal rectum morphology,14
MP:0000557 absent hindlimb,6
MP:0005298 abnormal clavicle morphology,26
MP:0003051 curly tail,82
MP:0003124 hypospadia,8
MP:0006011 abnormal endolymphatic duct morphology,14
MP:0003315 abnormal perineum morphology,9
MP:0003703 abnormal vestibulocochlear ganglion morphology,16
MP:0003816 abnormal pituitary gland development,12
MP:0004310 small otic vesicle,14
MP:0004343 small scapula,10
MP:0006288 small otic capsule,5
MP:0004507 abnormal ischium morphology,9
MP:0004619 caudal vertebral fusion,18
MP:0008320 absent adenohypophysis,6
MP:0013785 abnormal mammary gland bud morphology,5
MP:0000015 abnormal ear pigmentation,8
MP:0002075 abnormal coat/hair pigmentation,189
MP:0001921 reduced fertility,165
MP:0000042 abnormal organ of Corti morphology,46
MP:0000048 abnormal stria vascularis morphology,31
MP:0002857 cochlear ganglion degeneration,64
MP:0002894 abnormal otolith morphology,17
MP:0003149 abnormal tectorial membrane morphology,27
MP:0003143 enlarged otoliths,9
MP:0004324 vestibular hair cell degeneration,14
MP:0004364 thin stria vascularis,8
MP:0004368 abnormal stria vascularis vasculature morphology,9
MP:0004399 abnormal cochlear outer hair cell morphology,27
MP:0002135 abnormal kidney morphology,274
MP:0001175 abnormal lung morphology,148
MP:0000138 absent vertebrae,6
MP:0000939 decreased motor neuron number,52
MP:0000956 decreased spinal cord size,11
MP:0000787 abnormal telencephalon morphology,39
MP:0005163 cyclopia,17
MP:0005430 absent fibula,8
MP:0001704 abnormal dorsal-ventral axis patterning,21
MP:0004201 fetal growth retardation,102
MP:0004268 abnormal optic stalk morphology,30
MP:0006306 abnormal nasal pit morphology,7
MP:0012089 decreased midbrain size,17
MP:0012517 absent diencephalon,5
MP:0009903 abnormal medial nasal prominence morphology,8
MP:0000889 abnormal cerebellar molecular layer,37
MP:0003667 increased hemangiosarcoma incidence,24
MP:0006283 increased medulloblastoma incidence,5
MP:0010279 increased gastrointestinal tumor incidence,18
MP:0002231 abnormal primitive streak morphology,30
MP:0004714 truncated notochord,6
MP:0004837 abnormal neural fold formation,20
MP:0008533 abnormal anterior visceral endoderm morphology,13
MP:0010807 abnormal stomach position or orientation,13
"MP:0011102 embryonic lethality, incomplete penetrance",62
MP:0012081 absent heart tube,7
MP:0012176 abnormal head development,10
MP:0001790 abnormal immune system physiology,134
MP:0003085 abnormal egg cylinder morphology,29
MP:0009687 empty decidua capsularis,14
MP:0002007 increased cellular sensitivity to gamma-irradiation,49
"MP:0011095 embryonic lethality between implantation and placentation, complete penetrance",63
MP:0001714 absent trophoblast giant cells,10
MP:0002582 disorganized extraembryonic tissue,22
MP:0003890 abnormal embryonic-extraembryonic boundary morphology,19
MP:0011186 abnormal visceral endoderm morphology,47
MP:0011187 abnormal parietal endoderm morphology,9
MP:0001694 absent egg cylinders,20
MP:0000737 abnormal myotome development,13
MP:0001786 skin edema,48
MP:0001787 pericardial edema,77
MP:0001690 failure of somite differentiation,11
MP:0008856 fetal bleb,5
MP:0002081 perinatal lethality,55
MP:0002940 variable body spotting,28
MP:0008797 facial cleft,26
MP:0000522 kidney cortex cysts,35
MP:0011307 kidney medulla cysts,13
MP:0003336 pancreas cysts,11
MP:0010412 atrioventricular septal defect,105
MP:0012172 abnormal amniotic fluid composition,7
MP:0002206 abnormal CNS synaptic transmission,103
MP:0001473 reduced long term potentiation,124
MP:0002911 abnormal inhibitory postsynaptic potential,8
MP:0002945 abnormal inhibitory postsynaptic currents,66
MP:0001393 ataxia,275
MP:0001405 impaired coordination,405
MP:0000876 Purkinje cell degeneration,69
MP:0000747 muscle weakness,69
MP:0001954 respiratory distress,194
MP:0001053 abnormal neuromuscular synapse morphology,82
MP:0001055 failure of neuromuscular synapse postsynaptic differentiation,5
MP:0001388 abnormal stationary movement,25
MP:0001525 impaired balance,134
MP:0002407 abnormal double-negative T cell morphology,25
MP:0002183 gliosis,74
MP:0000890 thin cerebellar molecular layer,25
MP:0005424 jerky movement,26
MP:0004956 decreased thymus weight,34
"MP:0011110 preweaning lethality, incomplete penetrance",669
MP:0002066 abnormal motor capabilities/coordination/movement,164
MP:0001513 limb grasping,258
MP:0001402 hypoactivity,514
MP:0000857 abnormal cerebellar foliation,37
MP:0000877 abnormal Purkinje cell morphology,83
MP:0000819 abnormal olfactory bulb morphology,60
MP:0000886 abnormal cerebellar granule layer morphology,41
MP:0000852 small cerebellum,84
MP:0002741 small olfactory bulb,40
MP:0002804 abnormal motor learning,52
MP:0003633 abnormal nervous system physiology,123
MP:0003953 abnormal hormone level,28
MP:0004263 abnormal limb posture,29
MP:0008924 decreased cerebellar granule cell number,11
MP:0009946 abnormal olfactory bulb layer morphology,7
MP:0009948 abnormal olfactory bulb glomerular layer morphology,9
MP:0009949 abnormal olfactory bulb granule cell layer morphology,5
MP:0009951 abnormal olfactory bulb mitral cell layer morphology,8
MP:0009956 abnormal cerebellar layer morphology,11
MP:0010053 decreased grip strength,373
MP:0012490 abnormal cochlear VIII nucleus morphology,9
MP:0000424 retarded hair growth,12
MP:0000416 sparse hair,114
MP:0000875 abnormal cerebellar Purkinje cell layer,33
MP:0002910 abnormal excitatory postsynaptic currents,83
MP:0006099 thin cerebellar granule layer,13
MP:0008572 abnormal Purkinje cell dendrite morphology,56
MP:0000370 head blaze,9
MP:0005172 decreased eye pigmentation,26
MP:0009643 abnormal urine homeostasis,97
MP:0002136 abnormal kidney physiology,54
MP:0005421 loose skin,17
MP:0002082 postnatal lethality,206
MP:0002106 abnormal muscle physiology,98
MP:0002269 muscular atrophy,47
MP:0000755 hindlimb paralysis,75
MP:0000748 progressive muscle weakness,32
MP:0000921 demyelination,77
MP:0005402 abnormal action potential,83
MP:0005403 abnormal nerve conduction,30
MP:0002914 abnormal endplate potential,16
MP:0004142 abnormal muscle tone,14
MP:0004835 abnormal miniature endplate potential,25
MP:0009434 paraparesis,33
MP:0001410 head bobbing,80
MP:0003492 abnormal involuntary movement,19
MP:0005176 eyelids fail to open,24
MP:0005229 abnormal intervertebral disk development,11
MP:0005637 abnormal iron homeostasis,28
MP:0008388 hypochromic microcytic anemia,16
MP:0002102 abnormal ear morphology,28
MP:0001967 deafness,129
MP:0006024 collapsed Reissner membrane,8
MP:0004300 abnormal organ of Corti supporting cell morphology,7
MP:0004405 absent cochlear hair cells,12
MP:0011967 increased or absent threshold for auditory brainstem response,354
MP:0001516 abnormal motor coordination/balance,110
MP:0004301 absent organ of Corti supporting cells,5
MP:0006359 absent startle reflex,74
MP:0000623 decreased salivation,14
MP:0001411 spinning,10
MP:0000495 abnormal colon morphology,66
MP:0002843 decreased systemic arterial blood pressure,35
MP:0003151 absent tunnel of Corti,8
MP:0003169 abnormal scala media morphology,12
MP:0003878 abnormal ear physiology,11
MP:0004366 abnormal strial marginal cell morphology,7
MP:0004396 decreased cochlear inner hair cell number,10
MP:0004402 decreased cochlear outer hair cell number,25
MP:0004738 abnormal auditory brainstem response,44
MP:0006358 absent pinna reflex,77
MP:0000639 abnormal adrenal gland morphology,30
MP:0001547 abnormal lipid level,93
MP:0001556 increased circulating HDL cholesterol level,148
MP:0002446 abnormal macrophage morphology,31
MP:0005178 increased circulating cholesterol level,225
MP:0005278 abnormal cholesterol homeostasis,42
MP:0001337 dry eyes,9
MP:0002118 abnormal lipid homeostasis,141
MP:0005287 narrow eye opening,34
MP:0000184 abnormal circulating HDL cholesterol level,6
MP:0003947 abnormal cholesterol level,8
MP:0000180 abnormal circulating cholesterol level,29
MP:0001125 abnormal oocyte morphology,39
MP:0000248 macrocytosis,17
MP:0002643 poikilocytosis,31
MP:0002909 abnormal adrenal gland physiology,8
MP:0003406 failure of zygotic cell division,15
MP:0000065 abnormal bone marrow cavity morphology,23
MP:0002397 abnormal bone marrow morphology,39
MP:0001846 increased inflammatory response,105
MP:0000067 osteopetrosis,34
MP:0000119 abnormal tooth eruption,5
MP:0000135 decreased compact bone thickness,76
MP:0000125 absent incisors,14
MP:0000121 failure of tooth eruption,19
MP:0003419 delayed endochondral bone ossification,50
MP:0003795 abnormal bone structure,323
MP:0004214 abnormal long bone diaphysis morphology,21
MP:0004993 decreased bone resorption,31
MP:0006398 increased long bone epiphyseal plate size,25
MP:0010867 abnormal bone trabecula morphology,28
MP:0010872 increased trabecular bone mass,20
MP:0030069 broad face,7
MP:0001696 failure to gastrulate,52
MP:0012113 decreased inner cell mass proliferation,26
MP:0001510 abnormal coat appearance,131
MP:0003849 greasy coat,26
MP:0009659 striated fur,12
MP:0000566 synostosis,10
MP:0001963 abnormal hearing physiology,24
MP:0000063 decreased bone mineral density,389
MP:0008150 decreased diameter of long bones,5
MP:0000239 absent common myeloid progenitor cells,15
MP:0003396 abnormal embryonic hematopoiesis,32
MP:0001723 disorganized yolk sac vascular plexus,22
MP:0002725 abnormal vein morphology,20
MP:0009328 delayed heart looping,9
MP:0001438 aphagia,30
MP:0000759 abnormal skeletal muscle morphology,81
MP:0002280 abnormal intercostal muscle morphology,13
MP:0000024 lowered ear position,30
MP:0000080 abnormal exoccipital bone morphology,7
MP:0003257 abnormal abdominal wall morphology,10
MP:0008029 abnormal paraxial mesoderm morphology,20
MP:0009461 skeletal muscle hypertrophy,9
MP:0000527 abnormal kidney development,66
MP:0003446 renal hypoplasia,49
MP:0004936 impaired branching involved in ureteric bud morphogenesis,41
MP:0009323 abnormal spleen development,5
MP:0011363 renal glomerulus atrophy,8
MP:0001116 small gonad,23
MP:0000530 abnormal kidney blood vessel morphology,17
MP:0005325 abnormal renal glomerulus morphology,118
MP:0005326 abnormal podocyte morphology,32
MP:0003014 abnormal kidney medulla morphology,14
MP:0006032 abnormal ureteric bud morphology,19
MP:0004007 abnormal lung vasculature morphology,49
MP:0004505 decreased renal glomerulus number,31
MP:0004756 abnormal proximal convoluted tubule morphology,51
MP:0006382 abnormal lung epithelium morphology,20
MP:0008059 abnormal podocyte foot process morphology,14
MP:0010856 dilated respiratory conducting tubes,17
MP:0010902 abnormal pulmonary alveolar sac morphology,13
MP:0010911 abnormal pulmonary acinus morphology,8
MP:0010976 small lung lobe,7
MP:0010981 abnormal branching involved in ureteric bud morphogenesis,7
MP:0010985 abnormal kidney mesenchyme morphology,7
MP:0011028 impaired branching involved in bronchus morphogenesis,7
MP:0011290 decreased nephron number,18
MP:0011320 abnormal glomerular capillary morphology,28
MP:0011760 abnormal ureteric bud tip morphology,6
MP:0005092 decreased double-positive T cell number,107
MP:0008083 decreased single-positive T cell number,56
MP:0000681 abnormal thyroid gland morphology,30
MP:0001263 weight loss,197
MP:0000133 abnormal long bone metaphysis morphology,39
MP:0000064 failure of bone resorption,5
MP:0000165 abnormal long bone hypertrophic chondrocyte zone,53
MP:0000240 extramedullary hematopoiesis,117
MP:0002727 decreased circulating insulin level,301
MP:0003053 delayed tooth eruption,9
MP:0003059 decreased insulin secretion,95
MP:0004982 abnormal osteoclast morphology,50
MP:0008254 increased megakaryocyte cell number,43
MP:0030543 abnormal predentin morphology,5
MP:0000547 short limbs,101
MP:0000195 decreased circulating calcium level,80
MP:0000062 increased bone mineral density,166
MP:0001541 abnormal osteoclast physiology,67
MP:0002896 abnormal bone mineralization,124
MP:0003116 rickets,9
MP:0030610 absent teeth,10
MP:0001322 abnormal iris morphology,52
MP:0001320 small pupils,7
MP:0010263 total cataracts,17
MP:0001544 abnormal cardiovascular system physiology,146
MP:0001930 abnormal meiosis,24
MP:0000414 alopecia,129
MP:0000260 abnormal angiogenesis,77
MP:0002053 decreased incidence of induced tumors,12
MP:0002625 heart left ventricle hypertrophy,97
MP:0005093 decreased B cell proliferation,82
MP:0005095 decreased T cell proliferation,158
MP:0005168 abnormal female meiosis,65
MP:0005169 abnormal male meiosis,72
MP:0002795 dilated cardiomyopathy,55
MP:0001625 cardiac hypertrophy,121
MP:0002834 decreased heart weight,86
MP:0002972 abnormal cardiac muscle contractility,26
MP:0003205 testicular atrophy,55
MP:0003222 increased cardiomyocyte apoptosis,36
MP:0003567 abnormal fetal cardiomyocyte proliferation,28
MP:0003702 abnormal chromosome morphology,38
MP:0003786 premature aging,32
MP:0003824 decreased left ventricle developed pressure,6
MP:0003819 increased left ventricle diastolic pressure,13
MP:0003916 decreased heart left ventricle weight,9
MP:0004084 abnormal cardiac muscle relaxation,25
MP:0004502 decreased incidence of tumors by chemical induction,72
MP:0004567 decreased myocardial fiber number,15
MP:0006379 abnormal spermatocyte morphology,61
MP:0008280 abnormal male germ cell apoptosis,125
MP:0008470 abnormal spleen B cell follicle morphology,51
MP:0008482 decreased spleen germinal center number,25
MP:0008782 increased B cell apoptosis,27
MP:0001274 curly vibrissae,53
MP:0000383 abnormal hair follicle orientation,17
MP:0000396 increased curvature of hairs,5
MP:0000410 waved hair,48
MP:0001313 increased incidence of corneal inflammation,19
MP:0001302 eyelids open at birth,67
MP:0000013 abnormal adipose tissue distribution,13
MP:0000377 abnormal hair follicle morphology,77
MP:0001278 kinked vibrissae,10
MP:0001316 corneal scarring,7
MP:0001511 disheveled coat,57
MP:0003671 abnormal eyelid aperture,9
MP:0003809 abnormal hair shaft morphology,58
MP:0003812 abnormal hair medulla,14
MP:0008841 ruptured lens capsule,15
MP:0008852 retinal neovascularization,15
MP:0009651 abnormal eyelid development,7
MP:0000367 abnormal coat/ hair morphology,81
MP:0002074 abnormal hair texture,32
MP:0001279 wavy vibrissae,16
MP:0000402 abnormal zigzag hair morphology,20
MP:0001314 corneal opacity,105
MP:0001852 conjunctivitis,26
MP:0003704 abnormal hair follicle development,39
MP:0009264 failure of eyelid fusion,19
MP:0009742 increased corneal stroma thickness,5
MP:0001652 colonic necrosis,5
MP:0001869 pancreas inflammation,25
MP:0001870 salivary gland inflammation,32
MP:0001855 abnormal atrial thrombosis,10
MP:0001856 myocarditis,14
MP:0001862 interstitial pneumonia,13
MP:0005150 cachexia,118
MP:0003865 lymph node inflammation,10
MP:0008118 absent Langerhans cell,7
MP:0001526 abnormal placing response,14
MP:0004362 cochlear hair cell degeneration,50
MP:0004398 cochlear inner hair cell degeneration,54
MP:0004404 cochlear outer hair cell degeneration,79
MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology,28
MP:0004589 abnormal cochlear hair cell development,9
MP:0010323 retropulsion,13
MP:0000037 abnormal lateral semicircular canal morphology,16
MP:0002858 abnormal posterior semicircular canal morphology,13
MP:0001770 abnormal iron level,19
MP:0002591 decreased mean corpuscular volume,157
MP:0002813 microcytosis,24
MP:0005562 decreased mean corpuscular hemoglobin,119
MP:0003131 increased erythrocyte cell number,82
MP:0008743 decreased liver iron level,9
MP:0008808 decreased spleen iron level,16
MP:0008973 decreased erythroid progenitor cell number,49
MP:0002024 increased T cell derived lymphoma incidence,56
MP:0003204 decreased neuron apoptosis,37
MP:0008411 decreased cellular sensitivity to ultraviolet irradiation,12
MP:0008943 increased sensitivity to induced cell death,42
MP:0002947 increased hemangioma incidence,13
MP:0003299 gastric polyps,6
MP:0003269 colon polyps,9
MP:0004024 aneuploidy,46
MP:0004207 increased squamous cell carcinoma incidence,28
MP:0010363 increased fibrosarcoma incidence,12
MP:0001883 increased mammary adenocarcinoma incidence,21
MP:0002026 increased leukemia incidence,31
MP:0002027 increased lung adenocarcinoma incidence,53
MP:0003448 abnormal tumor morphology,22
MP:0008011 intestine polyps,10
MP:0009153 increased pancreas tumor incidence,8
MP:0009308 increased adenocarcinoma incidence,11
MP:0009321 increased histiocytic sarcoma incidence,23
MP:0010383 increased adenoma incidence,24
MP:0001347 absent lacrimal glands,6
MP:0001119 abnormal female reproductive system morphology,43
MP:0001284 absent vibrissae,44
MP:0000468 abnormal esophageal epithelium morphology,9
MP:0000549 absent limbs,6
MP:0000550 abnormal forelimb morphology,56
MP:0001159 absent prostate gland,6
MP:0000553 absent radius,9
MP:0000378 absent hair follicles,8
MP:0000540 abnormal urinary bladder urothelium morphology,9
MP:0001140 abnormal vagina epithelium morphology,9
MP:0003578 absent ovary,13
MP:0004575 small limb buds,5
MP:0009655 abnormal secondary palate development,17
MP:0001867 rhinitis,10
MP:0002499 chronic inflammation,31
MP:0001380 reduced male mating frequency,16
MP:0000465 gastrointestinal hemorrhage,31
MP:0002412 increased susceptibility to bacterial infection,236
MP:0001850 increased susceptibility to otitis media,33
MP:0001872 sinus inflammation,6
MP:0001893 non-obstructive hydrocephaly,7
MP:0001917 intraventricular hemorrhage,19
MP:0000807 abnormal hippocampus morphology,92
MP:0000825 dilated lateral ventricles,59
MP:0000812 abnormal dentate gyrus morphology,65
MP:0000808 abnormal hippocampus development,20
MP:0002761 abnormal hippocampal mossy fiber morphology,28
MP:0008143 abnormal dendrite morphology,76
MP:0008267 abnormal hippocampus CA3 region morphology,20
MP:0009485 distended ileum,7
MP:0009939 abnormal hippocampus neuron morphology,14
MP:0002047 increased hepatic hemangioma incidence,5
MP:0002048 increased lung adenoma incidence,33
MP:0010384 increased renal carcinoma incidence,7
MP:0000275 heart hyperplasia,11
MP:0005294 abnormal heart ventricle morphology,84
MP:0001261 obese,104
MP:0002079 increased circulating insulin level,180
MP:0001326 retinal degeneration,111
MP:0001552 increased circulating triglyceride level,178
MP:0000043 organ of Corti degeneration,54
MP:0001327 decreased retinal photoreceptor cell number,30
MP:0002792 abnormal retinal vasculature morphology,115
MP:0003730 abnormal photoreceptor inner segment morphology,24
MP:0004465 degeneration of organ of Corti supporting cells,12
MP:0006325 impaired hearing,140
MP:0008450 retinal photoreceptor degeneration,67
MP:0008518 retinal outer nuclear layer degeneration,35
MP:0008584 photoreceptor outer segment degeneration,22
MP:0011939 increased food intake,94
MP:0012029 abnormal electroretinogram waveform feature,23
MP:0005455 increased susceptibility to weight gain,39
MP:0003212 increased susceptibility to age related obesity,25
MP:0008515 thin retinal outer nuclear layer,93
MP:0030005 increased retinal apoptosis,29
MP:0003084 abnormal skeletal muscle fiber morphology,76
MP:0003225 axonal dystrophy,20
MP:0000161 scoliosis,42
MP:0004734 small thoracic cavity,12
MP:0000962 disorganized dorsal root ganglion,7
MP:0004612 fusion of vertebral bodies,13
MP:0005140 decreased cardiac muscle contractility,123
MP:0003566 abnormal cell adhesion,55
MP:0013166 small forelimb buds,5
MP:0001929 abnormal gametogenesis,51
MP:0002161 abnormal fertility/fecundity,79
MP:0000130 abnormal trabecular bone morphology,132
MP:0002115 abnormal limb bone morphology,38
MP:0001145 abnormal male reproductive system morphology,44
MP:0001283 sparse vibrissae,8
MP:0001156 abnormal spermatogenesis,223
MP:0001247 dermal cysts,9
MP:0001239 abnormal epidermis stratum granulosum morphology,39
MP:0001194 dermatitis,66
MP:0000198 decreased circulating phosphate level,77
MP:0001132 absent mature ovarian follicles,31
MP:0001121 uterus hypoplasia,14
MP:0001750 increased circulating follicle stimulating hormone level,33
MP:0001751 increased circulating luteinizing hormone level,30
MP:0002675 asthenozoospermia,184
MP:0002968 increased circulating alkaline phosphatase level,248
MP:0003941 abnormal skin development,10
MP:0004804 decreased susceptibility to autoimmune diabetes,40
MP:0004842 abnormal large intestine crypts of Lieberkuhn morphology,32
MP:0004851 increased testis weight,21
MP:0004988 increased osteoblast cell number,36
MP:0009257 dilated seminiferous tubules,6
MP:0009335 decreased splenocyte proliferation,18
MP:0009642 abnormal blood homeostasis,120
MP:0010760 abnormal macrophage chemotaxis,18
MP:0011228 abnormal vitamin D level,14
MP:0012175 flat face,8
MP:0012701 increased embryonic neuroepithelium apoptosis,18
MP:0002628 hepatic steatosis,206
MP:0011697 vacuolated lens,24
MP:0030930 decreased digit pigmentation,17
MP:0000565 oligodactyly,47
MP:0002765 short fibula,22
MP:0000461 decreased presacral vertebrae number,6
MP:0003826 abnormal Mullerian duct morphology,34
MP:0001120 abnormal uterus morphology,56
MP:0002637 small uterus,29
MP:0003572 abnormal uterus development,14
MP:0004360 absent ulna,7
MP:0008257 thin myometrium,10
MP:0009081 thin uterus,9
MP:0009097 absent endometrial glands,6
MP:0000788 abnormal cerebral cortex morphology,161
MP:0002064 seizures,127
MP:0002068 abnormal parental behavior,9
MP:0001152 Leydig cell hyperplasia,43
MP:0001932 abnormal spermiogenesis,79
MP:0001154 seminiferous tubule degeneration,84
MP:0001153 small seminiferous tubules,83
MP:0005159 azoospermia,190
MP:0005250 Sertoli cell hypoplasia,8
MP:0006380 abnormal spermatid morphology,129
MP:0010254 nuclear cataracts,23
MP:0001533 abnormal skeleton physiology,39
MP:0000061 fragile skeleton,25
MP:0000167 decreased chondrocyte number,14
MP:0000692 small spleen,113
MP:0000706 small thymus,106
MP:0005238 increased brain size,23
MP:0000208 decreased hematocrit,179
MP:0002966 decreased circulating alkaline phosphatase level,85
MP:0003068 enlarged kidney,76
MP:0004701 decreased circulating insulin-like growth factor I level,51
MP:0008396 abnormal osteoclast differentiation,78
MP:0008489 slow postnatal weight gain,168
MP:0005202 lethargy,96
MP:0005311 abnormal circulating amino acid level,43
MP:0005309 increased circulating ammonia level,14
MP:0008587 short photoreceptor outer segment,43
MP:0002100 abnormal tooth morphology,71
MP:0003885 abnormal rostral-caudal body axis extension,16
MP:0004573 absent limb buds,6
"MP:0011106 embryonic lethality between implantation and somite formation, incomplete penetrance",24
MP:0011205 excessive folding of visceral yolk sac,15
MP:0011208 small proamniotic cavity,5
MP:0000166 abnormal chondrocyte morphology,41
MP:0003662 abnormal long bone epiphyseal plate proliferative zone,62
MP:0004397 absent cochlear inner hair cells,6
MP:0004403 absent cochlear outer hair cells,10
MP:0006395 abnormal epiphyseal plate morphology,29
MP:0008151 increased diameter of long bones,21
MP:0008272 abnormal endochondral bone ossification,25
MP:0008736 micromelia,6
MP:0006429 abnormal hyaline cartilage morphology,7
MP:0006432 abnormal costal cartilage morphology,7
MP:0009908 protruding tongue,15
MP:0011966 abnormal auditory brainstem response waveform shape,38
MP:0008567 decreased interferon-gamma secretion,143
MP:0008688 decreased interleukin-2 secretion,56
MP:0008700 decreased interleukin-4 secretion,68
MP:0000689 abnormal spleen morphology,251
MP:0002406 increased susceptibility to infection,23
MP:0000322 increased granulocyte number,81
MP:0001806 decreased IgM level,109
MP:0001802 arrested B cell differentiation,47
MP:0001825 arrested T cell differentiation,32
MP:0002435 abnormal effector T cell morphology,10
MP:0005425 increased macrophage cell number,72
MP:0003080 increased natural killer cell mediated cytotoxicity,10
"MP:0008075 decreased CD4-positive, alpha beta T cell number",186
"MP:0008079 decreased CD8-positive, alpha-beta T cell number",191
MP:0008101 lymph node hypoplasia,37
MP:0008212 absent mature B cells,13
MP:0008754 abnormal T cell receptor V(D)J recombination,9
MP:0008755 abnormal immunoglobulin V(D)J recombination,7
MP:0000181 abnormal circulating LDL cholesterol level,5
MP:0005145 increased circulating VLDL cholesterol level,20
MP:0005317 increased triglyceride level,32
MP:0005339 increased susceptibility to atherosclerosis,10
MP:0001463 abnormal spatial learning,172
MP:0002207 abnormal long term potentiation,33
MP:0002798 abnormal active avoidance behavior,11
MP:0003313 abnormal locomotor activation,94
MP:0003354 astrocytosis,86
MP:0008817 hematoma,19
MP:0020408 altered susceptibility to induced thrombosis,5
MP:0003216 absence seizures,17
MP:0003312 abnormal locomotor coordination,39
MP:0001282 short vibrissae,22
MP:0002833 increased heart weight,181
MP:0002953 thick ventricular wall,57
MP:0004067 abnormal trabecula carnea morphology,16
MP:0004564 enlarged myocardial fiber,41
MP:0010594 thick aortic valve,13
MP:0010897 abnormal bronchiole epithelium morphology,8
MP:0001845 abnormal inflammatory response,77
MP:0002279 abnormal diaphragm morphology,40
MP:0001847 brain inflammation,22
MP:0001851 eye inflammation,21
MP:0001853 heart inflammation,30
MP:0001860 liver inflammation,129
MP:0001873 stomach inflammation,29
MP:0000218 increased leukocyte cell number,186
MP:0000702 enlarged lymph nodes,164
MP:0001655 multifocal hepatic necrosis,10
MP:0001861 lung inflammation,144
MP:0002391 abnormal Peyer's patch germinal center morphology,19
MP:0006085 myocardium necrosis,21
MP:0003282 gastric ulcer,5
MP:0004510 myositis,21
MP:0004947 skin inflammation,43
MP:0008133 decreased Peyer's patch number,24
MP:0008880 lacrimal gland inflammation,17
"MP:0011083 lethality at weaning, complete penetrance",50
MP:0005553 increased circulating creatinine level,110
MP:0004041 increased susceptibility to kidney reperfusion injury,6
MP:0004154 renal tubular necrosis,18
MP:0008872 abnormal physiological response to xenobiotic,71
MP:0005338 atherosclerotic lesions,7
MP:0001429 dehydration,78
MP:0002988 decreased urine osmolality,52
MP:0006317 decreased urine sodium level,29
MP:0008997 increased blood osmolality,14
MP:0001426 polydipsia,36
MP:0001762 polyuria,82
MP:0002644 decreased circulating triglyceride level,226
MP:0001906 increased dopamine level,35
MP:0005551 abnormal eye electrophysiology,138
MP:0008874 decreased physiological sensitivity to xenobiotic,152
MP:0009758 impaired behavioral response to cocaine,16
MP:0005310 abnormal salivary gland physiology,6
MP:0001759 increased urine glucose level,27
MP:0002679 abnormal corpus luteum morphology,15
MP:0005215 abnormal pancreatic islet morphology,53
MP:0003356 impaired luteinization,11
MP:0002078 abnormal glucose homeostasis,191
MP:0002421 abnormal cell-mediated immunity,19
MP:0001800 abnormal humoral immune response,117
MP:0002419 abnormal innate immunity,25
MP:0000321 increased bone marrow cell number,44
MP:0001212 skin lesions,76
MP:0000189 hypoglycemia,103
MP:0001553 abnormal circulating free fatty acids level,8
MP:0002343 abnormal lymph node cortex morphology,6
MP:0000691 enlarged spleen,338
MP:0002356 abnormal spleen red pulp morphology,37
MP:0002357 abnormal spleen white pulp morphology,44
MP:0001745 increased circulating corticosterone level,50
MP:0002451 abnormal macrophage physiology,199
MP:0002344 abnormal lymph node B cell domain morphology,15
MP:0002347 abnormal lymph node T cell domain morphology,6
MP:0002493 increased IgG level,75
MP:0002439 abnormal plasma cell morphology,9
MP:0002715 decreased glycogen catabolism rate,8
MP:0002702 decreased circulating free fatty acid level,98
MP:0002743 glomerulonephritis,89
MP:0002742 enlarged submandibular lymph nodes,5
MP:0005319 abnormal enzyme/coenzyme level,58
MP:0005399 increased susceptibility to fungal infection,24
MP:0005459 decreased percent body fat/body weight,80
MP:0005465 abnormal T-helper 1 physiology,48
MP:0005466 abnormal T-helper 2 physiology,59
MP:0002891 increased insulin sensitivity,155
MP:0005616 decreased susceptibility to type IV hypersensitivity reaction,58
MP:0005639 hemosiderosis,11
MP:0005666 abnormal adipose tissue physiology,20
MP:0005668 decreased circulating leptin level,105
MP:0003383 abnormal gluconeogenesis,48
MP:0008033 impaired lipolysis,13
MP:0008466 enlarged mesenteric lymph nodes,18
MP:0008596 increased circulating interleukin-6 level,78
MP:0008618 decreased circulating interleukin-12 level,11
MP:0009283 decreased gonadal fat pad weight,38
MP:0009623 enlarged inguinal lymph nodes,8
MP:0009631 enlarged axillary lymph nodes,5
MP:0011294 renal glomerulus hypertrophy,21
MP:0011353 expanded mesangial matrix,38
MP:0011427 mesangial cell hyperplasia,25
MP:0030021 increased muscle cell glucose uptake,22
MP:0002712 increased circulating glucagon level,19
MP:0005292 improved glucose tolerance,241
MP:0003058 increased insulin secretion,41
MP:0001048 absent enteric neurons,9
MP:0002926 aganglionic megacolon,6
MP:0005087 decreased acute inflammation,25
MP:0005100 abnormal choroid pigmentation,12
MP:0002938 white spotting,29
MP:0003270 intestinal obstruction,14
MP:0004381 abnormal hair follicle melanocyte morphology,9
MP:0010016 variable depigmentation,9
MP:0000172 abnormal bone marrow cell number,18
MP:0000599 enlarged liver,107
MP:0002401 abnormal lymphopoiesis,46
MP:0001354 increased aggression towards males,18
MP:0001167 prostate gland epithelial hyperplasia,7
MP:0001129 impaired ovarian folliculogenesis,42
MP:0000693 spleen hyperplasia,81
MP:0002458 abnormal B cell number,31
MP:0000220 increased monocyte cell number,129
MP:0000219 increased neutrophil cell number,178
MP:0002182 abnormal astrocyte morphology,47
MP:0000836 abnormal substantia nigra morphology,7
MP:0000859 abnormal somatosensory cortex morphology,13
MP:0002680 decreased corpora lutea number,26
MP:0002842 increased systemic arterial blood pressure,67
MP:0005460 abnormal leukopoiesis,11
MP:0005481 increased chronic myelocytic leukemia incidence,7
MP:0005595 abnormal vascular smooth muscle physiology,38
MP:0005592 abnormal vascular smooth muscle morphology,45
MP:0003025 increased vasoconstriction,21
MP:0003132 increased pre-B cell number,28
MP:0003224 neuron degeneration,52
MP:0003355 decreased ovulation rate,26
MP:0003638 abnormal response/metabolism to endogenous compounds,87
MP:0004145 abnormal muscle electrophysiology,28
MP:0004702 increased circulating insulin-like growth factor I level,9
MP:0004746 abnormal cochlear IHC afferent innervation pattern,10
MP:0008186 increased pro-B cell number,36
MP:0008859 abnormal hair cycle catagen phase,9
MP:0008869 anovulation,19
MP:0008948 decreased neuron number,43
MP:0009372 abnormal cumulus oophorus morphology,5
MP:0009580 increased keratinocyte apoptosis,8
MP:0010967 increased compact bone area,10
MP:0011747 myelofibrosis,9
MP:0005281 increased fatty acid level,36
MP:0005331 insulin resistance,147
MP:0001559 hyperglycemia,110
MP:0005164 abnormal response to injury,42
MP:0005293 impaired glucose tolerance,296
MP:0005449 abnormal food intake,72
MP:0003961 decreased lean body mass,407
MP:0011940 decreased food intake,118
MP:0002893 ketoaciduria,10
MP:0005439 decreased glycogen level,36
MP:0009674 decreased birth weight,121
MP:0005404 abnormal axon morphology,123
MP:0008663 increased interleukin-12 secretion,27
MP:0009788 increased susceptibility to bacterial infection induced morbidity/mortality,78
MP:0009791 increased susceptibility to viral infection induced morbidity/mortality,42
MP:0000511 abnormal intestinal mucosa morphology,45
MP:0005217 abnormal pancreatic beta cell morphology,37
MP:0003339 decreased pancreatic beta cell number,36
MP:0009146 abnormal pancreatic acinar cell morphology,23
MP:0009161 pancreatic acinar cell zymogen granule accumulation,7
MP:0009177 decreased pancreatic alpha cell number,12
MP:0009181 decreased pancreatic delta cell number,6
MP:0010802 abnormal intestinal enteroendocrine cell morphology,6
MP:0001928 abnormal ovulation,31
MP:0001377 abnormal mating frequency,15
MP:0001356 increased aggression towards females,5
MP:0001951 abnormal breathing pattern,37
MP:0002703 abnormal renal tubule morphology,66
MP:0005288 abnormal oxygen consumption,9
MP:0005289 increased oxygen consumption,103
MP:0005575 increased pulmonary ventilation,8
MP:0005573 increased pulmonary respiratory rate,17
MP:0005585 increased tidal volume,9
MP:0005600 increased ventricle muscle contractility,11
MP:0006036 abnormal mitochondrial physiology,81
MP:0003883 enlarged stomach,13
MP:0004220 abnormal peripheral nervous system regeneration,12
MP:0008770 decreased survivor rate,212
MP:0008873 increased physiological sensitivity to xenobiotic,107
MP:0000685 abnormal immune system morphology,49
MP:0002160 abnormal reproductive system morphology,51
MP:0002420 abnormal adaptive immunity,17
MP:0002166 altered tumor susceptibility,13
MP:0001783 decreased white adipose tissue amount,77
MP:0000230 abnormal systemic arterial blood pressure,35
MP:0005348 increased T cell proliferation,109
MP:0005410 abnormal fertilization,16
MP:0002865 increased growth rate,14
MP:0005610 increased circulating antidiuretic hormone level,6
MP:0006308 enlarged seminiferous tubules,5
MP:0008082 increased single-positive T cell number,41
MP:0009763 increased sensitivity to induced morbidity/mortality,198
MP:0001613 abnormal vasodilation,24
MP:0000233 abnormal blood flow velocity,15
MP:0000231 hypertension,51
MP:0002463 abnormal neutrophil physiology,102
MP:0002626 increased heart rate,79
MP:0005333 decreased heart rate,128
MP:0005591 decreased vasodilation,29
MP:0003548 pulmonary hypertension,12
MP:0003628 abnormal leukocyte adhesion,40
MP:0003990 decreased neurotransmitter release,13
MP:0004875 increased mean systemic arterial blood pressure,42
MP:0008235 increased susceptibility to neuronal excitotoxicity,21
MP:0010755 abnormal heart right ventricle pressure,8
MP:0020333 enhanced leukocyte tethering or rolling,9
MP:0005534 decreased body temperature,65
MP:0000484 abnormal pulmonary artery morphology,25
MP:0003071 decreased vascular permeability,14
MP:0003352 increased circulating renin level,19
MP:0001654 hepatic necrosis,49
MP:0002837 dystrophic cardiac calcinosis,13
MP:0002971 abnormal brown adipose tissue morphology,36
MP:0008211 decreased mature B cell number,106
MP:0009399 increased skeletal muscle fiber size,18
MP:0012080 chylous ascites,23
MP:0002459 abnormal B cell physiology,114
MP:0005017 decreased B cell number,248
MP:0005560 decreased circulating glucose level,343
MP:0008208 decreased pro-B cell number,39
MP:0008209 decreased pre-B cell number,62
MP:0030016 increased adipocyte glucose uptake,21
MP:0004560 abnormal chorionic plate morphology,14
MP:0010556 thin ventricle myocardium compact layer,11
MP:0010725 thin interventricular septum,21
MP:0000792 abnormal cortical marginal zone morphology,12
MP:0005623 abnormal meninges morphology,5
MP:0003385 abnormal body wall morphology,23
MP:0003843 abnormal sagittal suture morphology,11
MP:0004950 abnormal brain vasculature morphology,38
MP:0008031 decreased Cajal-Retzius cell number,5
MP:0005590 increased vasodilation,18
MP:0006055 abnormal vascular endothelial cell morphology,44
MP:0003658 abnormal capillary morphology,33
MP:0004703 abnormal vertebral column morphology,56
MP:0020329 decreased capillary density,6
MP:0002229 neurodegeneration,63
MP:0005225 abnormal vertebrae development,32
MP:0002270 abnormal pulmonary alveolus morphology,108
MP:0000936 small embryonic telencephalon,15
MP:0004277 abnormal lateral ganglionic eminence morphology,8
MP:0004321 short sternum,30
MP:0004620 cervical vertebral fusion,36
MP:0004621 lumbar vertebral fusion,11
MP:0004622 sacral vertebral fusion,13
MP:0008441 thin cortical plate,10
MP:0002133 abnormal respiratory system physiology,58
MP:0001182 lung hemorrhage,36
MP:0006050 pulmonary fibrosis,28
MP:0010903 abnormal pulmonary alveolus wall morphology,18
MP:0003829 impaired febrile response,9
MP:0001828 abnormal T cell activation,80
MP:0002753 dilated heart left ventricle,82
MP:0005362 abnormal Langerhans cell physiology,16
MP:0010018 pulmonary vascular congestion,23
MP:0002295 abnormal pulmonary circulation,8
MP:0005630 increased lung weight,24
MP:0003828 pulmonary edema,28
MP:0004038 lymphangiectasis,11
MP:0010019 liver vascular congestion,16
MP:0010909 pulmonary alveolar hemorrhage,14
MP:0000249 abnormal blood vessel physiology,25
MP:0002551 abnormal blood coagulation,71
MP:0005048 abnormal thrombosis,55
MP:0005464 abnormal platelet physiology,58
MP:0008531 increased chemical nociceptive threshold,26
MP:0009815 decreased prostaglandin level,13
MP:0009818 abnormal thromboxane level,6
MP:0000534 abnormal ureter morphology,30
MP:0002705 dilated renal tubules,88
MP:0003290 intestinal hypoperistalsis,12
MP:0003670 dilated renal glomerular capsule,12
MP:0003672 abnormal ureter development,11
MP:0003722 absent ureter,18
MP:0004754 abnormal kidney collecting duct morphology,21
MP:0010982 abnormal ureteric bud elongation,6
MP:0010983 abnormal ureteric bud invasion,9
MP:0011386 increased metanephric mesenchyme apoptosis,14
MP:0000188 abnormal circulating glucose level,30
MP:0003458 decreased circulating ketone body level,13
MP:0001876 decreased inflammatory response,89
MP:0000696 abnormal Peyer's patch morphology,29
MP:0002389 abnormal Peyer's patch follicle morphology,12
MP:0005232 abnormal mesenteric lymph node morphology,24
MP:0005334 abnormal fat pad morphology,33
MP:0003945 abnormal lymphocyte physiology,46
MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis,76
MP:0008201 absent follicular dendritic cells,9
MP:0008471 abnormal spleen primary B follicle morphology,7
MP:0008474 absent spleen germinal center,23
MP:0009584 decreased keratinocyte proliferation,11
MP:0030466 alveolar process atrophy,11
MP:0001793 altered susceptibility to infection,23
MP:0001805 decreased IgG level,126
MP:0005351 decreased susceptibility to autoimmune disorder,9
MP:0003009 abnormal cytokine secretion,160
MP:0008479 decreased spleen white pulp amount,33
MP:0008554 decreased circulating tumor necrosis factor level,47
MP:0008722 abnormal chemokine secretion,54
MP:0008734 decreased susceptibility to endotoxin shock,61
MP:0002051 increased skin papilloma incidence,21
MP:0002886 abnormal glutamate-mediated receptor currents,17
MP:0008553 increased circulating tumor necrosis factor level,67
MP:0008918 microgliosis,47
MP:0011452 decreased susceptibility to dopaminergic neuron neurotoxicity,12
MP:0006027 impaired lung alveolus development,39
MP:0000750 abnormal muscle regeneration,28
MP:0000730 increased satellite cell number,8
MP:0005671 abnormal response to transplant,28
MP:0003846 matted coat,8
MP:0011331 abnormal papillary duct morphology,5
MP:0011333 abnormal kidney inner medulla morphology,5
MP:0011360 kidney cortex hypoplasia,5
MP:0011565 kidney papillary hypoplasia,5
MP:0011843 abnormal kidney collecting duct epithelium morphology,6
MP:0001307 fused cornea and lens,14
MP:0002638 abnormal pupillary reflex,12
MP:0005099 abnormal ciliary body morphology,11
MP:0005204 abnormal canal of Schlemm morphology,8
MP:0005300 abnormal corneal stroma morphology,24
MP:0005542 corneal vascularization,31
MP:0004221 abnormal iridocorneal angle,19
MP:0001404 no spontaneous movement,26
MP:0000934 abnormal telencephalon development,52
MP:0004274 abnormal embryonic/fetal subventricular zone morphology,24
MP:0008540 abnormal cerebral hemisphere morphology,32
MP:0000705 athymia,16
MP:0003815 hairless,23
MP:0008070 absent T cells,15
MP:0000704 abnormal thymus development,15
MP:0000217 abnormal leukocyte cell number,27
MP:0000703 abnormal thymus morphology,77
MP:0005014 increased B cell number,134
MP:0009544 abnormal thymus epithelium morphology,8
MP:0000708 thymus hyperplasia,29
MP:0013176 abnormal tail position or orientation,11
MP:0001819 abnormal immune cell physiology,13
MP:0002444 abnormal T cell physiology,126
MP:0005002 abnormal T cell clonal deletion,6
MP:0002494 increased IgM level,123
MP:0003850 abnormal thymocyte activation,20
MP:0008284 abnormal hippocampus pyramidal cell layer,26
MP:0008500 increased IgG2a level,73
MP:0009940 abnormal hippocampus pyramidal cell morphology,35
MP:0001496 audiogenic seizures,17
MP:0001486 abnormal startle reflex,26
MP:0001984 abnormal olfaction,17
MP:0001384 abnormal pup retrieval,17
MP:0001386 abnormal maternal nurturing,76
MP:0002216 abnormal seminiferous tubule morphology,157
MP:0000920 abnormal myelination,91
MP:0000837 abnormal hypothalamus morphology,36
MP:0000790 abnormal stratification in cerebral cortex,32
MP:0000813 abnormal hippocampus layer morphology,15
MP:0002912 abnormal excitatory postsynaptic potential,91
MP:0003459 increased fear-related response,13
MP:0008560 increased tumor necrosis factor secretion,100
MP:0008568 abnormal interleukin secretion,40
MP:0009751 enhanced behavioral response to alcohol,8
MP:0009766 increased sensitivity to xenobiotic induced morbidity/mortality,115
MP:0010069 increased serotonin level,22
MP:0020355 abnormal Sertoli cell barrier morphology,6
MP:0020469 prolonged circadian behavior period,14
MP:0020477 abnormal locomotor circadian rhythm,11
MP:0000279 ventricular hypoplasia,27
MP:0001715 placental labyrinth hypoplasia,16
MP:0002754 dilated heart right ventricle,45
MP:0003153 early eyelid opening,10
MP:0004259 small placenta,51
MP:0008816 petechiae,13
MP:0002557 abnormal social/conspecific interaction,37
MP:0001447 abnormal nest building behavior,31
MP:0002757 decreased vertical activity,169
MP:0003461 abnormal response to novel object,58
MP:0004924 abnormal behavior,481
MP:0001134 absent corpus luteum,55
MP:0001127 small ovary,113
MP:0002016 ovary cysts,38
MP:0001130 abnormal ovarian folliculogenesis,34
MP:0000538 abnormal urinary bladder morphology,25
MP:0001044 abnormal enteric nervous system morphology,13
MP:0001046 abnormal enteric neuron morphology,16
MP:0005445 abnormal neurotransmitter secretion,14
MP:0002001 blindness,28
MP:0001360 abnormal social investigation,102
MP:0001361 social withdrawal,14
MP:0001408 stereotypic behavior,23
MP:0001488 increased startle reflex,121
MP:0003863 decreased aggression towards mice,19
MP:0009142 decreased prepulse inhibition,198
MP:0001183 overexpanded pulmonary alveoli,36
MP:0001392 abnormal locomotor behavior,131
MP:0002887 decreased susceptibility to pharmacologically induced seizures,28
MP:0001957 apnea,25
MP:0005277 abnormal brainstem morphology,35
MP:0001435 absent suckling reflex,15
MP:0001401 jumpy,5
MP:0001902 reduced NMDA-mediated synaptic currents,6
MP:0002196 absent corpus callosum,34
MP:0004096 abnormal midbrain-hindbrain boundary development,9
MP:0008223 absent hippocampal commissure,12
MP:0008227 absent anterior commissure,15
MP:0009901 abnormal frontonasal prominence morphology,6
MP:0010059 olfactory bulb hypoplasia,5
MP:0012138 decreased forebrain size,21
MP:0000933 abnormal rhombomere morphology,9
MP:0002316 anoxia,5
MP:0000033 absent scala media,5
MP:0000077 abnormal interparietal bone morphology,14
MP:0006013 absent endolymphatic sac,6
MP:0003147 absent cochlea,6
MP:0003146 absent cochlear ganglion,5
MP:0003987 small vestibular ganglion,10
MP:0004315 absent vestibular saccule,7
MP:0004330 abnormal vestibular saccular macula morphology,7
MP:0004333 abnormal utricular macula morphology,11
MP:0004369 absent utricle,6
MP:0001083 small geniculate ganglion,9
MP:0000848 abnormal pons morphology,14
MP:0000910 small facial motor nucleus,5
MP:0004320 split sternum,15
MP:0004568 fusion of glossopharyngeal and vagus nerve,12
MP:0010103 small thoracic cage,22
MP:0012283 decreased sternebra number,8
MP:0000580 deformed nails,11
MP:0000763 abnormal filiform papillae morphology,6
MP:0000764 abnormal tongue epithelium morphology,14
MP:0003848 brittle hair,10
MP:0004614 caudal vertebral transformation,9
"MP:0011100 preweaning lethality, complete penetrance",1400
MP:0005262 coloboma,32
MP:0002418 increased susceptibility to viral infection,118
MP:0002461 increased immunoglobulin level,44
MP:0002417 abnormal megakaryocyte morphology,33
MP:0005013 increased lymphocyte cell number,100
MP:0005018 decreased T cell number,199
MP:0005078 abnormal cytotoxic T cell physiology,46
MP:0008210 increased mature B cell number,41
MP:0008476 increased spleen red pulp amount,49
MP:0005251 blepharitis,19
MP:0000060 delayed bone ossification,81
MP:0000379 decreased hair follicle number,43
MP:0000734 muscle hypoplasia,8
MP:0000380 small hair follicles,6
MP:0000954 decreased oligodendrocyte progenitor number,7
MP:0002405 respiratory system inflammation,18
MP:0001005 abnormal retinal rod cell morphology,21
MP:0002871 albuminuria,56
MP:0002962 increased urine protein level,88
MP:0003732 abnormal retinal outer plexiform layer morphology,27
MP:0008139 fused podocyte foot processes,10
MP:0008582 short photoreceptor inner segment,16
MP:0011348 abnormal renal glomerulus basement membrane morphology,26
MP:0011409 increased renal glomerulus basement membrane thickness,20
MP:0011965 decreased total retina thickness,64
MP:0000749 muscle degeneration,29
MP:0000762 abnormal tongue morphology,33
MP:0000752 dystrophic muscle,33
MP:0000751 myopathy,48
MP:0003199 calcified muscle,10
MP:0000394 absent hair follicle melanin granules,5
MP:0000448 pointed snout,11
MP:0001289 persistence of hyaloid vascular system,60
MP:0000382 underdeveloped hair follicles,19
MP:0003931 absent molars,7
MP:0004790 absent upper incisors,11
MP:0004791 absent lower incisors,9
MP:0008843 absent subcutaneous adipose tissue,20
MP:0000814 absent dentate gyrus,5
MP:0002579 disorganized secondary lens fibers,10
MP:0002699 abnormal vitreous body morphology,36
MP:0001524 impaired limb coordination,79
MP:0000754 paresis,26
MP:0000519 hydronephrosis,126
MP:0002772 brachypodia,7
MP:0003586 dilated ureter,17
MP:0005584 abnormal enzyme/coenzyme activity,171
MP:0000430 absent maxillary shelf,10
MP:0000085 large anterior fontanelle,9
MP:0000128 growth retardation of molars,8
MP:0003842 abnormal metopic suture morphology,5
MP:0009887 abnormal palatal shelf fusion at midline,25
MP:0000854 abnormal cerebellum development,30
MP:0000017 big ears,5
MP:0000126 brittle teeth,11
MP:0000884 delaminated Purkinje cell layer,6
MP:0000867 abnormal cerebellum anterior vermis morphology,6
MP:0000866 cerebellum vermis hypoplasia,8
MP:0002657 chondrodystrophy,17
MP:0005114 premature hair loss,19
MP:0002826 tonic seizures,25
MP:0004985 decreased osteoclast cell number,48
MP:0009250 abnormal appendicular skeleton morphology,11
MP:0010747 abnormal enamel organ morphology,5
MP:0002209 decreased germ cell number,24
MP:0004930 small epididymis,23
MP:0004677 truncated ribs,5
MP:0001491 unresponsive to tactile stimuli,21
MP:0000005 increased brown adipose tissue amount,38
MP:0000761 thin diaphragm muscle,25
MP:0004819 decreased skeletal muscle mass,57
MP:0005025 abnormal response to infection,82
MP:0005088 increased acute inflammation,23
MP:0003026 decreased vasoconstriction,19
MP:0000434 megacephaly,17
MP:0000597 delayed hepatic development,12
MP:0000277 abnormal heart shape,24
MP:0000285 abnormal heart valve morphology,28
MP:0001656 focal hepatic necrosis,14
MP:0002740 heart hypoplasia,19
MP:0003808 increased atrioventricular cushion size,10
MP:0003888 liver hemorrhage,30
MP:0010334 pleural effusion,9
MP:0011364 abnormal metanephros morphology,9
MP:0002050 increased pheochromocytoma incidence,11
MP:0010264 increased hepatoma incidence,17
MP:0001970 abnormal pain threshold,31
MP:0003202 abnormal neuron apoptosis,7
MP:0006126 abnormal cardiac outflow tract development,48
MP:0010432 common ventricle,12
MP:0010662 abnormal intersomitic artery morphology,5
MP:0003228 abnormal sinus venosus morphology,7
MP:0001158 abnormal prostate gland morphology,15
MP:0001168 abnormal prostate gland epithelium morphology,10
MP:0000664 small prostate gland anterior lobe,6
MP:0009517 abnormal salivary gland duct morphology,6
MP:0002009 preneoplasia,7
MP:0003607 abnormal prostate gland physiology,7
MP:0005224 abnormal left-right axis symmetry of the somites,6
MP:0004258 abnormal placenta size,24
MP:0005365 abnormal bile salt homeostasis,22
MP:0003324 increased liver adenoma incidence,19
MP:0003331 increased hepatocellular carcinoma incidence,61
MP:0003893 increased hepatocyte proliferation,12
MP:0003980 increased circulating phospholipid level,8
MP:0004774 abnormal bile salt level,15
MP:0004789 increased bile salt level,15
MP:0008019 increased liver tumor incidence,28
MP:0009355 increased liver triglyceride level,84
MP:0010027 increased liver cholesterol level,23
MP:0010182 decreased susceptibility to weight gain,22
MP:0000295 trabecula carnea hypoplasia,46
MP:0000291 enlarged pericardium,34
MP:0003393 decreased cardiac output,30
MP:0001506 limp posture,7
MP:0000940 abnormal motor neuron innervation pattern,25
MP:0001078 abnormal phrenic nerve morphology,18
MP:0000966 decreased sensory neuron number,16
MP:0009404 centrally nucleated skeletal muscle fibers,73
MP:0001900 impaired synaptic plasticity,36
MP:0001469 abnormal contextual conditioning behavior,61
MP:0008225 abnormal anterior commissure morphology,18
MP:0009677 abnormal spinal cord dorsal column morphology,12
MP:0010860 abnormal anterior commissure pars posterior morphology,10
MP:0002067 abnormal sensory capabilities/reflexes/nociception,37
MP:0001052 abnormal innervation pattern to muscle,25
MP:0004297 abnormal proprioceptive neuron morphology,9
MP:0001527 athetotic walking movements,6
MP:0003637 cochlear ganglion hypoplasia,11
MP:0004069 abnormal muscle spindle morphology,9
MP:0001504 abnormal posture,98
MP:0001021 small L4 dorsal root ganglion,7
MP:0002726 abnormal pulmonary vein morphology,5
MP:0002746 abnormal semilunar valve morphology,24
MP:0002752 abnormal somatic nervous system morphology,15
MP:0003279 aneurysm,10
MP:0006128 pulmonary valve stenosis,17
MP:0010224 abnormal heart ventricle outflow tract morphology,6
MP:0010405 ostium secundum atrial septal defect,10
MP:0010449 heart right ventricle outflow tract stenosis,8
MP:0010593 thick aortic valve cusps,14
MP:0010617 thick mitral valve cusps,7
MP:0000427 abnormal hair cycle,44
MP:0001200 thick skin,38
MP:0002862 altered righting response,16
MP:0020560 abnormal pontine nuclei morphology,6
MP:0000421 mottled coat,17
MP:0000578 ulcerated paws,5
MP:0001973 increased thermal nociceptive threshold,98
MP:0001038 abnormal cholinergic neuron morphology,9
MP:0004183 abnormal sympathetic nervous system physiology,14
MP:0002856 abnormal vestibular ganglion morphology,12
MP:0003986 small cochlear ganglion,8
MP:0004409 abnormal crista ampullaris neuroepithelium morphology,11
MP:0000959 abnormal somatic sensory system morphology,6
MP:0001072 abnormal vestibulocochlear nerve morphology,7
MP:0009538 abnormal synapse morphology,55
MP:0000286 abnormal mitral valve morphology,28
MP:0002624 abnormal tricuspid valve morphology,15
MP:0002747 abnormal aortic valve morphology,31
MP:0006113 abnormal heart septum morphology,17
MP:0010261 sutural cataracts,6
MP:0000947 convulsive seizures,51
MP:0000948 nonconvulsive seizures,7
MP:0001155 arrest of spermatogenesis,98
MP:0002175 decreased brain weight,73
MP:0002780 decreased circulating testosterone level,45
MP:0001191 abnormal skin condition,60
MP:0000405 abnormal auchene hair morphology,11
MP:0000400 abnormal awl hair morphology,13
MP:0000420 ruffled hair,29
MP:0001123 dilated uterus,9
MP:0001143 constricted vagina orifice,6
MP:0001144 vagina atresia,18
MP:0004901 decreased male germ cell number,114
MP:0004970 kidney atrophy,20
"MP:0011104 embryonic lethality before implantation, incomplete penetrance",28
MP:0005408 hypopigmentation,29
MP:0006226 iris hypoplasia,8
MP:0000018 small ears,28
MP:0011932 abnormal endocrine pancreas development,7
MP:0011481 anterior iris synechia,19
MP:0020855 decreased corneal epithelium thickness,9
MP:0009178 absent pancreatic alpha cells,7
MP:0009254 disorganized pancreatic islets,14
MP:0000832 abnormal thalamus morphology,26
MP:0006362 abnormal male germ cell morphology,50
MP:0001958 emphysema,36
MP:0000276 heart right ventricle hypertrophy,75
MP:0003209 abnormal pulmonary elastic fiber morphology,16
MP:0010900 abnormal pulmonary interalveolar septum morphology,10
MP:0010901 abnormal pulmonary alveolar parenchyma morphology,9
MP:0001433 polyphagia,61
MP:0001441 increased grooming behavior,54
MP:0000951 sporadic seizures,24
MP:0000008 increased white adipose tissue amount,42
MP:0001260 increased body weight,278
MP:0002906 increased susceptibility to pharmacologically induced seizures,101
MP:0003997 tonic-clonic seizures,58
MP:0009288 increased epididymal fat pad weight,25
MP:0009302 increased renal fat pad weight,6
MP:0009747 impaired behavioral response to xenobiotic,36
MP:0005291 abnormal glucose tolerance,17
MP:0001211 wrinkled skin,35
MP:0002981 increased liver weight,100
MP:0008469 abnormal protein level,17
MP:0005266 abnormal metabolism,52
MP:0005332 abnormal amino acid level,29
MP:0000422 delayed hair appearance,21
MP:0000418 focal hair loss,47
MP:0002139 abnormal hepatobiliary system physiology,7
MP:0000183 decreased circulating LDL cholesterol level,82
MP:0005146 decreased circulating VLDL cholesterol level,22
MP:0004799 increased susceptibility to experimental autoimmune encephalomyelitis,59
MP:0004500 increased incidence of tumors by ionizing radiation induction,16
MP:0010267 decreased lung tumor incidence,6
MP:0011255 abnormal anterior visceral endoderm cell migration,8
MP:0010259 anterior polar cataracts,11
MP:0002796 impaired skin barrier function,58
MP:0009586 increased platelet aggregation,10
MP:0005274 abnormal viscerocranium morphology,11
MP:0006378 abnormal spermatogonia morphology,29
MP:0012702 increased embryonic neuroepithelium thickness,7
MP:0000571 interdigital webbing,16
MP:0000789 thickened cerebral cortex,7
MP:0003743 abnormal facial morphology,60
MP:0010955 abnormal respiratory electron transport chain,41
MP:0012174 flat head,5
MP:0001919 abnormal reproductive system physiology,42
MP:0001658 increased mortality induced by gamma-irradiation,34
MP:0001407 short stride length,59
MP:0001830 decreased activated T cell number,8
MP:0005058 abnormal lysosome morphology,45
MP:0005091 increased double-positive T cell number,30
MP:0002777 absent ovarian follicles,45
MP:0004805 absent oocytes,26
MP:0009009 absent estrous cycle,33
MP:0009021 absent estrus,7
MP:0011704 decreased fibroblast proliferation,96
MP:0003691 abnormal microglial cell physiology,31
MP:0008261 arrest of male meiosis,124
MP:0008496 decreased IgG2a level,80
MP:0008497 decreased IgG2b level,67
MP:0008498 decreased IgG3 level,77
MP:0013236 ovary degeneration,5
MP:0008215 decreased immature B cell number,57
MP:0009339 decreased splenocyte number,26
MP:0002145 abnormal T cell differentiation,123
MP:0000711 thymus cortex hypoplasia,20
MP:0004028 chromosome breakage,26
MP:0004227 increased cellular sensitivity to ionizing radiation,26
MP:0002608 increased hematocrit,85
MP:0005633 increased circulating sodium level,87
MP:0003019 increased circulating chloride level,56
MP:0003853 dry skin,26
"MP:0002436 abnormal CD8-positive, alpha-beta cytotoxic T cell morphology",11
MP:0008346 increased gamma-delta T cell number,26
MP:0005226 abnormal vertebral arch development,15
MP:0004462 small basisphenoid bone,12
MP:0004626 vertebral compression,6
MP:0004652 small caudal vertebrae,10
MP:0010029 abnormal basicranium morphology,18
MP:0001523 impaired righting response,122
MP:0002184 abnormal innervation,52
MP:0005574 decreased pulmonary respiratory rate,20
MP:0003989 abnormal barrel cortex morphology,7
MP:0013795 abnormal colon goblet cell morphology,12
MP:0001412 excessive scratching,15
MP:0000159 abnormal xiphoid process morphology,31
MP:0000525 renal tubular acidosis,9
MP:0005493 stomach epithelial hyperplasia,8
MP:0003017 decreased circulating bicarbonate level,9
MP:0003271 abnormal duodenum morphology,22
MP:0002490 abnormal immunoglobulin level,61
MP:0002492 decreased IgE level,76
MP:0004978 decreased B-1 B cell number,55
MP:0008495 decreased IgG1 level,124
MP:0002739 abnormal olfactory bulb development,19
MP:0005112 abnormal spinal cord ventral horn morphology,13
MP:0002883 chromatolysis,6
MP:0004097 abnormal cerebellar cortex morphology,23
MP:0008439 abnormal cortical plate morphology,15
MP:0000781 decreased corpus callosum size,39
MP:0008440 abnormal subplate morphology,5
MP:0009969 abnormal cerebral cortex pyramidal cell morphology,24
MP:0012468 decreased striatum area,21
MP:0002176 increased brain weight,33
MP:0003075 altered response to CNS ischemic injury,8
MP:0003917 increased kidney weight,61
MP:0004809 increased hematopoietic stem cell number,37
MP:0004910 decreased seminal vesicle weight,41
MP:0004948 abnormal neuronal precursor proliferation,52
MP:0004962 decreased prostate gland weight,6
MP:0004980 increased neuronal precursor cell number,11
MP:0008057 abnormal DNA replication,20
MP:0008410 increased cellular sensitivity to ultraviolet irradiation,24
MP:0009130 increased white fat cell number,7
MP:0009292 increased inguinal fat pad weight,16
MP:0009300 increased parametrial fat pad weight,5
MP:0009381 abnormal prostate gland dorsolateral lobe morphology,5
MP:0010763 abnormal hematopoietic stem cell physiology,28
MP:0000714 increased thymocyte number,20
MP:0004952 increased spleen weight,136
MP:0004955 increased thymus weight,19
MP:0009006 prolonged estrous cycle,29
MP:0009017 prolonged estrus,12
MP:0001264 increased body size,27
MP:0000642 enlarged adrenal glands,23
MP:0001131 abnormal ovarian follicle morphology,49
MP:0001148 enlarged testis,18
MP:0002041 increased pituitary adenoma incidence,14
MP:0000709 enlarged thymus,40
MP:0005015 increased T cell number,106
MP:0004832 enlarged ovary,11
MP:0008105 increased amacrine cell number,5
MP:0008868 abnormal granulosa cell morphology,15
MP:0009092 endometrium hyperplasia,13
MP:0009363 abnormal secondary ovarian follicle morphology,14
MP:0010236 abnormal retina outer limiting membrane morphology,5
MP:0000635 pituitary gland hyperplasia,7
MP:0000636 enlarged pituitary gland,8
MP:0000131 abnormal long bone epiphysis morphology,26
MP:0002581 abnormal ileum morphology,12
MP:0003154 abnormal soft palate morphology,6
MP:0003756 abnormal hard palate morphology,7
MP:0009247 meteorism,22
MP:0009888 palatal shelves fail to meet at midline,43
MP:0000462 abnormal digestive system morphology,31
MP:0001938 delayed sexual maturation,22
MP:0003830 abnormal testis development,18
MP:0004255 abnormal spongiotrophoblast layer morphology,33
MP:0004260 enlarged placenta,11
MP:0004920 increased placenta weight,13
MP:0008273 abnormal intramembranous bone ossification,11
MP:0009709 hydrometra,54
MP:0013317 abnormal seminal vesicle development,6
MP:0004002 abnormal jejunum morphology,11
MP:0005241 abnormal retinal ganglion layer morphology,27
MP:0003099 retinal detachment,14
MP:0003236 abnormal lens capsule morphology,11
MP:0003733 abnormal retinal inner nuclear layer morphology,40
MP:0004499 increased incidence of tumors by chemical induction,103
MP:0010711 persistent hyperplastic primary vitreous,6
MP:0002023 increased B cell derived lymphoma incidence,57
MP:0008478 increased spleen white pulp amount,25
MP:0002362 abnormal spleen marginal zone morphology,31
MP:0000688 lymphoid hyperplasia,30
MP:0002619 abnormal lymphocyte morphology,45
MP:0008102 lymph node hyperplasia,29
MP:0008522 abnormal lymph node germinal center morphology,14
MP:0000630 mammary gland hyperplasia,8
MP:0000523 cortical renal glomerulopathies,17
MP:0006262 increased testis tumor incidence,10
MP:0009504 abnormal mammary gland epithelium morphology,20
MP:0001728 failure of embryo implantation,24
MP:0002044 increased colon adenoma incidence,7
MP:0002404 increased intestinal adenoma incidence,19
MP:0003036 vertebral transformation,53
MP:0012114 absent inner cell mass proliferation,42
MP:0003111 abnormal cell nucleus morphology,51
MP:0004966 abnormal inner cell mass proliferation,5
MP:0003694 failure of blastocyst to hatch from the zona pellucida,32
"MP:0011094 embryonic lethality before implantation, complete penetrance",147
MP:0006007 abnormal basal ganglion morphology,16
MP:0002730 head shaking,31
MP:0005098 abnormal optic choroid morphology,16
MP:0000333 decreased bone marrow cell number,77
MP:0000532 kidney vascular congestion,5
MP:0000533 kidney hemorrhage,10
MP:0000853 absent cerebellar foliation,7
MP:0000873 thin external granule cell layer,15
MP:0005606 increased bleeding time,75
MP:0000264 failure of vascular branching,8
MP:0006057 decreased vascular endothelial cell number,7
MP:0002088 abnormal embryonic growth/weight/body size,14
MP:0000457 maxilla hypoplasia,9
MP:0005076 abnormal cell differentiation,41
MP:0005318 decreased triglyceride level,38
MP:0002801 abnormal long term object recognition memory,33
MP:0005659 decreased susceptibility to diet-induced obesity,121
MP:0005669 increased circulating leptin level,98
MP:0004892 increased adiponectin level,29
MP:0008752 abnormal tumor necrosis factor level,44
MP:0009269 decreased fat cell size,21
MP:0002441 abnormal granulocyte morphology,11
MP:0004810 decreased hematopoietic stem cell number,50
MP:0006410 abnormal common myeloid progenitor cell morphology,59
MP:0008246 abnormal leukocyte morphology,25
MP:0008813 decreased common myeloid progenitor cell number,36
MP:0010296 increased hemolymphoid system tumor incidence,5
MP:0002932 abnormal joint morphology,56
MP:0004679 xiphoid process foramen,5
MP:0003421 abnormal thyroid gland development,7
MP:0003923 abnormal heart left atrium morphology,7
MP:0004062 dilated heart right atrium,9
MP:0004380 short frontal bone,11
MP:0008525 decreased cranium height,39
MP:0010465 aberrant origin of the right subclavian artery,13
MP:0000316 cellular necrosis,7
MP:0004556 enlarged allantois,15
MP:0011259 abnormal cephalic neural fold morphology,9
MP:0003920 abnormal heart right ventricle morphology,20
MP:0004937 dilated heart,26
MP:0000652 enlarged sebaceous gland,22
MP:0001222 epidermal hyperplasia,63
MP:0001874 acanthosis,43
MP:0002722 abnormal immune system organ morphology,64
MP:0003644 thymus atrophy,53
MP:0009600 hypergranulosis,8
MP:0009675 orthokeratosis,15
MP:0010179 rough coat,34
MP:0000604 amyloidosis,13
MP:0001245 thick dermal layer,21
MP:0001219 thick epidermis,81
MP:0001192 scaly skin,58
MP:0001196 shiny skin,21
MP:0001242 hyperkeratosis,82
MP:0005468 abnormal thyroid hormone level,7
MP:0005471 decreased thyroxine level,10
MP:0004973 increased regulatory T cell number,16
MP:0009583 increased keratinocyte proliferation,25
MP:0030571 dilated piliary canal,7
MP:0000575 increased foot pad pigmentation,33
MP:0001208 blistering,24
MP:0000324 increased mast cell number,13
MP:0002497 increased IgE level,82
MP:0004939 abnormal B cell morphology,29
MP:0002718 abnormal inner cell mass morphology,41
"MP:0011093 embryonic lethality at implantation, complete penetrance",28
MP:0000384 distorted hair follicle pattern,8
MP:0005565 increased blood urea nitrogen level,189
MP:0006254 thin cerebral cortex,74
MP:0004860 dilated kidney collecting duct,24
MP:0010685 abnormal hair follicle inner root sheath morphology,13
MP:0006097 abnormal cerebellar lobule formation,11
MP:0006098 absent cerebellar lobules,5
MP:0000579 abnormal nail morphology,27
MP:0000568 ectopic digits,7
MP:0000850 absent cerebellum,12
MP:0009038 decreased inferior colliculus size,9
MP:0004322 abnormal sternebra morphology,19
MP:0003867 increased defecation amount,10
MP:0000301 decreased atrioventricular cushion size,12
MP:0000938 motor neuron degeneration,38
MP:0001382 abnormal nursing,31
MP:0001395 bidirectional circling,34
MP:0002895 abnormal otolithic membrane morphology,6
MP:0003150 detached tectorial membrane,7
MP:0004331 vestibular saccular macula degeneration,13
MP:0004413 absent cochlear microphonics,10
MP:0004416 absent cochlear nerve compound action potential,7
MP:0004586 pillar cell degeneration,8
MP:0006335 abnormal hearing electrophysiology,10
MP:0005032 abnormal ectoplacental cone morphology,18
MP:0000044 absent organ of Corti,5
MP:0003604 single kidney,42
MP:0004922 abnormal common crus morphology,6
MP:0005023 abnormal wound healing,16
MP:0001270 distended abdomen,54
MP:0001202 skin photosensitivity,7
MP:0001570 abnormal circulating enzyme level,21
MP:0000611 jaundice,15
MP:0002640 reticulocytosis,81
MP:0002642 anisocytosis,65
MP:0005097 polychromatophilia,34
MP:0005344 increased circulating bilirubin level,68
MP:0002874 decreased hemoglobin content,178
MP:0003657 abnormal erythrocyte osmotic lysis,31
MP:0008387 hypochromic anemia,11
MP:0010067 increased red blood cell distribution width,77
MP:0010175 leptocytosis,8
MP:0011188 increased erythrocyte protoporphyrin level,9
MP:0000003 abnormal adipose tissue morphology,19
MP:0000488 abnormal intestinal epithelium morphology,49
MP:0000537 abnormal urethra morphology,7
MP:0005314 absent thyroid gland,7
MP:0005315 absent pituitary gland,6
MP:0000486 abnormal pulmonary trunk morphology,6
MP:0000662 abnormal branching of the mammary ductal tree,40
MP:0003334 pancreas fibrosis,7
MP:0003358 abnormal hypaxial muscle morphology,11
MP:0003924 diaphragmatic hernia,30
MP:0004140 abnormal gastric chief cell morphology,19
MP:0004247 small pancreas,21
MP:0004830 short incisors,9
MP:0006402 small molars,12
MP:0008904 abnormal mammary fat pad morphology,6
MP:0011195 increased hair follicle apoptosis,6
MP:0011305 dilated kidney calyx,6
MP:0011457 abnormal metanephric ureteric bud development,5
MP:0013956 decreased colon length,16
MP:0001548 hyperlipidemia,20
MP:0002957 increased intestinal adenocarcinoma incidence,16
MP:0008528 polycystic kidney,79
MP:0011376 abnormal kidney corticomedullary boundary morphology,11
MP:0011413 colorless urine,7
MP:0003293 rectal hemorrhage,11
MP:0002951 small thyroid gland,16
MP:0002376 abnormal dendritic cell physiology,109
MP:0002095 abnormal skin pigmentation,48
MP:0000780 abnormal corpus callosum morphology,60
MP:0008221 abnormal hippocampal commissure morphology,9
MP:0011723 ectopic neuron,10
MP:0012676 dilated brain ventricles,20
MP:0004856 decreased ovary weight,32
MP:0002411 decreased susceptibility to bacterial infection,72
MP:0005027 increased susceptibility to parasitic infection,94
MP:0008699 increased interleukin-4 secretion,55
MP:0002663 absent blastocoele,29
MP:0009781 abnormal preimplantation embryo development,26
MP:0012111 failure of morula compaction,7
MP:0012129 failure of blastocyst formation,6
MP:0000186 decreased circulating HDL cholesterol level,169
MP:0000182 increased circulating LDL cholesterol level,62
MP:0002660 abnormal caput epididymis morphology,11
MP:0002662 abnormal cauda epididymis morphology,16
MP:0000242 impaired fertilization,81
MP:0004543 abnormal sperm physiology,53
MP:0004777 abnormal phospholipid level,33
MP:0020859 disorganized corneal epithelium,5
MP:0001968 abnormal touch/ nociception,17
MP:0002733 abnormal thermal nociception,16
MP:0005316 abnormal response to tactile stimuli,21
MP:0001442 decreased grooming behavior,24
MP:0000811 hippocampal neuron degeneration,18
MP:0000243 myoclonus,31
MP:0002398 abnormal bone marrow cell morphology/development,70
MP:0003450 enlarged pancreas,8
MP:0003892 abnormal gastric gland morphology,8
MP:0008842 lipofuscinosis,18
MP:0009160 abnormal pancreatic acinar cell zymogen granule morphology,8
MP:0009978 abnormal cerebellum white matter morphology,10
MP:0011521 decreased placental labyrinth size,19
MP:0003954 abnormal Reichert's membrane morphology,14
MP:0011191 increased embryonic epiblast cell apoptosis,10
MP:0011199 abnormal amniotic cavity morphology,10
MP:0000288 abnormal pericardium morphology,37
MP:0005598 decreased ventricle muscle contractility,78
MP:0004001 decreased hepatocyte proliferation,25
MP:0004056 abnormal myocardium compact layer morphology,32
MP:0010413 complete atrioventricular septal defect,29
MP:0010420 muscular ventricular septal defect,93
MP:0010519 atrioventricular block,22
MP:0010559 heart block,7
MP:0010640 ventricular myocardium compact layer hypoplasia,5
MP:0010457 pulmonary artery stenosis,10
MP:0011531 abnormal syncytiotrophoblast morphology,5
MP:0002080 prenatal lethality,102
MP:0000269 abnormal heart looping,49
MP:0002584 small ectoplacental cone,13
MP:0004601 abnormal vertebral spinous process morphology,11
MP:0000716 abnormal immune system cell morphology,40
MP:0009397 increased trophoblast giant cell number,15
MP:0003845 abnormal decidualization,14
MP:0004965 inner cell mass degeneration,33
MP:0000521 abnormal kidney cortex morphology,28
MP:0002267 abnormal bronchiole morphology,11
MP:0002750 exophthalmos,20
MP:0004469 abnormal zygomatic arch morphology,9
MP:0009050 dilated proximal convoluted tubules,23
MP:0009051 dilated distal convoluted tubules,7
MP:0030350 premature coronal suture closure,7
MP:0002060 abnormal skin morphology,144
MP:0002655 abnormal keratinocyte morphology,24
MP:0003420 delayed intramembranous bone ossification,20
MP:0004032 abnormal interventricular groove morphology,7
MP:0004055 atrium hypoplasia,8
MP:0002427 disproportionate dwarf,54
MP:0003936 abnormal reproductive system development,12
MP:0004016 decreased bone mass,40
MP:0003895 increased ectoderm apoptosis,7
MP:0003872 absent heart right ventricle,6
MP:0002724 enhanced wound healing,23
MP:0002908 delayed wound healing,47
MP:0002998 abnormal bone remodeling,34
MP:0003721 increased tumor growth/size,42
MP:0004986 abnormal osteoblast morphology,26
MP:0004989 decreased osteoblast cell number,38
MP:0005042 abnormal level of surface class II molecules,16
"MP:0005463 abnormal CD4-positive, alpha-beta T cell physiology",73
MP:0004919 abnormal positive T cell selection,15
MP:0002471 abnormal complement pathway,9
MP:0002472 impaired complement alternative pathway,7
MP:0006269 abnormal mammary gland growth during pregnancy,29
MP:0013716 hypolactation,15
MP:0000417 short hair,18
MP:0000627 abnormal mammary gland morphology,19
MP:0001882 abnormal lactation,30
MP:0010591 enlarged aortic valve,6
MP:0001353 increased aggression towards mice,24
MP:0001417 decreased exploration in new environment,102
MP:0003734 abnormal retinal inner plexiform layer morphology,16
MP:0006303 abnormal retinal nerve fiber layer morphology,15
MP:0008511 thin retinal inner nuclear layer,35
MP:0011380 enlarged brain ventricles,55
MP:0006047 aortic valve regurgitation,9
MP:0003820 increased left ventricle systolic pressure,8
MP:0003896 prolonged PR interval,30
MP:0010506 prolonged RR interval,23
MP:0005011 increased eosinophil cell number,69
MP:0008720 impaired neutrophil chemotaxis,41
MP:0020332 impaired leukocyte tethering or rolling,19
MP:0004783 abnormal cardinal vein morphology,20
MP:0001364 decreased anxiety-related response,151
MP:0001899 absent long term depression,28
MP:0003963 abnormal corticosterone level,13
MP:0002191 abnormal artery morphology,37
MP:0003921 abnormal heart left ventricle morphology,85
MP:0009658 increased placenta apoptosis,6
MP:0011525 abnormal placenta intervillous maternal lacunae morphology,6
MP:0011526 abnormal placenta fetal blood space morphology,7
MP:0000453 absent mouth,9
MP:0001739 abnormal adrenal gland secretion,15
MP:0004160 retroesophageal right subclavian artery,23
MP:0004539 absent maxilla,8
MP:0004838 abnormal neural fold elevation formation,10
MP:0008392 decreased primordial germ cell number,28
MP:0005264 glomerulosclerosis,62
MP:0003918 decreased kidney weight,51
MP:0004969 pale kidney,34
MP:0008140 podocyte foot process effacement,31
MP:0009640 abnormal renal tubule epithelium morphology,29
MP:0009641 kidney degeneration,16
MP:0011334 abnormal nephrogenic zone morphology,11
MP:0011368 increased kidney apoptosis,28
MP:0011369 increased renal glomerulus apoptosis,7
MP:0011408 renal tubule hypertrophy,5
MP:0011430 mesangiolysis,10
MP:0011453 abnormal glomerular capillary endothelium morphology,18
MP:0011483 renal glomerular synechia,5
MP:0011498 abnormal glomerular capsule parietal layer morphology,7
MP:0011871 podocyte hypertrophy,6
MP:0030188 round snout,5
MP:0009577 abnormal developmental vascular remodeling,11
MP:0001824 abnormal thymus involution,14
"MP:0002432 abnormal CD4-positive, alpha beta T cell morphology",31
"MP:0005010 abnormal CD8-positive, alpha beta T cell morphology",33
MP:0005090 increased double-negative T cell number,65
MP:0003719 abnormal pericyte morphology,15
MP:0006413 increased T cell apoptosis,29
MP:0009361 abnormal primordial ovarian follicle morphology,10
MP:0009660 abnormal induced retinal neovascularization,20
MP:0011365 small metanephros,5
MP:0011425 abnormal kidney interstitium morphology,8
MP:0011440 increased kidney cell proliferation,15
MP:0001025 abnormal sympathetic neuron morphology,9
MP:0001011 abnormal superior cervical ganglion morphology,12
MP:0008067 retinal ganglion cell degeneration,15
MP:0005079 decreased cytotoxic T cell cytolysis,37
MP:0004597 increased susceptibility to noise-induced hearing loss,13
MP:0006035 abnormal mitochondrion morphology,75
MP:0004996 abnormal CNS synapse formation,9
MP:0011750 abnormal seminiferous tubule epithelium morphology,39
MP:0002920 decreased paired-pulse facilitation,22
MP:0002922 decreased post-tetanic potentiation,12
MP:0001864 vasculitis,11
MP:0002495 increased IgA level,63
MP:0005153 abnormal B cell proliferation,14
MP:0005350 increased susceptibility to autoimmune disorder,21
MP:0003179 thrombocytopenia,184
MP:0003725 increased autoantibody level,46
MP:0004762 increased anti-double stranded DNA antibody level,63
MP:0004771 increased anti-single stranded DNA antibody level,18
MP:0004794 increased anti-nuclear antigen antibody level,59
MP:0004796 increased anti-histone antibody level,10
"MP:0008074 increased CD4-positive, alpha beta T cell number",141
"MP:0008078 increased CD8-positive, alpha-beta T cell number",134
MP:0008173 increased follicular B cell number,18
MP:0008181 increased marginal zone B cell number,35
MP:0008189 increased transitional stage B cell number,16
MP:0008214 increased immature B cell number,27
MP:0008783 decreased B cell apoptosis,10
MP:0008826 abnormal splenic cell ratio,42
MP:0009338 increased splenocyte number,20
MP:0011402 renal cast,32
MP:0011506 glomerular crescent,19
MP:0020519 renal glomerular immunoglobulin deposits,31
MP:0003643 spleen atrophy,20
MP:0004953 decreased spleen weight,76
MP:0009322 increased splenocyte apoptosis,10
MP:0000069 kyphoscoliosis,24
MP:0000194 increased circulating calcium level,80
MP:0002904 increased circulating parathyroid hormone level,15
MP:0002980 abnormal postural reflex,13
MP:0002986 decreased urine calcium level,10
MP:0003112 enlarged parathyroid gland,5
MP:0010092 increased circulating magnesium level,18
MP:0002802 abnormal discrimination learning,11
MP:0002805 abnormal conditioned taste aversion behavior,18
MP:0003008 enhanced long term potentiation,60
MP:0012685 abnormal primitive streak elongation,11
MP:0001454 abnormal cued conditioning behavior,55
MP:0003460 decreased fear-related response,13
MP:0000633 abnormal pituitary gland morphology,17
MP:0001475 reduced long term depression,38
MP:0000818 abnormal amygdala morphology,12
MP:0005267 abnormal olfactory cortex morphology,6
MP:0004000 impaired passive avoidance behavior,29
MP:0006300 abnormal entorhinal cortex morphology,6
MP:0005330 cardiomyopathy,50
MP:0005620 abnormal muscle contractility,27
MP:0003141 cardiac fibrosis,96
MP:0004087 abnormal muscle fiber morphology,35
MP:0004121 abnormal sarcolemma morphology,13
MP:0010090 increased circulating creatine kinase level,30
MP:0005327 abnormal mesangial cell morphology,5
MP:0003044 impaired basement membrane formation,10
MP:0003449 abnormal intestinal goblet cell morphology,36
MP:0004566 myocardial fiber degeneration,25
MP:0009885 abnormal palatal shelf elevation,11
MP:0005528 decreased renal glomerular filtration rate,14
MP:0009644 uremia,7
MP:0011346 renal tubule atrophy,29
MP:0003632 abnormal nervous system morphology,91
MP:0003871 abnormal myelin sheath morphology,50
MP:0000609 abnormal liver physiology,110
MP:0010400 increased liver glycogen level,27
MP:0001666 abnormal intestinal absorption,15
MP:0002276 abnormal lung interstitium morphology,16
MP:0001179 thick pulmonary interalveolar septum,37
MP:0001195 flaky skin,23
MP:0002275 abnormal type II pneumocyte morphology,29
MP:0009931 abnormal skin appearance,29
MP:0010890 decreased alveolar lamellar body number,8
MP:0003244 loss of dopaminergic neurons,11
MP:0010978 absent ureteric bud,8
MP:0002132 abnormal respiratory system morphology,15
MP:0006143 increased systemic arterial diastolic blood pressure,44
MP:0006144 increased systemic arterial systolic blood pressure,69
MP:0002748 abnormal pulmonary valve morphology,10
MP:0010428 abnormal heart right ventricle outflow tract morphology,6
MP:0000847 abnormal metencephalon morphology,8
MP:0002258 abnormal cricoid cartilage morphology,10
MP:0008222 decreased hippocampal commissure size,7
MP:0008226 decreased anterior commissure size,11
MP:0002063 abnormal learning/memory/conditioning,56
MP:0002065 abnormal fear/anxiety-related behavior,12
MP:0002797 increased thigmotaxis,56
MP:0008414 abnormal spatial reference memory,37
MP:0008056 abnormal retinal ganglion cell morphology,30
MP:0002686 globozoospermia,57
MP:0001780 decreased brown adipose tissue amount,40
MP:0005336 abnormal inguinal fat pad morphology,11
MP:0005419 decreased circulating serum albumin level,140
MP:0005438 abnormal glycogen homeostasis,20
MP:0005450 abnormal energy expenditure,25
MP:0004780 abnormal surfactant secretion,20
MP:0001934 increased litter size,13
MP:0001943 abnormal respiration,31
MP:0002690 akinesia,20
MP:0004831 long incisors,12
MP:0011183 abnormal primitive endoderm morphology,9
MP:0005030 absent amnion,20
MP:0010736 abnormal extraembryonic ectoderm morphology,14
MP:0011197 abnormal proamniotic cavity morphology,9
MP:0002590 increased mean corpuscular volume,142
MP:0005642 decreased mean corpuscular hemoglobin concentration,55
MP:0003656 abnormal erythrocyte physiology,26
"MP:0010831 lethality, incomplete penetrance",53
MP:0002577 reduced enamel thickness,10
MP:0002649 abnormal enamel rod pattern,6
MP:0000490 abnormal crypts of Lieberkuhn morphology,35
MP:0001346 abnormal lacrimal gland morphology,8
MP:0003303 peritoneal inflammation,10
MP:0009144 dilated pancreatic duct,8
MP:0005156 bradykinesia,38
MP:0004905 decreased uterus weight,18
MP:0002282 abnormal trachea morphology,21
MP:0005084 abnormal gallbladder morphology,13
MP:0009343 dilated gallbladder,7
MP:0010861 increased respiratory mucosa goblet cell number,5
MP:0002769 abnormal vas deferens morphology,16
MP:0000491 crypts of Lieberkuhn abscesses,10
MP:0000512 intestinal ulcer,24
MP:0009342 enlarged gallbladder,6
MP:0010155 abnormal intestine physiology,33
MP:0001784 abnormal fluid regulation,15
MP:0001765 abnormal ion homeostasis,13
MP:0002693 abnormal pancreas physiology,20
MP:0002928 abnormal bile duct morphology,21
MP:0005012 decreased eosinophil cell number,82
MP:0002790 decreased circulating follicle stimulating hormone level,23
MP:0005130 decreased follicle stimulating hormone level,13
MP:0005185 decreased circulating progesterone level,28
MP:0003402 decreased liver weight,82
MP:0003453 abnormal keratinocyte physiology,24
MP:0011523 thin placenta labyrinth,11
MP:0012251 abnormal diaphragm development,11
MP:0004187 cardia bifida,17
MP:0002223 lymphoid hypoplasia,15
MP:0030733 decreased gamma-aminobutyric acid level,7
MP:0001363 increased anxiety-related response,168
MP:0003063 increased coping response,24
MP:0003862 decreased aggression towards males,15
MP:0012493 absent pharyngeal arch arteries,5
MP:0003161 absent lateral semicircular canal,16
MP:0003164 decreased posterior semicircular canal size,6
MP:0004314 absent inner ear vestibule,5
MP:0008875 abnormal xenobiotic pharmacokinetics,26
MP:0001333 absent optic nerve,15
MP:0010956 abnormal mitochondrial ATP synthesis coupled electron transport,35
MP:0011630 increased mitochondria size,21
MP:0011636 disorganized mitochondrial cristae,12
MP:0011639 decreased mitochondrial DNA content,17
MP:0004334 utricular macular degeneration,7
MP:0004427 abnormal vestibular labyrinth morphology,9
MP:0002982 abnormal primordial germ cell migration,11
MP:0001348 abnormal lacrimal gland physiology,6
MP:0004674 thin ribs,9
MP:0004834 ovary hemorrhage,9
MP:0009433 polyovular ovarian follicle,7
MP:0010595 abnormal aortic valve cusp morphology,8
MP:0010602 abnormal pulmonary valve cusp morphology,12
MP:0010605 thick pulmonary valve cusps,6
MP:0030302 abnormal maxillary zygomatic process morphology,5
MP:0010299 increased mammary gland tumor incidence,22
MP:0002575 increased circulating ketone body level,34
MP:0003562 abnormal pancreatic beta cell physiology,38
MP:0001729 impaired embryo implantation,13
MP:0005028 abnormal trophectoderm morphology,18
MP:0003718 maternal effect,79
MP:0012102 absent trophectoderm,8
"MP:0011103 embryonic lethality at implantation, incomplete penetrance",7
MP:0002656 abnormal keratinocyte differentiation,29
MP:0005165 increased susceptibility to injury,57
MP:0005186 increased circulating progesterone level,10
MP:0002907 abnormal parturition,10
MP:0005527 increased renal glomerular filtration rate,7
MP:0004014 abnormal uterine environment,15
MP:0004144 hypotonia,22
MP:0004484 altered response of heart to induced stress,21
MP:0008537 increased susceptibility to induced colitis,100
MP:0008735 increased susceptibility to endotoxin shock,60
MP:0011021 abnormal circadian regulation of heart rate,6
MP:0011022 abnormal circadian regulation of systemic arterial blood pressure,5
MP:0011308 kidney corticomedullary cysts,5
MP:0011403 pyelonephritis,5
MP:0003197 nephrocalcinosis,17
MP:0003215 renal interstitial fibrosis,47
MP:0003288 intestinal edema,10
MP:0003357 impaired granulosa cell differentiation,6
MP:0004193 abnormal kidney papilla morphology,9
MP:0011405 tubulointerstitial nephritis,23
MP:0011423 kidney cortex atrophy,14
MP:0003799 impaired macrophage chemotaxis,38
MP:0005601 increased angiogenesis,25
MP:0003822 decreased left ventricle systolic pressure,13
MP:0003915 increased left ventricle weight,21
MP:0003946 renal necrosis,8
MP:0004244 abnormal miscarriage rate,8
MP:0004266 pale placenta,13
MP:0004485 increased response of heart to induced stress,37
MP:0004898 uterine hemorrhage,6
MP:0006298 abnormal platelet activation,22
MP:0010144 abnormal tumor vascularization,22
MP:0004616 lumbar vertebral transformation,42
MP:0012732 abnormal perineural vascular plexus morphology,5
MP:0004197 abnormal fetal growth/weight/body size,6
MP:0004264 abnormal extraembryonic tissue physiology,10
MP:0006372 impaired placental function,6
MP:0009429 decreased embryo weight,27
MP:0002544 brachydactyly,27
MP:0000767 abnormal smooth muscle morphology,12
MP:0005175 non-pigmented tail tip,24
MP:0009379 abnormal foot pigmentation,20
MP:0000336 decreased mast cell number,16
MP:0002543 brachyphalangia,24
MP:0002286 cryptorchism,33
MP:0003103 liver degeneration,28
MP:0004921 decreased placenta weight,28
MP:0005102 abnormal iris pigmentation,19
MP:0005208 abnormal iris stroma morphology,5
MP:0005608 cardiac interstitial fibrosis,46
MP:0012106 impaired exercise endurance,38
MP:0008454 absent retinal rod cells,6
MP:0005655 increased aggression,12
MP:0004645 decreased vertebrae number,6
MP:0002410 decreased susceptibility to viral infection,54
MP:0002460 decreased immunoglobulin level,59
MP:0002738 hyperresponsive to tactile stimuli,12
MP:0003690 abnormal glial cell physiology,11
MP:0003998 decreased thermal nociceptive threshold,44
MP:0008561 decreased tumor necrosis factor secretion,111
MP:0008706 decreased interleukin-6 secretion,86
MP:0008721 abnormal chemokine level,40
MP:0008916 abnormal astrocyte physiology,21
MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality,28
MP:0020449 decreased microglial cell activation,6
MP:0003698 abnormal male reproductive system physiology,24
MP:0004600 abnormal vertebral transverse process morphology,8
MP:0004191 neuronal intranuclear inclusions,9
MP:0006397 disorganized long bone epiphyseal plate,22
MP:0014101 decreased chondrocyte proliferation,14
MP:0030029 wide cranial sutures,16
MP:0002273 abnormal pulmonary alveolus epithelial cell morphology,13
MP:0011032 impaired branching involved in terminal bronchiole morphogenesis,5
MP:0004134 abnormal chest morphology,8
MP:0004148 increased compact bone thickness,33
MP:0004376 absent frontal bone,6
MP:0004419 absent parietal bone,8
MP:0004471 short nasal bone,39
MP:0011514 skin hemorrhage,9
MP:0013906 absent embryonic telencephalon,6
MP:0002018 increased malignant tumor incidence,20
MP:0008136 enlarged Peyer's patches,8
MP:0009219 increased prostate intraepithelial neoplasia incidence,7
MP:0010346 increased thyroid carcinoma incidence,6
MP:0011705 absent fibroblast proliferation,6
MP:0009858 abnormal cellular extravasation,28
MP:0008751 abnormal interleukin level,55
MP:0009789 decreased susceptibility to bacterial infection induced morbidity/mortality,38
MP:0004890 decreased energy expenditure,34
MP:0002359 abnormal spleen germinal center morphology,30
MP:0002358 abnormal spleen periarteriolar lymphoid sheath morphology,14
MP:0004977 increased B-1 B cell number,33
MP:0008241 abnormal metallophilic macrophage morphology,6
MP:0008502 increased IgG3 level,31
MP:0005447 abnormal synaptic norepinephrine release,5
MP:0008213 absent immature B cells,5
MP:0001942 abnormal lung volume,11
MP:0005075 abnormal melanosome morphology,21
MP:0004382 abnormal hair follicle melanogenesis,5
MP:0010815 enlarged alveolar lamellar bodies,5
MP:0010891 increased alveolar lamellar body number,5
MP:0010895 increased lung compliance,15
MP:0010908 dilated pulmonary alveolar ducts,7
MP:0000753 paralysis,39
MP:0002403 abnormal pre-B cell morphology,8
MP:0013501 increased fibroblast apoptosis,30
MP:0008578 decreased circulating interferon-gamma level,31
MP:0010766 abnormal NK cell physiology,65
MP:0005190 osteomyelitis,6
MP:0004992 increased bone resorption,29
MP:0008597 decreased circulating interleukin-6 level,45
MP:0010214 abnormal circulating serum amyloid protein level,9
MP:0002221 abnormal lymph organ size,6
MP:0001585 hemolytic anemia,29
MP:0005036 diarrhea,41
MP:0002816 colitis,39
MP:0008037 abnormal T cell morphology,42
MP:0008049 increased memory T cell number,31
MP:0008499 increased IgG1 level,78
MP:0008501 increased IgG2b level,41
MP:0000653 abnormal sex gland morphology,5
MP:0001829 increased activated T cell number,27
MP:0008050 decreased memory T cell number,18
MP:0008097 increased plasma cell number,38
MP:0008217 abnormal B cell activation,32
MP:0008247 abnormal mononuclear cell morphology,7
MP:0002138 abnormal hepatobiliary system morphology,10
MP:0002339 abnormal lymph node morphology,58
MP:0001858 intestinal inflammation,22
MP:0002467 impaired neutrophil phagocytosis,13
MP:0002416 abnormal proerythroblast morphology,32
MP:0003333 liver fibrosis,48
MP:0003596 epididymal inflammation,5
MP:0008127 decreased dendritic cell number,45
MP:0008713 abnormal cytokine level,67
MP:0008750 abnormal interferon level,25
MP:0010373 myeloid hyperplasia,34
MP:0001835 abnormal antigen presentation,14
MP:0005026 decreased susceptibility to parasitic infection,36
MP:0002252 abnormal oropharynx morphology,5
MP:0011160 dermal-epidermal separation,7
MP:0005313 absent adrenal gland,11
MP:0006063 abnormal inferior vena cava morphology,51
MP:0004158 right aortic arch,88
MP:0010404 ostium primum atrial septal defect,19
MP:0002396 abnormal hematopoietic system morphology/development,30
MP:0005070 impaired natural killer cell mediated cytotoxicity,65
MP:0002831 absent Peyer's patches,25
MP:0004816 abnormal class switch recombination,72
MP:0008046 absent NK cells,5
MP:0008098 decreased plasma cell number,16
MP:0008399 abnormal alpha-beta intraepithelial T cell morphology,6
MP:0008348 absent gamma-delta T cells,5
MP:0008356 abnormal gamma-delta T cell differentiation,9
MP:0002455 abnormal dendritic cell antigen presentation,37
MP:0008115 abnormal dendritic cell differentiation,15
MP:0008566 increased interferon-gamma secretion,114
MP:0008673 decreased interleukin-13 secretion,27
MP:0008703 decreased interleukin-5 secretion,25
MP:0000136 abnormal microglial cell morphology,31
MP:0008661 decreased interleukin-10 secretion,39
MP:0005644 agonadal,7
MP:0008335 decreased gonadotroph cell number,10
MP:0006415 absent testes,10
MP:0002572 abnormal emotion/affect behavior,33
MP:0001764 abnormal homeostasis,57
MP:0002573 behavioral despair,39
MP:0001458 abnormal object recognition memory,36
MP:0000952 abnormal CNS glial cell morphology,22
MP:0002999 abnormal bone healing,12
MP:0004101 abnormal brain interneuron morphology,28
MP:0006271 abnormal involution of the mammary gland,21
MP:0004811 abnormal neuron physiology,107
MP:0009410 abnormal skeletal muscle satellite cell proliferation,6
MP:0010211 abnormal acute phase protein level,6
MP:0020340 abnormal inhibitory learning,8
MP:0008024 absent lymph nodes,17
MP:0004189 abnormal alveolar process morphology,10
MP:0010234 abnormal vibrissa follicle morphology,11
MP:0002293 long gestation period,10
MP:0008028 pregnancy-related premature death,20
MP:0006387 abnormal T cell number,25
MP:0002880 opisthotonus,9
MP:0004757 abnormal distal convoluted tubule morphology,9
MP:0008138 absent podocyte foot process,7
MP:0011359 decreased glomerular capillary number,8
MP:0011509 dilated glomerular capillary,10
MP:0009652 abnormal palatal rugae morphology,6
MP:0004753 abnormal miniature excitatory postsynaptic currents,98
MP:0001952 increased airway responsiveness,21
MP:0008088 abnormal T-helper 1 cell differentiation,22
MP:0008090 increased T-helper 2 cell number,11
MP:0009698 heart hemorrhage,8
MP:0010551 abnormal coronary vessel morphology,16
MP:0012183 decreased paraxial mesoderm size,10
MP:0010808 right-sided stomach,37
MP:0010854 lung situs inversus,10
MP:0010853 abnormal lung position or orientation,6
MP:0006345 absent second pharyngeal arch,12
MP:0010642 absent third pharyngeal arch,9
MP:0002378 abnormal gut-associated lymphoid tissue morphology,10
MP:0008054 abnormal uterine NK cell morphology,5
MP:0008135 small Peyer's patches,30
MP:0008256 abnormal myometrium morphology,5
MP:0009394 increased uterine NK cell number,6
MP:0005501 abnormal skin physiology,36
MP:0006080 CNS ischemia,6
MP:0003710 abnormal physiological neovascularization,21
MP:0008719 impaired neutrophil recruitment,47
MP:0002442 abnormal leukocyte physiology,50
MP:0002217 small lymph nodes,26
MP:0008236 decreased susceptibility to neuronal excitotoxicity,21
MP:0011190 thick embryonic epiblast,6
MP:0011192 decreased embryonic epiblast cell proliferation,8
MP:0006267 abnormal intercalated disk morphology,16
MP:0004994 abnormal brain wave pattern,60
MP:0009748 abnormal behavioral response to addictive substance,13
MP:0009776 decreased behavioral withdrawal response,7
MP:0005517 decreased liver regeneration,19
MP:0020467 abnormal circadian behavior,34
MP:0020550 multinucleated giant male germ cells,35
MP:0006059 decreased susceptibility to ischemic brain injury,21
MP:0003957 abnormal nitric oxide homeostasis,31
MP:0001522 impaired swimming,89
MP:0001489 decreased startle reflex,195
MP:0001396 unidirectional circling,10
MP:0002666 increased circulating aldosterone level,23
MP:0003233 prolonged QT interval,34
MP:0003868 abnormal feces composition,29
MP:0004119 hypokalemia,11
MP:0004742 abnormal vestibular system physiology,20
MP:0002174 abnormal gastrulation movements,8
MP:0005657 abnormal neural plate morphology,28
"MP:0011107 embryonic lethality between somite formation and embryo turning, incomplete penetrance",19
MP:0011256 abnormal neural fold morphology,8
MP:0000081 premature cranial suture closure,7
MP:0012085 midface hypoplasia,12
MP:0030438 increased osteoblast proliferation,5
MP:0006281 abnormal tail development,17
MP:0002058 neonatal lethality,37
MP:0000066 osteoporosis,47
MP:0003195 calcinosis,8
MP:0003196 calcified skin,5
MP:0006133 calcified artery,8
MP:0004833 ovary atrophy,20
MP:0004894 uterus atrophy,10
MP:0006357 abnormal circulating mineral level,8
MP:0008844 decreased subcutaneous adipose tissue amount,83
MP:0005089 decreased double-negative T cell number,35
MP:0000628 abnormal mammary gland development,43
MP:0002682 decreased mature ovarian follicle number,32
MP:0002773 decreased circulating luteinizing hormone level,18
MP:0005121 decreased circulating prolactin level,18
MP:0008000 increased ovary tumor incidence,22
MP:0008347 decreased gamma-delta T cell number,21
MP:0008351 decreased gamma-delta intraepithelial T cell number,8
MP:0002734 abnormal mechanical nociception,24
MP:0002272 abnormal nervous system electrophysiology,95
MP:0001588 abnormal hemoglobin,17
MP:0002913 abnormal PNS synaptic transmission,11
MP:0012156 rostral-caudal axis duplication,9
MP:0006219 optic nerve degeneration,12
MP:0008535 enlarged lateral ventricles,67
MP:0002578 impaired ability to fire action potentials,13
MP:0004231 abnormal calcium ion homeostasis,41
MP:0004434 abnormal cochlear outer hair cell physiology,13
MP:0004530 absent outer hair cell stereocilia,9
MP:0004737 absent distortion product otoacoustic emissions,35
MP:0009114 decreased pancreatic beta cell mass,27
MP:0009168 decreased pancreatic islet number,14
MP:0009175 abnormal pancreatic beta cell differentiation,10
MP:0009176 increased pancreatic alpha cell number,17
MP:0011820 decreased pancreatic beta cell proliferation,9
MP:0001629 abnormal heart rate,19
MP:0006142 abnormal sinoatrial node conduction,17
MP:0003928 increased heart rate variability,16
MP:0004122 abnormal sinus arrhythmia,8
MP:0004215 abnormal myocardial fiber physiology,72
MP:0004433 abnormal cochlear inner hair cell physiology,13
MP:0004736 abnormal distortion product otoacoustic emission,41
MP:0004740 sensorineural hearing loss,35
MP:0010637 sinus bradycardia,11
MP:0000815 abnormal Ammon gyrus morphology,8
MP:0002961 abnormal axon guidance,45
MP:0005627 increased circulating potassium level,59
MP:0005634 decreased circulating sodium level,27
MP:0002916 increased synaptic depression,13
MP:0002969 impaired social transmission of food preference,11
MP:0005181 decreased circulating estradiol level,22
MP:0030934 decreased primordial germ cell proliferation,11
MP:0001157 small seminal vesicle,34
MP:0005148 seminal vesicle hypoplasia,5
MP:0005189 abnormal anogenital distance,13
MP:0005188 small penis,8
MP:0005536 Leydig cell hypoplasia,20
MP:0003608 prostate gland inflammation,5
MP:0013307 increased adrenal gland weight,5
MP:0000010 abnormal abdominal fat pad morphology,23
MP:0001142 abnormal vagina orifice morphology,10
MP:0002631 abnormal epididymis morphology,92
MP:0002774 small prostate gland,11
MP:0005182 increased circulating estradiol level,15
MP:0004929 decreased epididymis weight,23
MP:0004933 abnormal epididymis epithelium morphology,15
MP:0008258 thin endometrium,9
MP:0009096 decreased endometrial gland number,7
MP:0006084 abnormal circulating phospholipid level,6
MP:0008892 abnormal sperm flagellum morphology,63
MP:0009237 kinked sperm flagellum,28
MP:0009238 coiled sperm flagellum,24
MP:0009243 hairpin sperm flagellum,15
MP:0009719 reduced cerebellar foliation,19
MP:0009831 abnormal sperm midpiece morphology,32
MP:0009832 abnormal sperm mitochondrial sheath morphology,28
MP:0009289 decreased epididymal fat pad weight,53
MP:0002723 abnormal immune serum protein physiology,19
MP:0008234 absent spleen marginal zone,11
MP:0008464 absent peripheral lymph nodes,6
MP:0001807 decreased IgA level,56
MP:0005154 increased B cell proliferation,65
MP:0002583 absent extraembryonic ectoderm,10
MP:0003558 absent uterus,5
MP:0003557 absent vas deferens,5
MP:0003642 absent seminal vesicle,12
MP:0004727 absent epididymis,8
MP:0001705 abnormal proximal-distal axis patterning,11
MP:0020470 shortened circadian behavior period,38
MP:0005174 abnormal tail pigmentation,12
MP:0005405 axon degeneration,61
MP:0003409 decreased width of hypertrophic chondrocyte zone,42
MP:0004340 short scapula,7
MP:0006396 decreased long bone epiphyseal plate size,35
MP:0008526 decreased cranium width,11
MP:0003306 small intestinal inflammation,12
MP:0000493 rectal prolapse,29
MP:0001272 increased metastatic potential,31
MP:0005094 abnormal T cell proliferation,30
MP:0005109 abnormal talus morphology,6
MP:0002685 abnormal spermatogonia proliferation,21
MP:0002781 increased circulating testosterone level,23
MP:0004642 fused metatarsal bones,7
MP:0004651 increased thoracic vertebrae number,10
MP:0008159 increased diameter of fibula,5
MP:0009656 delayed chorioallantoic fusion,7
MP:0001440 abnormal grooming behavior,14
MP:0000505 decreased digestive secretion,13
MP:0005211 increased stomach mucosa thickness,9
MP:0004139 abnormal gastric parietal cell morphology,24
MP:0004731 increased circulating gastrin level,8
MP:0010792 abnormal stomach mucosa morphology,26
MP:0008158 increased diameter of femur,10
MP:0030245 round head,8
MP:0002415 abnormal neutrophil differentiation,9
MP:0002414 abnormal myeloblast morphology/development,9
MP:0000223 decreased monocyte cell number,70
MP:0002620 abnormal monocyte morphology,7
MP:0012235 abnormal liver bud morphology,8
MP:0010954 abnormal cellular respiration,40
MP:0005567 decreased circulating total protein level,72
MP:0003806 abnormal nucleotide metabolism,17
MP:0005415 intrahepatic cholestasis,5
MP:0006092 abnormal olfactory sensory neuron morphology,22
MP:0008152 decreased diameter of femur,13
MP:0008156 decreased diameter of tibia,5
MP:0003211 abnormal aorta elastic fiber morphology,12
MP:0006116 calcified aortic valve,7
MP:0009865 abnormal aorta smooth muscle morphology,12
MP:0009873 abnormal aorta tunica media morphology,15
MP:0011207 absent ectoplacental cavity,7
MP:0011209 absent extraembryonic coelom,5
MP:0009761 abnormal meiotic spindle morphology,10
MP:0004325 absent vestibular hair cells,7
MP:0009456 impaired cued conditioning behavior,46
MP:0009712 impaired conditioned place preference behavior,25
MP:0020468 abnormal circadian behavior period,5
MP:0004527 abnormal outer hair cell stereociliary bundle morphology,34
MP:0004532 abnormal inner hair cell stereociliary bundle morphology,22
MP:0002844 aortic hypertrophy,6
MP:0012515 abnormal heart apex morphology,7
MP:0000411 shiny fur,10
MP:0003456 absent tail,17
MP:0006082 CNS inflammation,22
MP:0003289 abnormal intestinal peristalsis,8
MP:0008026 abnormal brain white matter morphology,37
MP:0011617 abnormal habituation,6
MP:0006264 decreased systemic arterial systolic blood pressure,39
MP:0010574 aorta dilation,13
MP:0010714 iris coloboma,11
MP:0010451 kidney microaneurysm,6
MP:0011441 decreased kidney cell proliferation,9
MP:0001863 vascular inflammation,5
MP:0005006 abnormal osteoblast physiology,50
MP:0005167 abnormal blood-brain barrier function,23
MP:0005341 decreased susceptibility to atherosclerosis,10
MP:0003157 impaired muscle relaxation,19
MP:0003394 increased cardiac output,9
MP:0004801 increased susceptibility to systemic lupus erythematosus,20
"MP:0008073 abnormal CD4-positive, alpha beta T cell number",7
MP:0008174 decreased follicular B cell number,47
MP:0008182 decreased marginal zone B cell number,53
MP:0008544 impaired olfaction,21
MP:0009866 abnormal aorta wall morphology,15
MP:0010868 increased bone trabecula number,43
MP:0010935 increased airway resistance,8
MP:0011309 abnormal kidney arterial blood vessel morphology,8
MP:0011508 glomerular capillary thrombosis,7
MP:0011951 increased cardiac stroke volume,9
MP:0002978 absent otoliths,16
MP:0006012 dilated endolymphatic duct,11
MP:0006014 dilated endolymphatic sac,5
MP:0004533 fused inner hair cell stereocilia,9
MP:0000397 abnormal guard hair morphology,8
MP:0004115 abnormal sinoatrial node morphology,6
MP:0013239 impaired skeletal muscle regeneration,15
MP:0001859 kidney inflammation,54
MP:0003944 abnormal T cell subpopulation ratio,36
MP:0003985 renal fibrosis,17
MP:0004829 increased anti-chromatin antibody level,13
MP:0004917 abnormal T cell selection,5
MP:0008481 increased spleen germinal center number,22
MP:0000953 abnormal oligodendrocyte morphology,22
MP:0002711 decreased glucagon secretion,9
MP:0002948 abnormal neuron specification,11
MP:0003877 abnormal serotonergic neuron morphology,7
MP:0009174 absent pancreatic beta cells,8
MP:0008828 abnormal lymph node cell ratio,20
MP:0002452 abnormal professional antigen presenting cell physiology,16
MP:0002872 polycythemia,11
MP:0005564 increased hemoglobin content,72
MP:0010024 increased total body fat amount,218
MP:0012671 retinal spots,23
MP:0003810 abnormal hair cuticle,16
MP:0004501 increased incidence of tumors by UV-induction,9
MP:0010300 increased skin tumor incidence,21
MP:0000647 abnormal sebaceous gland morphology,14
MP:0002021 increased incidence of induced tumors,21
MP:0009115 abnormal fat cell morphology,41
MP:0005138 decreased prolactin level,10
MP:0005578 teratozoospermia,120
MP:0003191 abnormal cellular cholesterol metabolism,6
MP:0003982 increased cholesterol level,31
MP:0004542 impaired acrosome reaction,28
MP:0004781 abnormal surfactant composition,8
MP:0008245 abnormal alveolar macrophage morphology,12
MP:0008365 adenohypophysis hypoplasia,8
MP:0008545 absent sperm flagellum,31
MP:0008570 lipidosis,8
MP:0009230 abnormal sperm head morphology,67
MP:0009234 absent sperm head,14
MP:0009287 decreased abdominal fat pad weight,9
MP:0010161 decreased brain cholesterol level,7
MP:0010813 abnormal alveolar lamellar body morphology,5
MP:0010998 pulmonary alveolar proteinosis,5
MP:0011743 abnormal Golgi apparatus morphology,6
MP:0003699 abnormal female reproductive system physiology,23
MP:0009172 small pancreatic islets,40
MP:0003645 increased pancreatic beta cell number,16
MP:0004386 enlarged interparietal bone,6
MP:0002019 abnormal tumor incidence,7
MP:0002014 increased papilloma incidence,12
MP:0001189 absent skin pigmentation,11
MP:0002939 head spot,16
MP:0011279 decreased ear pigmentation,22
MP:0011568 decreased foot pigmentation,8
MP:0004883 abnormal vascular wound healing,60
MP:0000950 abnormal seizure response to pharmacological agent,5
MP:0003037 increased myocardial infarction size,26
MP:0008406 increased cellular sensitivity to hydrogen peroxide,21
MP:0008513 thin retinal inner plexiform layer,11
MP:0008519 thin retinal outer plexiform layer,19
MP:0001554 increased circulating free fatty acid level,76
MP:0005448 abnormal energy homeostasis,15
MP:0002970 abnormal white adipose tissue morphology,18
MP:0005605 increased bone mass,37
MP:0005658 increased susceptibility to diet-induced obesity,61
MP:0003948 abnormal gas homeostasis,11
MP:0004149 increased bone strength,11
MP:0004889 increased energy expenditure,61
MP:0008907 decreased total fat pad weight,17
MP:0008963 increased carbon dioxide production,25
MP:0010869 decreased bone trabecula number,58
MP:0010878 increased trabecular bone volume,39
MP:0010879 decreased trabecular bone volume,44
MP:0011922 abnormal circulating osteocalcin level,6
MP:0012575 increased noradrenaline level,12
MP:0020039 increased bone ossification,24
MP:0020040 decreased bone ossification,29
MP:0010502 ventricle myocardium hypoplasia,5
MP:0005366 variegated coat color,9
MP:0005458 increased percent body fat/body weight,76
MP:0005179 decreased circulating cholesterol level,254
MP:0004768 abnormal axonal transport,23
MP:0004792 abnormal synaptic vesicle number,34
MP:0003049 abnormal lumbar vertebrae morphology,33
MP:0004708 short lumbar vertebrae,6
MP:0008027 abnormal spinal cord white matter morphology,17
MP:0008283 small hippocampus,27
MP:0008415 abnormal neurite morphology,41
MP:0008456 abnormal retinal rod cell outer segment morphology,26
MP:0008893 detached sperm flagellum,14
MP:0009232 abnormal sperm nucleus morphology,30
MP:0009376 abnormal manchette morphology,13
MP:0001391 abnormal tail movements,25
MP:0004814 reduced linear vestibular evoked potential,13
MP:0009971 decreased hippocampus pyramidal cell number,10
MP:0010011 ectopic hippocampus pyramidal cells,7
MP:0001657 abnormal induced morbidity/mortality,5
MP:0002423 abnormal mast cell physiology,44
MP:0005166 decreased susceptibility to injury,75
MP:0002941 increased circulating alanine transaminase level,93
MP:0002942 decreased circulating alanine transaminase level,88
MP:0008484 decreased spleen germinal center size,20
MP:0003326 liver failure,8
MP:0003913 increased heart right ventricle weight,7
MP:0010750 increased susceptibility to parasitic infection induced morbidity/mortality,8
MP:0011854 cerebral edema,8
MP:0001443 poor grooming,10
MP:0002810 microcytic anemia,22
MP:0004151 decreased circulating iron level,44
MP:0004153 increased renal tubule apoptosis,12
MP:0011352 proximal convoluted tubule brush border loss,12
MP:0011890 increased circulating ferritin level,11
MP:0008025 brain vacuoles,30
MP:0002762 ectopic cerebellar granule cells,14
MP:0002878 abnormal corticospinal tract morphology,12
MP:0003979 increased circulating carnitine level,10
MP:0005152 pancytopenia,19
MP:0005407 hyperalgesia,14
MP:0001332 abnormal optic nerve innervation,10
MP:0005103 abnormal retinal pigmentation,39
MP:0005060 accumulation of giant lysosomes in kidney/renal tubule cells,8
MP:0003797 abnormal compact bone morphology,44
MP:0004604 abnormal vertebral pedicle morphology,8
MP:0010932 increased trabecular bone connectivity density,6
MP:0000132 thickened long bone epiphysis,5
MP:0002759 abnormal caudal vertebrae morphology,46
MP:0006394 abnormal vertebral epiphyseal plate morphology,8
MP:0020080 increased bone mineralization,9
MP:0005411 delayed fertilization,5
MP:0000733 abnormal muscle development,22
MP:0009402 decreased skeletal muscle fiber diameter,37
MP:0010398 decreased liver glycogen level,20
MP:0010399 decreased skeletal muscle glycogen level,8
MP:0004090 abnormal sarcomere morphology,46
MP:0001415 increased exploration in new environment,44
MP:0002574 increased vertical activity,99
MP:0005661 decreased circulating adrenaline level,9
MP:0030762 decreased adrenaline level,6
MP:0011049 impaired adaptive thermogenesis,53
MP:0009011 prolonged diestrus,19
MP:0020475 delayed circadian behavior phase,12
MP:0005444 abnormal retinol metabolism,5
MP:0011232 abnormal vitamin A level,7
MP:0004190 abnormal direction of embryo turning,12
MP:0005283 increased unsaturated fatty acid level,6
MP:0004773 abnormal bile composition,20
MP:0011019 abnormal adaptive thermogenesis,9
MP:0004940 abnormal B-1 B cell morphology,5
MP:0008168 decreased B-1a cell number,39
MP:0001362 abnormal anxiety-related response,28
MP:0002424 abnormal reticulocyte morphology,12
MP:0002812 spherocytosis,14
MP:0005096 erythroblastosis,6
MP:0000314 schistocytosis,12
MP:0001798 impaired macrophage phagocytosis,42
MP:0005597 decreased susceptibility to type I hypersensitivity reaction,35
MP:0003038 decreased myocardial infarction size,21
MP:0004867 decreased platelet calcium level,5
MP:0009549 decreased platelet aggregation,59
MP:0002433 abnormal T-helper 1 cell morphology,9
MP:0000904 abnormal superior colliculus morphology,14
MP:0004165 abnormal lateral geniculate nucleus morphology,7
MP:0009004 progressive hair loss,11
MP:0003088 abnormal prepulse inhibition,17
MP:0002629 hyperactivity elicited by ethanol administration,8
MP:0005240 abnormal amacrine cell morphology,12
MP:0002864 abnormal ocular fundus morphology,34
MP:0002671 belted,6
MP:0001512 trunk curl,35
MP:0005596 increased susceptibility to type I hypersensitivity reaction,38
MP:0002148 abnormal hypersensitivity reaction,7
MP:0001650 abnormal seizure response to electrical stimulation,18
MP:0012675 enlarged floor plate,5
MP:0002335 decreased airway responsiveness,24
MP:0008641 increased circulating interleukin-1 beta level,30
MP:0002708 nephrolithiasis,6
MP:0005558 decreased creatinine clearance,16
MP:0009645 crystalluria,10
MP:0011424 decreased urine uric acid level,9
MP:0011625 cystolithiasis,9
MP:0011941 increased fluid intake,53
MP:0003311 aminoaciduria,16
MP:0011422 kidney medulla atrophy,10
MP:0010177 acanthocytosis,13
MP:0011171 increased number of Heinz bodies,6
MP:0004363 stria vascularis degeneration,15
MP:0004632 abnormal cochlear OHC efferent innervation pattern,10
MP:0002830 gallstones,11
MP:0002491 decreased IgD level,17
MP:0008203 absent B-1a cells,8
MP:0008523 absent lymph node germinal center,8
MP:0005000 abnormal immune tolerance,7
MP:0010809 abnormal Clara cell morphology,5
MP:0001777 abnormal body temperature homeostasis,29
MP:0008338 decreased thyrotroph cell number,6
MP:0002641 anisopoikilocytosis,22
MP:0005343 increased circulating aspartate transaminase level,77
MP:0005561 increased mean corpuscular hemoglobin,123
MP:0008807 increased liver iron level,26
MP:0008956 decreased cellular hemoglobin content,8
MP:0010375 increased kidney iron level,14
MP:0005641 increased mean corpuscular hemoglobin concentration,38
MP:0008809 increased spleen iron level,20
MP:0005119 decreased circulating thyroid-stimulating hormone level,6
MP:0005478 decreased circulating thyroxine level,38
MP:0006319 abnormal epididymal fat pad morphology,31
MP:0008965 increased basal metabolism,23
MP:0010249 lactation failure,16
MP:0001844 autoimmune response,31
MP:0006056 increased vascular endothelial cell number,6
MP:0005141 liver hyperplasia,9
MP:0030737 decreased glutamic acid level,5
MP:0000436 abnormal head movements,15
MP:0010734 abnormal paranode morphology,5
MP:0001515 abnormal grip strength,13
MP:0004411 decreased endocochlear potential,15
MP:0010748 abnormal visual evoked potential,10
MP:0000659 prostate gland hyperplasia,6
MP:0005124 increased circulating prolactin level,8
MP:0005599 increased cardiac muscle contractility,35
MP:0006263 decreased systemic arterial diastolic blood pressure,8
MP:0003929 decreased heart rate variability,28
MP:0004184 abnormal baroreceptor physiology,10
MP:0004876 decreased mean systemic arterial blood pressure,24
MP:0004909 increased seminal vesicle weight,9
MP:0004961 increased prostate gland weight,7
MP:0008279 arrest of spermiogenesis,22
MP:0008898 abnormal acrosome morphology,36
MP:0009285 increased gonadal fat pad weight,26
MP:0001545 abnormal hematopoietic system physiology,24
MP:0008249 abnormal common lymphocyte progenitor cell morphology,13
MP:0008404 increased cellular sensitivity to methylmethanesulfonate,6
MP:0004030 induced chromosome breakage,22
MP:0004029 spontaneous chromosome breakage,27
MP:0002375 abnormal thymus medulla morphology,18
MP:0005416 abnormal circulating protein level,56
MP:0002936 joint swelling,8
MP:0002965 increased circulating serum albumin level,36
MP:0005568 increased circulating total protein level,35
MP:0004111 abnormal coronary artery morphology,20
MP:0004696 abnormal thyroid follicle morphology,19
MP:0008180 abnormal marginal zone B cell morphology,9
MP:0008879 submandibular gland inflammation,6
MP:0013585 thymus cortex atrophy,7
MP:0020518 renal glomerular protein deposits,12
MP:0000756 forelimb paralysis,10
MP:0008536 enlarged third ventricle,22
MP:0005543 decreased cornea thickness,17
MP:0003092 decreased corneal stroma thickness,9
MP:0008438 abnormal cutaneous collagen fibril morphology,24
MP:0002789 male pseudohermaphroditism,6
MP:0004896 abnormal endometrium morphology,7
MP:0009082 uterus cysts,10
MP:0009671 abnormal uterus physiology,7
MP:0009814 increased prostaglandin level,13
MP:0000717 abnormal lymphocyte cell number,25
MP:0001665 chronic diarrhea,5
MP:0004751 increased length of allograft survival,22
"MP:0008401 abnormal CD8 positive, alpha-beta intraepithelial T cell morphology",6
MP:0005618 decreased urine potassium level,17
MP:0008289 abnormal adrenal medulla morphology,7
MP:0011460 decreased urine chloride ion level,9
MP:0003076 increased susceptibility to ischemic brain injury,20
MP:0006060 increased cerebral infarction size,24
MP:0010433 double inlet heart left ventricle,5
MP:0008975 delayed male fertility,8
MP:0002841 impaired skeletal muscle contractility,38
MP:0009406 decreased skeletal muscle fiber number,17
MP:0009409 abnormal skeletal muscle fiber type ratio,35
MP:0009413 skeletal muscle fiber atrophy,24
MP:0011942 decreased fluid intake,19
MP:0009374 absent cumulus expansion,5
MP:0001596 hypotension,32
MP:0002500 granulomatous inflammation,29
MP:0002594 low mean erythrocyte cell number,13
MP:0002814 hyperchromasia,5
MP:0005563 abnormal hemoglobin content,7
MP:0002647 decreased intestinal cholesterol absorption,14
MP:0002576 abnormal enamel morphology,22
MP:0002650 abnormal ameloblast morphology,14
MP:0000376 folliculitis,5
MP:0001209 spontaneous skin ulceration,27
MP:0002975 vascular smooth muscle hypertrophy,8
MP:0003254 bile duct inflammation,6
MP:0002635 reduced sensorimotor gating,12
MP:0004182 abnormal spermiation,22
MP:0004759 decreased mitotic index,8
MP:0001889 delayed brain development,7
MP:0000827 dilated third ventricle,32
MP:0008966 abnormal chiasmata formation,13
MP:0002310 decreased susceptibility to hepatic steatosis,68
MP:0005085 abnormal gallbladder physiology,11
MP:0012335 increased circulating homocysteine level,11
MP:0030644 increased circulating methionine level,5
MP:0002653 abnormal ependyma morphology,5
MP:0004091 abnormal Z line morphology,28
MP:0004272 abnormal basement membrane morphology,25
MP:0009838 abnormal sperm axoneme morphology,32
MP:0020473 abnormal circadian behavior phase,15
MP:0004262 abnormal physical strength,7
MP:0009417 skeletal muscle atrophy,24
MP:0009422 decreased gastrocnemius weight,11
MP:0003484 abnormal channel response,22
MP:0008532 decreased chemical nociceptive threshold,8
MP:0006433 abnormal articular cartilage morphology,12
MP:0011473 increased urine glycosaminoglycan level,6
MP:0030066 short face,18
MP:0006320 abnormal interscapular fat pad morphology,6
MP:0008108 abnormal small intestinal villus morphology,26
MP:0008114 abnormal Kupffer cell morphology,20
MP:0008989 abnormal liver sinusoid morphology,8
MP:0009124 increased brown fat cell lipid droplet size,8
MP:0004558 delayed allantois development,5
MP:0008391 abnormal primordial germ cell morphology,10
MP:0013600 testis degeneration,14
MP:0008976 delayed female fertility,11
MP:0002915 abnormal synaptic depression,5
MP:0002674 abnormal sperm motility,47
MP:0009231 detached acrosome,18
MP:0005422 osteosclerosis,13
MP:0003416 premature bone ossification,8
MP:0003560 osteoarthritis,20
MP:0010941 abnormal foramen magnum morphology,7
MP:0030420 short basicranium,8
MP:0000778 abnormal nervous system tract morphology,19
MP:0003247 abnormal glutaminergic neuron morphology,9
MP:0008128 abnormal brain internal capsule morphology,23
MP:0008458 abnormal cortical ventricular zone morphology,18
MP:0002888 abnormal NMDA-mediated synaptic currents,9
MP:0004551 decreased tracheal cartilage ring number,6
MP:0010464 abnormal aortic arch and aortic arch branch attachment,9
MP:0010488 abnormal left subclavian artery morphology,15
MP:0012729 abnormal common carotid artery morphology,12
MP:0000680 absent parathyroid glands,10
MP:0002256 abnormal laryngeal cartilage morphology,9
MP:0002260 abnormal thyroid cartilage morphology,12
MP:0006031 abnormal pharyngeal pouch morphology,6
MP:0004159 double aortic arch,13
MP:0004760 increased mitotic index,10
MP:0003122 maternal imprinting,21
MP:0011478 abnormal urine catecholamine level,6
MP:0001243 abnormal dermal layer morphology,40
MP:0001190 reddish skin,33
MP:0001246 mixed cellular infiltration to dermis,18
MP:0001193 psoriasis,10
MP:0002606 increased basophil cell number,17
MP:0005505 thrombocytosis,79
MP:0003427 parakeratosis,26
MP:0008086 increased T-helper 1 cell number,15
MP:0001462 abnormal avoidance learning behavior,6
MP:0006045 mitral valve regurgitation,5
MP:0003898 abnormal QRS complex,9
MP:0004071 prolonged P wave,11
MP:0010508 abnormal heart electrocardiography waveform feature,23
MP:0010724 thick interventricular septum,28
MP:0011020 abnormal circadian temperature homeostasis,15
MP:0008737 abnormal spleen physiology,8
MP:0003622 ischuria,5
MP:0009979 abnormal cerebellum deep nucleus morphology,8
MP:0003413 hair follicle degeneration,12
MP:0003653 decreased skin turgor,5
MP:0002919 enhanced paired-pulse facilitation,32
MP:0003177 allodynia,12
MP:0004077 abnormal striatum morphology,33
MP:0005065 abnormal neutrophil morphology,20
MP:0008623 increased circulating interleukin-3 level,5
MP:0001492 abnormal pilomotor reflex,12
MP:0006072 abnormal retinal apoptosis,16
MP:0030006 decreased retinal apoptosis,6
MP:0003975 increased circulating VLDL triglyceride level,14
MP:0009171 enlarged pancreatic islets,18
MP:0003304 large intestinal inflammation,16
MP:0003696 abnormal zona pellucida morphology,6
MP:0009403 increased variability of skeletal muscle fiber size,37
MP:0002658 abnormal liver regeneration,5
MP:0004047 abnormal milk composition,22
MP:0006270 abnormal mammary gland growth during lactation,26
MP:0009830 abnormal sperm connecting piece morphology,5
MP:0009839 multiflagellated sperm,9
MP:0030590 abnormal sperm fibrous sheath morphology,9
MP:0008412 increased cellular sensitivity to oxidative stress,20
MP:0002413 abnormal megakaryocyte progenitor cell morphology,21
MP:0005607 decreased bleeding time,11
MP:0002371 abnormal thymus cortex morphology,21
MP:0002993 arthritis,17
MP:0008091 decreased T-helper 2 cell number,7
MP:0003240 loss of hippocampal neurons,6
MP:0013741 absent thymus corticomedullary boundary,6
MP:0008705 increased interleukin-6 secretion,74
MP:0005040 abnormal MHC II cell surface expression on macrophages,7
MP:0009020 prolonged metestrus,8
MP:0012098 increased spongiotrophoblast size,8
MP:0012109 decreased trophoblast glycogen cell number,5
MP:0009356 decreased liver triglyceride level,66
MP:0005423 abnormal somatic nervous system physiology,12
MP:0002917 decreased synaptic depression,13
MP:0003996 clonic seizures,16
MP:0004417 decreased cochlear nerve compound action potential,13
MP:0004562 abnormal inner hair cell synaptic ribbon morphology,6
MP:0008714 increased lung carcinoma incidence,17
MP:0008764 increased mast cell degranulation,12
MP:0003880 abnormal central pattern generator function,7
MP:0010746 abnormal pre-Botzinger complex physiology,6
MP:0030137 abnormal upper incisor morphology,7
MP:0008263 abnormal hippocampus CA1 region morphology,25
MP:0008428 abnormal spatial working memory,71
MP:0008432 abnormal long term spatial reference memory,23
MP:0001214 skin hyperplasia,8
MP:0020386 adipose tissue inflammation,13
MP:0009375 thin zona pellucida,5
MP:0005265 abnormal blood urea nitrogen level,5
MP:0000923 abnormal roof plate morphology,8
MP:0006282 abnormal spinal cord dorsal horn morphology,8
MP:0004639 fused metacarpal bones,6
MP:0008919 fused tarsal bones,12
MP:0001257 increased body length,65
MP:0002408 abnormal double-positive T cell morphology,20
MP:0000315 hemoglobinuria,6
MP:0000256 echinocytosis,7
MP:0008995 early reproductive senescence,22
MP:0009325 necrospermia,7
MP:0008374 abnormal malleus manubrium morphology,5
MP:0009914 abnormal hyoid bone lesser horn morphology,9
MP:0003227 abnormal vascular branching morphogenesis,25
MP:0003814 vascular smooth muscle hypoplasia,14
MP:0008509 disorganized retinal ganglion layer,5
MP:0008512 disorganized retinal inner nuclear layer,11
MP:0008516 disorganized retinal outer nuclear layer,12
MP:0008585 absent photoreceptor outer segment,18
MP:0009450 abnormal axon fasciculation,20
MP:0004046 abnormal mitosis,67
MP:0008058 abnormal DNA repair,47
MP:0001985 abnormal gustatory system physiology,9
MP:0001986 abnormal taste sensitivity,11
MP:0004210 abnormal bitter taste sensitivity,8
MP:0004209 abnormal sweet taste sensitivity,8
MP:0000473 abnormal stomach glandular epithelium morphology,18
MP:0008001 hypochlorhydria,5
MP:0000168 abnormal bone marrow development,8
MP:0001601 abnormal myelopoiesis,46
MP:0000454 abnormal jaw morphology,33
MP:0004659 abnormal odontoid process morphology,7
MP:0010799 stomach mucosa hyperplasia,5
MP:0003405 abnormal platelet shape,8
MP:0008801 abnormal erythroid progenitor cell morphology,9
MP:0010178 increased number of Howell-Jolly bodies,11
MP:0005230 ectrodactyly,7
MP:0005270 abnormal zygomatic bone morphology,20
MP:0003056 abnormal hyoid bone morphology,20
MP:0010939 abnormal mandibular prominence morphology,9
MP:0030383 small presphenoid bone,9
MP:0002923 increased post-tetanic potentiation,6
MP:0004807 abnormal paired-pulse inhibition,10
MP:0004998 decreased CNS synapse formation,17
MP:0002632 vestigial tail,10
MP:0004653 absent caudal vertebrae,9
MP:0006301 abnormal mesenchyme morphology,14
MP:0009204 absent external male genitalia,5
MP:0009907 decreased tongue size,17
"MP:0000727 absent CD8-positive, alpha-beta T cells",10
"MP:0003790 absent CD4-positive, alpha beta T cells",10
MP:0001233 abnormal epidermis suprabasal layer morphology,10
MP:0001241 absent epidermis stratum corneum,9
MP:0003130 anal atresia,17
MP:0003276 esophageal atresia,6
MP:0001792 impaired wound healing,35
MP:0008821 increased blood uric acid level,18
MP:0009246 pale spleen,7
MP:0002285 abnormal tracheal ciliated epithelium morphology,17
MP:0005239 abnormal Bruch membrane morphology,14
MP:0003011 delayed dark adaptation,10
MP:0004772 abnormal bile secretion,11
MP:0000610 cholestasis,5
MP:0001573 abnormal circulating alanine transaminase level,7
MP:0003253 dilated bile duct,13
MP:0003255 bile duct proliferation,6
MP:0002334 abnormal airway responsiveness,13
MP:0002602 abnormal eosinophil cell number,5
MP:0001273 decreased metastatic potential,27
MP:0008041 absent NK T cells,6
MP:0008237 abnormal ventral coat pigmentation,13
MP:0009358 environmentally induced seizures,20
MP:0009977 abnormal cerebellar granule cell migration,12
MP:0005656 decreased aggression,18
MP:0008660 increased interleukin-10 secretion,32
MP:0008866 chromosomal instability,52
MP:0009797 abnormal mismatch repair,5
MP:0005044 sepsis,18
MP:0010308 decreased tumor latency,19
MP:0008008 early cellular replicative senescence,51
MP:0002062 abnormal associative learning,23
MP:0020411 increased abdominal adipose tissue amount,8
MP:0030022 decreased muscle cell glucose uptake,21
MP:0009349 increased urine pH,12
MP:0010386 abnormal urinary bladder physiology,17
MP:0011535 increased urination frequency,5
MP:0002807 abnormal eye blink conditioning behavior,9
MP:0001188 hyperpigmentation,17
MP:0011276 increased tail pigmentation,14
MP:0011278 increased ear pigmentation,11
MP:0000650 mesocardia,27
MP:0005290 decreased oxygen consumption,52
MP:0005480 increased circulating triiodothyronine level,11
MP:0005533 increased body temperature,28
MP:0010379 decreased respiratory quotient,65
MP:0006094 increased fat cell size,37
MP:0003851 skeletal muscle interstitial fibrosis,7
MP:0004273 abnormal basal lamina morphology,6
MP:0009414 skeletal muscle fiber necrosis,17
MP:0003852 skeletal muscle necrosis,14
MP:0004089 dilated sarcoplasmic reticulum,9
MP:0004818 increased skeletal muscle mass,9
MP:0009401 increased skeletal muscle fiber diameter,10
MP:0009420 skeletal muscle endomysial fibrosis,7
MP:0005566 decreased blood urea nitrogen level,70
MP:0005360 urolithiasis,8
MP:0005441 increased urine calcium level,21
MP:0001413 abnormal response to new environment,34
MP:0003992 increased mortality induced by ionizing radiation,16
MP:0002704 tubular nephritis,6
MP:0009454 impaired contextual conditioning behavior,65
MP:0002717 abnormal male preputial gland morphology,6
MP:0002716 small male preputial glands,7
MP:0011964 increased total retina thickness,9
MP:0004410 absent endocochlear potential,7
MP:0011426 abnormal ureter smooth muscle morphology,7
MP:0010380 abnormal inner cell mass apoptosis,26
MP:0011184 absent embryonic epiblast,12
MP:0005643 decreased dopamine level,37
MP:0005646 abnormal pituitary gland physiology,10
MP:0011448 decreased dopaminergic neuron number,17
MP:0009661 abnormal pregnancy,18
MP:0004003 abnormal vascular endothelial cell physiology,29
MP:0004256 abnormal maternal decidual layer morphology,14
MP:0010138 arteritis,7
MP:0002090 abnormal vision,40
MP:0011234 abnormal retinol level,10
MP:0001409 increased stereotypic behavior,34
MP:0005022 abnormal immature B cell morphology,7
MP:0008908 increased total fat pad weight,13
MP:0005491 pancreatic islet hyperplasia,33
MP:0004194 abnormal kidney pelvis morphology,13
MP:0008933 abnormal motile primary cilium physiology,6
MP:0009145 abnormal pancreatic acinus morphology,9
MP:0009149 decreased pancreatic acinar cell number,5
MP:0011501 increased glomerular capsule space,20
MP:0011682 renal glomerulus cysts,21
MP:0011493 double ureter,17
MP:0005645 abnormal hypothalamus physiology,10
MP:0004803 increased susceptibility to autoimmune diabetes,19
MP:0006353 increased glycosylated hemoglobin level,5
MP:0010957 abnormal aerobic respiration,18
MP:0001731 abnormal postnatal growth,27
MP:0005129 increased adrenocorticotropin level,8
MP:0003564 abnormal insulin secretion,14
MP:0003960 increased lean body mass,271
MP:0008814 decreased nerve conduction velocity,32
MP:0009294 increased interscapular fat pad weight,7
MP:0013279 increased fasting circulating glucose level,113
MP:0000559 abnormal femur morphology,66
MP:0002885 abnormal AMPA-mediated synaptic currents,12
MP:0009357 abnormal seizure response to inducing agent,5
MP:0008586 disorganized photoreceptor outer segment,25
MP:0004515 abnormal vestibular hair cell stereociliary bundle morphology,10
MP:0004529 decreased outer hair cell stereocilia number,16
MP:0030961 abnormal outer hair cell kinocilium location or orientation,6
MP:0003070 increased vascular permeability,39
MP:0001983 abnormal olfactory system physiology,15
MP:0009932 skin fibrosis,14
MP:0009333 abnormal splenocyte physiology,15
MP:0004815 abnormal somatic hypermutation frequency,17
MP:0008177 increased germinal center B cell number,18
MP:0001664 abnormal digestion,13
MP:0030281 thin parietal bone,7
MP:0010108 abnormal renal water reabsorbtion,6
MP:0011467 decreased urine urea nitrogen level,8
MP:0011471 decreased urine creatinine level,23
MP:0005170 cleft upper lip,37
MP:0004538 abnormal maxillary shelf morphology,8
MP:0002729 abnormal inner ear canal morphology,7
MP:0003069 abnormal superior semicircular canal morphology,9
MP:0003144 decreased otolith number,7
MP:0008488 abnormal semicircular canal ampulla morphology,6
MP:0002244 abnormal turbinate morphology,5
MP:0004179 transmission ratio distortion,33
MP:0002876 abnormal thyroid gland physiology,8
MP:0005479 decreased circulating triiodothyronine level,18
MP:0003503 decreased activity of thyroid gland,18
MP:0010124 decreased bone mineral content,361
MP:0010968 decreased compact bone area,19
MP:0013618 decreased areal bone mineral density,7
MP:0005488 bronchial epithelial hyperplasia,5
MP:0008583 absent photoreceptor inner segment,5
MP:0000640 adrenal gland hypoplasia,5
MP:0002665 decreased circulating corticosterone level,38
MP:0002664 decreased circulating adrenocorticotropin level,11
MP:0000676 abnormal body water content,6
MP:0004770 abnormal synaptic vesicle recycling,16
MP:0008941 reticulocytopenia,8
MP:0009859 eye opacity,10
MP:0010896 decreased lung compliance,8
MP:0005503 abnormal tendon morphology,18
MP:0003189 fused joints,13
MP:0003200 calcified joint,7
MP:0003198 calcified tendon,5
MP:0003930 abnormal tooth hard tissue morphology,5
MP:0030863 decreased joint mobility,5
MP:0003156 abnormal leukocyte migration,53
MP:0005409 darkened coat color,33
MP:0000489 abnormal large intestine morphology,14
MP:0002731 megacolon,18
MP:0009480 distended cecum,8
MP:0005046 absent spleen white pulp,6
MP:0001198 tight skin,14
MP:0002736 abnormal nociception after inflammation,38
MP:0010055 abnormal sensory neuron physiology,9
MP:0020523 decreased susceptibility to induced hypothermia,12
MP:0003894 abnormal Purkinje cell innervation,8
MP:0014185 cerebellum atrophy,12
MP:0008260 abnormal autophagy,47
MP:0006162 thick eyelids,5
MP:0013178 tail necrosis,5
MP:0004222 iris synechia,10
MP:0008810 increased circulating iron level,48
MP:0011708 decreased fibroblast cell migration,24
MP:0020472 arrhythmic circadian behavior persistence,9
MP:0002429 abnormal blood cell morphology/development,22
MP:0000346 broad head,9
MP:0004085 abnormal heartbeat,7
MP:0009541 increased thymocyte apoptosis,26
MP:0014143 decreased body fat mass,31
MP:0008274 failure of bone ossification,7
MP:0030451 abnormal dentin mineralization,9
MP:0030494 abnormal molar root morphology,9
MP:0004328 decreased vestibular hair cell number,8
MP:0004517 decreased vestibular hair cell stereocilia number,5
MP:0008974 proportional dwarf,23
MP:0005619 increased urine potassium level,16
MP:0005628 decreased circulating potassium level,41
MP:0003866 abnormal defecation,13
MP:0010180 increased susceptibility to weight loss,45
MP:0000516 abnormal renal/urinary system morphology,17
MP:0001748 increased circulating adrenocorticotropin level,13
MP:0005502 abnormal renal/urinary system physiology,7
MP:0003585 large ureter,5
MP:0009109 decreased pancreas weight,8
MP:0009347 increased trabecular bone thickness,34
MP:0010875 increased bone volume,22
MP:0008395 abnormal osteoblast differentiation,28
MP:0000466 esophageal epithelium hyperplasia,5
MP:0004036 abnormal muscle relaxation,7
MP:0010803 abnormal stomach enteroendocrine cell morphology,5
MP:0013566 dilated gastric glands,5
MP:0005526 decreased renal plasma flow rate,5
MP:0011534 granular kidney,7
MP:0005223 abnormal dorsal-ventral polarity of the somites,11
MP:0003329 amyloid beta deposits,15
MP:0004725 decreased platelet serotonin level,16
MP:0009446 abnormal platelet dense granule physiology,13
MP:0020432 decreased platelet dense granule number,13
MP:0005237 abnormal olfactory tract morphology,8
MP:0000965 abnormal sensory neuron morphology,16
MP:0030279 thin neurocranium,9
MP:0011081 decreased macrophage apoptosis,12
MP:0008190 decreased transitional stage B cell number,27
MP:0008858 abnormal hair cycle anagen phase,16
MP:0009351 thin hair shaft,9
MP:0004748 increased susceptibility to age-related hearing loss,25
MP:0012261 increased hindbrain apoptosis,6
MP:0008727 enlarged heart right atrium,10
MP:0002498 abnormal acute inflammation,10
MP:0001982 decreased chemically-elicited antinociception,20
MP:0030356 premature lambdoid suture closure,5
MP:0000192 abnormal mineral level,13
MP:0005059 lysosomal protein accumulation,15
MP:0005061 abnormal eosinophil morphology,5
MP:0002877 abnormal melanocyte morphology,10
MP:0003173 decreased lysosomal enzyme secretion,7
MP:0009746 enhanced behavioral response to xenobiotic,22
MP:0010922 alveolitis,6
MP:0008065 short endolymphatic duct,6
MP:0004716 abnormal cochlear nerve morphology,9
MP:0000359 abnormal mast cell morphology,13
MP:0000539 distended urinary bladder,20
MP:0003624 anuria,7
MP:0004813 absent linear vestibular evoked potential,20
MP:0005498 hyporesponsive to tactile stimuli,41
MP:0001529 abnormal vocalization,51
MP:0002803 abnormal operant conditioning behavior,11
MP:0004081 abnormal globus pallidus morphology,7
MP:0004793 abnormal synaptic vesicle clustering,7
MP:0008402 increased cellular sensitivity to alkylating agents,5
MP:0003646 muscle fatigue,14
MP:0008171 abnormal mature B cell morphology,7
MP:0008577 increased circulating interferon-gamma level,43
MP:0009619 abnormal optokinetic reflex,7
MP:0009646 urinary bladder inflammation,8
MP:0009810 increased urine uric acid level,8
MP:0005243 hemothorax,9
MP:0005435 hemoperitoneum,10
MP:0003089 decreased skin tensile strength,24
MP:0006083 abnormal blood vessel elastic tissue morphology,6
MP:0006278 aortic aneurysm,12
MP:0009862 abnormal aorta elastic tissue morphology,12
MP:0002274 abnormal type I pneumocyte morphology,5
MP:0003390 lymphedema,11
MP:0003659 abnormal lymph circulation,11
MP:0001006 abnormal retinal cone cell morphology,26
MP:0005122 increased circulating thyroid-stimulating hormone level,15
MP:0008687 increased interleukin-2 secretion,40
MP:0004492 abnormal orientation of inner hair cell stereociliary bundles,12
MP:0009884 palatal shelf fusion with tongue or mandible,7
MP:0008444 retinal cone cell degeneration,24
MP:0008446 decreased retinal cone cell number,24
MP:0005135 increased thyroid-stimulating hormone level,7
MP:0005477 increased circulating thyroxine level,18
MP:0004466 short cochlear outer hair cells,6
MP:0004591 enlarged tectorial membrane,8
MP:0004664 delayed inner ear development,6
MP:0014091 abnormal tectorial membrane striated-sheet matrix morphology,7
MP:0011643 abnormal tendon collagen fibril morphology,5
MP:0002667 decreased circulating aldosterone level,13
MP:0002768 small adrenal glands,30
MP:0008288 abnormal adrenal cortex morphology,15
MP:0008076 abnormal CD4-positive T cell differentiation,40
MP:0002767 situs ambiguus,9
MP:0008818 abnormal interfrontal bone morphology,6
MP:0001727 abnormal embryo implantation,6
MP:0006221 optic nerve hypoplasia,14
MP:0020857 corneal epithelium hyperplasia,6
MP:0005132 decreased luteinizing hormone level,13
MP:0009622 absent inguinal lymph nodes,11
MP:0009628 absent brachial lymph nodes,6
MP:0009630 absent axillary lymph nodes,11
MP:0009633 absent cervical lymph nodes,9
MP:0005136 decreased growth hormone level,17
MP:0003884 decreased macrophage cell number,51
MP:0003760 decreased palatal length,5
MP:0030258 small mandibular condyloid process,7
MP:0030458 abnormal tooth wear,6
MP:0009275 bruising,7
MP:0008839 absent acrosome,10
MP:0001059 optic nerve atrophy,8
MP:0002697 abnormal eye size,17
MP:0002984 retina hypoplasia,7
MP:0006071 abnormal retinal progenitor cell morphology,9
MP:0003711 pathological neovascularization,12
MP:0006309 decreased retinal ganglion cell number,23
MP:0008507 thin retinal ganglion layer,10
MP:0004984 increased osteoclast cell number,63
MP:0008987 abnormal liver lobule morphology,7
MP:0009286 increased abdominal fat pad weight,11
MP:0013507 increased ovary apoptosis,5
MP:0004393 abnormal cochlear inner hair cell morphology,22
MP:0001485 abnormal pinna reflex,18
MP:0002623 abnormal vestibular hair cell morphology,6
MP:0003825 abnormal pillar cell morphology,10
MP:0006336 abnormal otoacoustic response,5
MP:0008126 increased dendritic cell number,34
MP:0008840 abnormal spike wave discharge,23
MP:0003201 extremity edema,9
MP:0004338 small clavicle,6
MP:0004354 absent deltoid tuberosity,10
MP:0004623 thoracic vertebral fusion,12
MP:0004846 absent skeletal muscle,5
MP:0002901 increased urine phosphate level,13
MP:0002786 abnormal Leydig cell morphology,13
MP:0002776 Sertoli cell hyperplasia,7
MP:0004806 absent germ cells,9
MP:0008297 retention of the adrenal gland x-zone,5
MP:0008639 decreased circulating interleukin-1 alpha level,6
MP:0008642 decreased circulating interleukin-1 beta level,19
MP:0020400 cystinuria,5
MP:0004964 absent inner cell mass,19
MP:0000661 small prostate gland ventral lobe,5
MP:0009007 short estrous cycle,5
MP:0014052 increased male germ cell apoptosis,21
MP:0011125 decreased primary ovarian follicle number,8
MP:0002832 coarse hair,9
MP:0008779 abnormal maternal behavior,12
MP:0008957 abnormal placenta junctional zone morphology,6
MP:0000084 abnormal fontanelle morphology,7
MP:0008463 abnormal peripheral lymph node morphology,9
MP:0009481 cecum inflammation,10
MP:0002465 abnormal eosinophil physiology,12
MP:0008603 decreased circulating interleukin-4 level,16
MP:0008723 impaired eosinophil recruitment,18
MP:0009676 abnormal hemostasis,5
MP:0000187 abnormal triglyceride level,18
MP:0005398 decreased susceptibility to fungal infection,6
MP:0008658 decreased interleukin-1 beta secretion,39
MP:0008702 increased interleukin-5 secretion,23
MP:0010936 decreased airway resistance,9
MP:0004899 absent temporal bone squamous part,6
MP:0004164 abnormal neurohypophysis morphology,9
MP:0009094 abnormal endometrial gland morphology,5
MP:0000334 decreased granulocyte number,30
MP:0004536 short inner hair cell stereocilia,7
MP:0008111 abnormal granulocyte differentiation,20
MP:0008112 abnormal monocyte differentiation,8
MP:0008657 increased interleukin-1 beta secretion,38
MP:0002791 steatorrhea,8
MP:0001128 ovary hyperplasia,5
MP:0000423 delayed hair regrowth,5
MP:0010107 abnormal renal reabsorbtion,15
MP:0030108 abnormal incudostapedial joint morphology,6
MP:0000583 long toenails,11
MP:0008853 decreased abdominal adipose tissue amount,19
MP:0003811 abnormal hair cortex morphology,6
MP:0003353 decreased circulating renin level,9
MP:0003666 impaired sperm capacitation,14
MP:0004512 anosmia,6
MP:0009749 enhanced behavioral response to addictive substance,11
MP:0009754 enhanced behavioral response to cocaine,19
MP:0009412 skeletal muscle fiber degeneration,17
MP:0009419 skeletal muscle fibrosis,12
MP:0008762 embryonic lethality,56
MP:0004761 increased susceptibility to induced pancreatitis,9
MP:0011925 abnormal heart echocardiography feature,23
MP:0003507 abnormal ovary physiology,9
MP:0009648 abnormal superovulation,11
MP:0002208 abnormal germ cell morphology,11
MP:0008299 adrenal cortical hyperplasia,7
MP:0002392 abnormal Peyer's patch T cell area morphology,8
MP:0001999 photosensitivity,6
MP:0006400 decreased molar number,10
MP:0010743 delayed cranial suture closure,11
MP:0012078 abnormal tail ring morphology,5
MP:0030080 small lower incisors,6
MP:0030083 long upper incisors,5
MP:0030457 abnormal molar cusp morphology,15
MP:0005074 impaired granulocyte bactericidal activity,9
MP:0001236 abnormal epidermis stratum spinosum morphology,15
MP:0003426 pulmonary interstitial fibrosis,8
MP:0008477 decreased spleen red pulp amount,12
MP:0009278 abnormal bone marrow cell physiology,31
MP:0030927 decreased telomere length,9
MP:0008167 increased B-1a cell number,18
MP:0008207 decreased B-2 B cell number,29
"MP:0008080 abnormal CD8-positive, alpha-beta T cell differentiation",37
MP:0005548 retinal pigment epithelium atrophy,9
MP:0006290 proboscis,8
MP:0012254 absent intersomitic vessels,6
MP:0010912 herniated liver,18
MP:0008959 abnormal spongiotrophoblast cell morphology,11
MP:0030542 abnormal dentin development,8
MP:0009239 short sperm flagellum,27
MP:0009836 abnormal sperm principal piece morphology,12
MP:0002599 increased mean platelet volume,71
MP:0008253 absent megakaryocytes,5
MP:0005161 hematuria,14
MP:0008255 decreased megakaryocyte cell number,15
MP:0008333 absent lactotrophs,6
MP:0008337 increased thyrotroph cell number,6
MP:0012014 abnormal olfactory neuron innervation pattern,8
MP:0000740 impaired smooth muscle contractility,11
MP:0001905 abnormal dopamine level,21
MP:0003434 decreased susceptibility to induced choroidal neovascularization,11
MP:0006058 decreased cerebral infarction size,31
MP:0001240 abnormal epidermis stratum corneum morphology,52
MP:0030605 abnormal corneocyte morphology,7
MP:0004565 small myocardial fiber,10
MP:0009415 skeletal muscle degeneration,9
MP:0003701 elevated level of mitotic sister chromatid exchange,10
MP:0003280 urinary incontinence,9
MP:0009511 distended stomach,7
MP:0004415 abnormal cochlear nerve compound action potential,7
MP:0004633 abnormal cochlear IHC efferent innervation pattern,7
MP:0001385 pup cannibalization,16
MP:0009964 abnormal cerebellum lobule morphology,6
MP:0008109 abnormal small intestinal microvillus morphology,8
MP:0001203 increased sensitivity to skin irradiation,9
MP:0002963 decreased urine protein level,6
MP:0005462 abnormal mast cell differentiation,8
MP:0001501 abnormal sleep pattern,53
MP:0008961 abnormal basal metabolism,6
MP:0010080 abnormal hepatocyte physiology,25
MP:0020478 abnormal circadian sleep/wake cycle,8
MP:0012270 cardiac edema,18
MP:0004391 abnormal respiratory conducting tube morphology,12
MP:0009346 decreased trabecular bone thickness,48
MP:0009780 abnormal chondrocyte physiology,24
MP:0004506 abnormal pubis morphology,9
MP:0003891 increased allantois apoptosis,6
MP:0004232 decreased muscle weight,10
MP:0005670 abnormal white adipose tissue physiology,25
MP:0003442 decreased circulating glycerol level,28
MP:0005128 decreased adrenocorticotropin level,7
MP:0008449 abnormal retinal cone cell outer segment morphology,10
MP:0011710 enhanced osteoblast differentiation,9
MP:0014167 ectopic bone,6
MP:0008546 abnormal vesicle-mediated transport,20
MP:0009448 decreased platelet ATP level,10
MP:0010050 hypermyelination,5
MP:0008071 absent B cells,16
MP:0008124 decreased plasmacytoid dendritic cell number,13
MP:0008760 abnormal immunoglobulin heavy chain V(D)J recombination,9
MP:0008758 abnormal T cell receptor beta chain V(D)J recombination,7
MP:0000467 abnormal esophagus morphology,13
MP:0009476 enlarged cecum,17
MP:0006204 embryonic lethality before implantation,17
MP:0012411 increased granulosa cell tumor incidence,5
MP:0009452 abnormal synaptonemal complex,26
MP:0006021 abnormal Reissner membrane morphology,8
MP:0004749 nonsyndromic hearing loss,6
MP:0030049 prominent forehead,8
MP:0002059 abnormal seminal vesicle morphology,148
MP:0001376 abnormal mating receptivity,6
MP:0003491 abnormal voluntary movement,17
MP:0011014 decreased core body temperature,12
MP:0003098 decreased tendon stiffness,5
MP:0011505 camptomelia,5
MP:0030837 abnormal knee joint morphology,7
MP:0003705 abnormal hypodermis morphology,6
MP:0002952 ventricular cardiomyopathy,7
MP:0003648 abnormal radial glial cell morphology,13
MP:0004991 decreased bone strength,32
MP:0006423 dilated rete testis,6
MP:0009304 increased retroperitoneal fat pad weight,16
MP:0009444 ovarian follicular cyst,5
MP:0005216 abnormal pancreatic alpha cell morphology,11
MP:0005218 abnormal pancreatic delta cell morphology,6
MP:0003123 paternal imprinting,17
MP:0002531 abnormal type I hypersensitivity reaction,6
MP:0003436 decreased susceptibility to induced arthritis,57
MP:0008664 decreased interleukin-12 secretion,28
MP:0009336 increased splenocyte proliferation,14
MP:0008765 decreased mast cell degranulation,18
MP:0011200 abnormal extraembryonic coelom morphology,12
MP:0005034 abnormal anus morphology,7
MP:0000464 increased presacral vertebrae number,6
MP:0030441 increased osteoblast apoptosis,5
MP:0014103 increased chondrocyte apoptosis,5
MP:0004882 enlarged lung,11
MP:0001661 extended life span,20
MP:0001898 abnormal long term depression,20
MP:0009251 enlarged endometrial glands,5
MP:0009282 reduced hyperactivated sperm motility,8
MP:0005323 dystonia,21
MP:0003639 abnormal response to vitamins,5
MP:0009608 abnormal epidermal lamellar body morphology,10
MP:0009233 enlarged sperm head,7
MP:0002534 abnormal type IV hypersensitivity reaction,9
MP:0002052 decreased tumor incidence,23
MP:0000479 abnormal enterocyte morphology,20
MP:0000199 abnormal circulating serum albumin level,5
MP:0005554 decreased circulating creatinine level,79
MP:0005617 increased susceptibility to type IV hypersensitivity reaction,23
MP:0010873 decreased trabecular bone mass,17
MP:0010962 decreased compact bone mass,6
MP:0008099 abnormal plasma cell differentiation,6
MP:0004859 abnormal synaptic plasticity,24
MP:0009453 enhanced contextual conditioning behavior,23
MP:0012184 absent paraxial mesoderm,6
MP:0008170 decreased B-1b cell number,12
MP:0002925 abnormal cardiovascular development,26
MP:0009926 decreased transitional stage T2 B cell number,17
MP:0030095 abnormal midface morphology,7
MP:0010825 abnormal lung saccule morphology,25
MP:0001280 loss of vibrissae,6
MP:0001230 epidermal desquamation,7
MP:0009474 thick epidermis stratum spinosum,6
MP:0009599 thick epidermis stratum granulosum,6
MP:0005285 decreased unsaturated fatty acid level,6
MP:0008555 abnormal interferon secretion,13
MP:0004486 decreased response of heart to induced stress,28
MP:0004928 increased epididymis weight,9
MP:0001329 retina hyperplasia,7
MP:0006200 vitreous body deposition,8
MP:0003958 heart valve hyperplasia,5
MP:0004627 abnormal trochanter morphology,6
MP:0009085 abnormal uterine horn morphology,7
MP:0010419 inlet ventricular septal defect,6
MP:0010460 pulmonary artery hypoplasia,21
MP:0010469 ascending aorta hypoplasia,6
MP:0010485 aortic arch hypoplasia,16
MP:0010572 persistent right dorsal aorta,16
MP:0010620 thick mitral valve,5
MP:0030388 large fontanelles,6
MP:0004431 abnormal hair cell mechanoelectric transduction,11
MP:0004491 abnormal orientation of outer hair cell stereociliary bundles,23
MP:0008784 craniorachischisis,17
MP:0011877 absent liver,5
MP:0012504 increased forebrain apoptosis,7
MP:0012505 increased neural tube apoptosis,10
MP:0012706 decreased embryonic neuroepithelial cell proliferation,9
MP:0004199 increased fetal size,5
MP:0004514 dystocia,6
MP:0009503 abnormal mammary gland duct morphology,18
MP:0003983 decreased cholesterol level,21
MP:0009743 preaxial polydactyly,45
MP:0000478 delayed intestine development,5
MP:0001586 abnormal erythrocyte cell number,12
MP:0006001 abnormal intestinal transit time,11
MP:0011252 situs inversus totalis,30
MP:0008034 enhanced lipolysis,23
MP:0010819 primary atelectasis,24
MP:0005426 tachypnea,12
MP:0010943 abnormal bronchus epithelium morphology,8
MP:0002450 abnormal lymph organ development,10
MP:0009165 abnormal endocrine pancreas morphology,5
MP:0004414 decreased cochlear microphonics,6
MP:0000250 abnormal vasoconstriction,14
MP:0005335 abnormal gonadal fat pad morphology,10
MP:0009122 decreased white fat cell lipid droplet size,7
MP:0003978 decreased circulating carnitine level,6
MP:0003107 abnormal response to novelty,20
MP:0012142 absent amniotic cavity,5
MP:0008917 abnormal oligodendrocyte physiology,11
MP:0010017 visceral vascular congestion,6
MP:0002959 increased urine microalbumin level,7
MP:0011753 decreased podocyte number,5
MP:0020416 decreased fibroblast chemotaxis,5
MP:0020849 abnormal actin cytoskeleton morphology,10
MP:0030876 abnormal costochondral joint morphology,5
MP:0010070 decreased serotonin level,21
MP:0012574 decreased noradrenaline level,16
MP:0012288 abnormal paradoxical sleep pattern,6
MP:0012289 abnormal non-rapid eye movement sleep pattern,8
MP:0004025 polyploidy,25
MP:0005280 abnormal fatty acid level,13
MP:0003976 decreased circulating VLDL triglyceride level,14
MP:0004957 abnormal blastocyst morphology,23
MP:0003172 abnormal lysosome physiology,29
MP:0005546 choroidal neovascularization,8
MP:0004042 decreased susceptibility to kidney reperfusion injury,18
MP:0004918 abnormal negative T cell selection,9
MP:0006414 decreased T cell apoptosis,18
MP:0008882 abnormal enterocyte physiology,9
MP:0008883 abnormal enterocyte proliferation,26
MP:0008259 abnormal optic disk morphology,30
MP:0009967 abnormal neuron proliferation,24
MP:0002944 increased lactate dehydrogenase level,14
MP:0008850 increased hemoglobin concentration distribution width,15
MP:0009141 increased prepulse inhibition,60
MP:0011339 abnormal glomerular mesangium morphology,17
MP:0008845 abnormal paraventricular hypothalamic nucleus morphology,7
MP:0003414 epidermal cyst,6
MP:0002351 abnormal cervical lymph node morphology,6
MP:0010197 abnormal lymphatic vessel endothelial cell morphology,5
MP:0011159 abnormal epidermal-dermal junction morphology,5
MP:0030798 joint contracture,5
MP:0000022 abnormal ear shape,10
MP:0014082 decreased small intestinal villus height,6
MP:0011176 abnormal erythroblast morphology,8
MP:0011243 decreased fetal derived definitive erythrocyte cell number,6
MP:0011229 abnormal vitamin C level,6
MP:0005134 decreased thyroid-stimulating hormone level,9
MP:0003137 abnormal impulse conducting system conduction,24
MP:0003897 abnormal ST segment,6
MP:0004528 fused outer hair cell stereocilia,7
MP:0004531 short outer hair cell stereocilia,5
MP:0001981 increased chemically-elicited antinociception,7
MP:0008552 abnormal circulating tumor necrosis factor level,6
MP:0008669 increased interleukin-12b secretion,11
MP:0004243 abnormal motor nerve collateral sprouting,6
MP:0008294 abnormal adrenal gland zona fasciculata morphology,15
MP:0008006 increased stomach pH,14
MP:0000501 abnormal digestive secretion,5
MP:0010301 increased stomach tumor incidence,14
MP:0010335 fused first pharyngeal arch,6
MP:0008465 absent mesenteric lymph nodes,9
MP:0009634 absent popliteal lymph nodes,8
MP:0006073 abnormal retinal bipolar cell morphology,13
MP:0003956 abnormal body size,11
MP:0009548 abnormal platelet aggregation,12
MP:0001566 increased circulating phosphate level,57
MP:0003030 acidemia,7
MP:0010163 hemolysis,8
MP:0012551 metabolic acidosis,10
MP:0009713 enhanced conditioned place preference behavior,10
MP:0010758 increased right ventricle systolic pressure,8
MP:0011198 absent proamniotic cavity,11
MP:0008913 weaving,8
MP:0008092 abnormal T-helper 2 cell differentiation,17
MP:0005544 corneal deposits,7
MP:0011632 dilated mitochondria,10
MP:0008897 decreased IgG2c level,7
MP:0009058 decreased interleukin-21 secretion,5
MP:0005322 abnormal serotonin level,17
MP:0003447 decreased tumor growth/size,55
MP:0008045 decreased NK cell number,88
MP:0005324 ascites,11
MP:0004508 abnormal pectoral girdle bone morphology,13
MP:0008051 abnormal memory T cell physiology,13
MP:0004666 absent stapedial artery,17
MP:0004739 conductive hearing loss,15
"MP:0004392 abnormal CD8-positive, alpha-beta T cell physiology",29
MP:0003620 oliguria,21
MP:0010500 myocardium hypoplasia,6
MP:0010503 myocardial trabeculae hypoplasia,12
MP:0003031 acidosis,13
MP:0011417 abnormal renal transport,8
MP:0001349 excessive tearing,8
MP:0006167 eyelid edema,5
MP:0003005 abnormal hippocampal fimbria morphology,8
MP:0014146 decreased white adipose tissue mass,8
MP:0014169 decreased brown adipose tissue mass,16
MP:0006123 tricuspid valve atresia,9
MP:0002818 abnormal dentin morphology,14
MP:0002819 abnormal dental pulp cavity morphology,6
MP:0010231 transverse fur striping,7
MP:0011077 decreased macrophage nitric oxide production,6
MP:0011079 decreased macrophage cytokine production,10
MP:0011182 decreased hematopoietic cell number,7
MP:0008250 abnormal myeloid leukocyte morphology,12
MP:0009506 abnormal mammary gland alveolus morphology,21
MP:0002271 abnormal pulmonary alveolar duct morphology,6
MP:0010894 pulmonary alveolar edema,5
MP:0008193 abnormal marginal zone B cell physiology,8
MP:0002828 abnormal renal glomerular capsule morphology,15
MP:0009750 impaired behavioral response to addictive substance,16
MP:0010701 fusion of atlas and odontoid process,10
MP:0004235 abnormal masseter muscle morphology,5
MP:0006365 absent guard hair,10
MP:0006173 abnormal myeloid dendritic cell morphology,5
MP:0008122 decreased myeloid dendritic cell number,9
MP:0008524 increased plasmacytoid dendritic cell number,11
MP:0005282 decreased fatty acid level,30
MP:0002992 abnormal sebaceous lipid secretion,10
MP:0009133 decreased white fat cell size,51
MP:0004684 intervertebral disk degeneration,5
MP:0003178 left pulmonary isomerism,42
MP:0002946 delayed axon extension,5
MP:0002822 catalepsy,7
MP:0008295 abnormal adrenal gland zona reticularis morphology,6
MP:0000829 dilated fourth ventricle,9
MP:0004103 abnormal ventral striatum morphology,6
MP:0005342 abnormal intestinal lipid absorption,17
MP:0002696 decreased circulating glucagon level,19
MP:0003499 thyroid gland hypoplasia,6
MP:0006285 absent inner ear,5
MP:0010729 absent arcus anterior,5
MP:0008950 ventricular tachycardia,14
MP:0009732 ventricular premature beat,12
MP:0010520 sinoatrial block,7
MP:0009263 abnormal eyelid fusion,6
MP:0013745 abnormal eyelid margin morphology,5
MP:0009882 absent palatal shelf,5
MP:0005195 abnormal posterior eye segment morphology,9
MP:0014164 abnormal ciliary process morphology,6
MP:0005440 increased glycogen level,10
MP:0014060 abnormal platelet alpha-granule morphology,6
MP:0009594 abnormal corneocyte envelope morphology,8
MP:0005356 positive geotaxis,9
MP:0003740 fusion of middle ear ossicles,5
MP:0009653 abnormal palate development,13
MP:0009895 decreased palatine bone horizontal plate size,10
MP:0004267 abnormal optic tract morphology,7
MP:0008307 short scala media,5
MP:0009771 absent optic chiasm,7
MP:0011366 absent metanephros,8
MP:0005359 growth retardation of incisors,6
MP:0009543 abnormal thymus corticomedullary boundary morphology,12
MP:0008960 abnormal axon pruning,8
MP:0002314 abnormal respiratory mechanics,12
MP:0002835 abnormal cranial suture morphology,16
MP:0011799 increased urinary bladder weight,5
MP:0004893 decreased adiponectin level,35
MP:0009113 increased pancreatic beta cell mass,19
MP:0009117 abnormal white fat cell morphology,11
MP:0008061 absent podocyte slit diaphragm,7
MP:0011455 absent glomerular endothelium fenestra,5
MP:0009745 abnormal behavioral response to xenobiotic,21
MP:0003194 abnormal frequency of paradoxical sleep,11
MP:0004782 abnormal surfactant physiology,12
MP:0010814 absent alveolar lamellar bodies,6
MP:0009280 reduced activated sperm motility,8
MP:0008911 induced hyperactivity,30
MP:0002899 fatigue,11
MP:0030018 increased cardiac cell glucose uptake,6
MP:0011468 abnormal urine amino acid level,5
MP:0003245 abnormal GABAergic neuron morphology,16
MP:0008571 abnormal synaptic bouton morphology,12
MP:0003010 decreased mortality induced by ionizing radiation,7
MP:0005473 decreased triiodothyronine level,6
MP:0004884 abnormal testis physiology,12
MP:0011377 renal glomerulus fibrosis,10
MP:0004213 abnormal umami taste sensitivity,6
MP:0010202 focal dorsal hair loss,7
MP:0004534 decreased inner hair cell stereocilia number,11
MP:0009400 decreased skeletal muscle fiber size,36
MP:0005556 abnormal renal filtration rate,7
MP:0014171 increased fatty acid oxidation,15
MP:0020474 advanced circadian behavior phase,7
MP:0020476 abnormal circardian behavior entrainment,23
MP:0009974 decreased cerebral cortex pyramidal cell number,5
MP:0003840 abnormal coronal suture morphology,9
MP:0011504 abnormal limb long bone morphology,7
MP:0011998 decreased embryonic cilium length,10
MP:0009180 increased pancreatic delta cell number,5
MP:0004088 abnormal sarcoplasmic reticulum morphology,14
MP:0006316 increased urine sodium level,25
MP:0008055 increased urine osmolality,11
MP:0011459 increased urine chloride ion level,11
MP:0011470 increased urine creatinine level,8
MP:0000958 peripheral nervous system degeneration,10
MP:0004143 muscle hypertonia,12
MP:0011202 abnormal ectoplacental cavity morphology,5
MP:0003223 decreased cardiomyocyte apoptosis,7
MP:0008483 increased spleen germinal center size,20
MP:0010210 abnormal circulating cytokine level,23
MP:0004125 abnormal venule morphology,5
MP:0012307 impaired spatial learning,49
MP:0004871 premaxilla hypoplasia,6
MP:0008593 increased circulating interleukin-10 level,21
MP:0010934 increased subcutaneous adipose tissue amount,11
MP:0002434 abnormal T-helper 2 cell morphology,9
MP:0003708 binucleate,7
MP:0009760 abnormal mitotic spindle morphology,28
MP:0009298 increased mesenteric fat pad weight,6
MP:0005123 increased circulating growth hormone level,14
MP:0009867 abnormal ascending aorta morphology,5
MP:0006137 venoocclusion,6
MP:0005068 abnormal NK cell morphology,8
MP:0002673 abnormal sperm number,20
MP:0009387 abnormal epidermal pigmentation,7
MP:0004525 thin cochlear hair cell stereocilia,5
MP:0003496 increased thyroid adenoma incidence,5
MP:0004112 abnormal arteriole morphology,5
MP:0005604 hyperekplexia,5
MP:0009435 abnormal miniature inhibitory postsynaptic currents,43
MP:0008932 abnormal embryonic tissue physiology,9
MP:0003962 abnormal adrenaline level,5
MP:0000032 cochlear degeneration,8
MP:0004292 abnormal spiral ligament fibrocyte morphology,5
MP:0004490 type IV spiral ligament fibrocyte degeneration,5
MP:0001422 abnormal drinking behavior,8
MP:0005258 ocular hypertension,10
MP:0011277 decreased tail pigmentation,26
MP:0009293 decreased inguinal fat pad weight,31
MP:0009305 decreased retroperitoneal fat pad weight,21
MP:0011629 decreased mitochondria number,8
MP:0002345 abnormal lymph node primary follicle morphology,7
MP:0005406 abnormal heart size,7
MP:0012119 increased trophectoderm apoptosis,5
MP:0001717 absent ectoplacental cone,7
MP:0011174 lipodystrophy,10
MP:0008725 enlarged heart atrium,19
MP:0030940 impaired autophagy,11
MP:0009596 abnormal stratum corneum lipid matrix formation,7
MP:0009597 impaired stratum corneum desquamation,6
MP:0009255 degranulated pancreatic beta cells,5
MP:0004603 absent vertebral arch,7
MP:0009148 pancreas necrosis,7
MP:0009808 decreased oligodendrocyte number,15
MP:0020351 decreased vocalization,27
MP:0009350 decreased urine pH,10
MP:0006087 increased body mass index,16
MP:0009277 increased brain tumor incidence,7
MP:0030407 abnormal stapes crus morpholgy,5
MP:0002863 improved righting response,5
MP:0004778 increased macrophage derived foam cell number,7
MP:0010026 decreased liver cholesterol level,19
MP:0020448 increased microglial cell activation,6
MP:0001296 macrophthalmia,6
MP:0004284 abnormal Descemet membrane,5
MP:0020378 abnormal cell cytoskeleton morphology,9
MP:0006086 decreased body mass index,18
MP:0003136 yellow coat color,14
MP:0006341 small first pharyngeal arch,10
MP:0006411 upturned snout,7
MP:0010977 fused right lung lobes,7
MP:0010194 absent lymphatic vessels,5
MP:0000447 flattened snout,15
MP:0008986 abnormal liver parenchyma morphology,11
MP:0010035 increased erythrocyte clearance,11
MP:0010751 decreased susceptibility to parasitic infection induced morbidity/mortality,12
MP:0008617 increased circulating interleukin-12 level,21
MP:0002654 spongiform encephalopathy,15
MP:0012230 abnormal sphingolipid level,7
MP:0000925 abnormal floor plate morphology,18
MP:0004906 enlarged uterus,24
MP:0001950 abnormal respiratory sounds,5
MP:0002881 long hair,5
MP:0012260 encephalomeningocele,12
MP:0006149 decreased visual acuity,8
MP:0002799 abnormal passive avoidance behavior,16
MP:0003381 vitreal fibroplasia,6
MP:0000917 obstructive hydrocephaly,9
MP:0002892 decreased superior colliculus size,5
MP:0011868 podocyte microvillus transformation,6
MP:0006117 aortic valve stenosis,17
MP:0002462 abnormal granulocyte physiology,12
MP:0008042 abnormal NK T cell physiology,14
MP:0010865 prenatal growth retardation,17
MP:0010940 abnormal maxillary prominence morphology,10
MP:0004769 abnormal synaptic vesicle morphology,18
MP:0009615 abnormal zinc homeostasis,8
MP:0002905 decreased circulating parathyroid hormone level,10
MP:0006236 absent Meibomian glands,9
MP:0006366 absent zigzag hairs,6
MP:0030636 decreased taurine level,6
MP:0030589 increased pancreatic alpha cell mass,5
MP:0004130 abnormal muscle cell glucose uptake,6
MP:0008291 abnormal adrenocortical cell morphology,6
MP:0014117 increased pancreatic beta cell apoptosis,7
MP:0001423 abnormal liquid preference,9
MP:0001432 abnormal food preference,11
MP:0003858 enhanced coordination,29
MP:0001560 abnormal circulating insulin level,23
MP:0011819 increased pancreatic beta cell proliferation,11
MP:0013558 abnormal exocrine gland morphology,5
MP:0004697 abnormal thyroid follicular cell morphology,7
MP:0005489 vascular smooth muscle hyperplasia,10
MP:0010589 common truncal valve,7
MP:0009167 increased pancreatic islet number,11
MP:0004812 abnormal linear vestibular evoked potential,5
MP:0001499 abnormal kindling response,9
MP:0004494 abnormal synaptic glutamate release,6
MP:0009762 abnormal mitotic spindle assembly checkpoint,7
MP:0000771 abnormal brain size,7
MP:0004904 increased uterus weight,10
MP:0010160 increased oligodendrocyte number,8
MP:0013438 dysmyelination,13
MP:0010401 increased skeletal muscle glycogen level,13
MP:0014071 increased cardiac muscle glycogen level,11
MP:0014074 increased brain glycogen level,5
MP:0009913 abnormal hyoid bone greater horn morphology,5
MP:0010371 abnormal epiglottis morphology,5
MP:0010527 bicuspid pulmonary valve,6
MP:0010541 aorta hypoplasia,7
MP:0008418 abnormal cutaneous elastic fiber morphology,6
MP:0006075 abnormal retinal cone bipolar cell morphology,8
MP:0009136 decreased brown fat cell size,11
MP:0006355 abnormal sixth pharyngeal arch artery morphology,10
MP:0013405 increased circulating lactate level,10
MP:0005582 increased renin activity,13
MP:0009828 increased tumor latency,8
MP:0002990 short ureter,8
MP:0002694 abnormal pancreas secretion,8
MP:0002659 pituitary gland hypoplasia,8
MP:0008846 abnormal supraoptic nucleus morphology,6
MP:0002991 abnormal sebaceous gland physiology,5
MP:0010093 decreased circulating magnesium level,23
MP:0001987 alcohol preference,13
MP:0011442 abnormal renal sodium ion transport,6
MP:0004839 bile duct hyperplasia,7
MP:0008772 increased heart ventricle size,20
MP:0001849 ear inflammation,13
MP:0003412 abnormal afterhyperpolarization,14
MP:0003881 abnormal nephron morphology,9
MP:0011361 pelvic kidney,5
MP:0005638 hemochromatosis,7
MP:0004836 abnormal synaptic acetylcholine release,7
MP:0010173 increased mammary gland epithelial cell proliferation,6
MP:0009116 abnormal brown fat cell morphology,14
MP:0008451 retinal rod cell degeneration,23
MP:0008539 decreased susceptibility to induced colitis,26
MP:0010695 abnormal blood pressure regulation,5
MP:0002204 abnormal neurotransmitter level,11
MP:0003855 abnormal forelimb zeugopod morphology,10
MP:0004657 small sacral vertebrae,5
MP:0014106 delayed chondrocyte differentiation,6
MP:0008035 behavioral arrest,5
MP:0011233 abnormal vitamin A metabolism,7
MP:0008985 hemimelia,10
MP:0004750 syndromic hearing loss,5
MP:0012730 abnormal internal carotid artery morphology,6
MP:0011304 kidney papillary atrophy,8
MP:0011805 decreased cell migration,7
MP:0004646 decreased cervical vertebrae number,5
MP:0006135 artery stenosis,8
MP:0003561 rheumatoid arthritis,6
MP:0000262 poor arterial differentiation,6
MP:0030533 abnormal snout skin morphology,5
MP:0020316 decreased vascular endothelial cell proliferation,9
MP:0010959 abnormal oxidative phosphorylation,14
"MP:0011111 lethality during fetal growth through weaning, complete penetrance",11
MP:0005345 abnormal circulating corticosterone level,8
MP:0008106 decreased amacrine cell number,8
MP:0009772 abnormal retinal development,10
MP:0005654 porphyria,6
MP:0003668 abnormal periodontal ligament morphology,9
MP:0010926 increased osteoid volume,6
MP:0030484 abnormal osteocyte lacuna morphology,6
MP:0004963 abnormal blastocoele morphology,6
MP:0010754 abnormal heart left ventricle pressure,11
MP:0002829 abnormal juxtaglomerular apparatus morphology,7
MP:0010128 hypovolemia,5
MP:0009755 impaired behavioral response to alcohol,9
MP:0010698 abnormal impulsive behavior control,11
MP:0008475 intermingled spleen red and white pulp,14
MP:0008704 abnormal interleukin-6 secretion,5
MP:0001619 abnormal vascular permeability,7
MP:0008330 absent somatotrophs,5
MP:0011612 increased circulating ghrelin level,8
MP:0004647 decreased lumbar vertebrae number,33
MP:0004808 abnormal hematopoietic stem cell morphology,28
MP:0000413 polyphalangy,8
MP:0008574 decreased circulating interferon-alpha level,11
MP:0009820 abnormal liver vasculature morphology,13
MP:0012303 umbilical vein stenosis,11
MP:0008282 enlarged hippocampus,5
MP:0004102 abnormal dorsal striatum morphology,11
MP:0009426 decreased soleus weight,10
MP:0001881 abnormal mammary gland physiology,11
MP:0003046 liver cirrhosis,6
MP:0008142 decreased small intestinal villus size,6
MP:0008802 abnormal intestinal smooth muscle morphology,5
MP:0011431 increased urine flow rate,6
MP:0006068 abnormal horizontal cell morphology,11
MP:0006159 ocular albinism,5
MP:0002710 increased glucagon secretion,8
MP:0005452 abnormal adipose tissue amount,6
MP:0008753 abnormal osteocyte morphology,7
MP:0030191 narrow snout,6
MP:0009445 osteomalacia,7
MP:0012006 abnormal hippocampus physiology,7
MP:0009552 urinary bladder obstruction,7
MP:0011774 abnormal urinary bladder detrusor smooth muscle morphology,5
MP:0008686 abnormal interleukin-2 secretion,5
MP:0003454 erythroderma,5
MP:0004287 abnormal spiral limbus morphology,6
MP:0011066 abnormal renal tubule epithelial cell primary cilium morphology,15
MP:0003443 increased circulating glycerol level,20
MP:0003949 abnormal circulating lipid level,25
MP:0005199 abnormal iris pigment epithelium,5
MP:0008556 abnormal tumor necrosis factor secretion,8
MP:0020220 decreased tear production,8
MP:0003082 abnormal gastrocnemius morphology,14
MP:0003081 abnormal soleus morphology,15
MP:0003083 abnormal tibialis anterior morphology,11
MP:0006185 retinal hemorrhage,5
MP:0010505 abnormal T wave,8
MP:0011312 abnormal kidney afferent arteriole morphology,5
MP:0011316 abnormal kidney interlobular artery morphology,5
MP:0008655 decreased interleukin-1 alpha secretion,6
MP:0008685 decreased interleukin-18 secretion,5
MP:0008602 increased circulating interleukin-4 level,12
MP:0008626 increased circulating interleukin-5 level,6
MP:0013502 decreased fibroblast apoptosis,16
MP:0013219 abnormal substantia nigra pars compacta morphology,6
MP:0012194 decreased keratinocyte migration,5
MP:0009295 decreased interscapular fat pad weight,14
MP:0011179 decreased erythroblast number,8
MP:0009125 decreased brown fat cell lipid droplet size,17
MP:0009131 decreased white fat cell number,14
MP:0009137 decreased brown fat lipid droplet number,6
MP:0010601 thick pulmonary valve,9
"MP:0011105 embryonic lethality between implantation and placentation, incomplete penetrance",13
MP:0009817 decreased leukotriene level,5
MP:0009811 abnormal prostaglandin level,7
MP:0011372 decreased renal tubule apoptosis,6
MP:0003545 increased alcohol consumption,17
MP:0013743 ciliary body hypoplasia,6
MP:0003424 premature neuronal precursor differentiation,9
MP:0004279 abnormal rostral migratory stream morphology,15
MP:0009845 abnormal neural crest cell morphology,6
MP:0006141 abnormal atrioventricular node conduction,7
MP:0011953 prolonged PQ interval,9
MP:0006338 abnormal second pharyngeal arch morphology,5
MP:0006197 ocular hypotelorism,10
MP:0001756 abnormal urination,9
MP:0009728 abnormal calcaneum morphology,8
MP:0009118 increased white fat cell size,25
MP:0009767 decreased sensitivity to xenobiotic induced morbidity/mortality,36
MP:0008040 decreased NK T cell number,58
MP:0004548 dilated esophagus,5
MP:0009757 impaired behavioral response to morphine,10
MP:0003064 decreased coping response,18
MP:0010378 increased respiratory quotient,47
MP:0014142 increased body fat mass,15
MP:0008827 abnormal thymus cell ratio,17
MP:0006074 abnormal retinal rod bipolar cell morphology,17
MP:0008183 absent marginal zone B cells,7
MP:0008912 nervous,6
MP:0005673 decreased susceptibility to graft versus host disease,5
MP:0011050 abnormal respiratory motile cilium morphology,16
MP:0011055 abnormal respiratory motile cilium physiology,22
MP:0005474 increased triiodothyronine level,6
MP:0004545 enlarged esophagus,7
MP:0012547 spina bifida cystica,6
MP:0003126 abnormal external female genitalia morphology,5
MP:0009199 abnormal external male genitalia morphology,6
MP:0004329 vestibular saccular degeneration,5
MP:0011281 abnormal olfactory epithelium cilium morphology,6
MP:0010864 abnormal enamel knot morphology,5
MP:0001220 epidermal necrosis,6
MP:0003266 biliary cyst,10
MP:0002735 abnormal chemical nociception,7
MP:0030943 abnormal centrosome morphology,13
MP:0011633 abnormal mitochondrial shape,13
MP:0011635 abnormal mitochondrial crista morphology,30
MP:0012757 abnormal cranial neural crest cell migration,7
MP:0002933 joint inflammation,15
MP:0012010 parturition failure,7
MP:0005263 ectopia lentis,5
MP:0013258 abnormal extracellular matrix morphology,8
MP:0004357 long tibia,31
MP:0003234 enhanced NMDA-mediated synaptic currents,6
MP:0005461 abnormal dendritic cell morphology,15
MP:0003994 abnormal dorsal spinal root morphology,8
MP:0000785 telencephalon hypoplasia,8
MP:0010898 abnormal pulmonary alveolus epithelium morphology,6
MP:0010993 decreased surfactant secretion,9
MP:0003243 abnormal dopaminergic neuron morphology,14
MP:0003617 urinary bladder hypoplasia,6
MP:0008999 absent anus,6
MP:0009252 absent urinary bladder,6
MP:0002958 cerebral aqueductal stenosis,9
MP:0012159 absent anterior visceral endoderm,7
MP:0004720 abnormal platelet morphology,13
MP:0020431 decreased platelet alpha-granule number,5
MP:0010876 decreased bone volume,43
MP:0003649 decreased heart right ventricle size,10
MP:0009883 palatal shelf hypoplasia,12
MP:0009891 abnormal palate bone morphology,5
MP:0010116 abnormal primitive urogenital sinus morphology,5
MP:0010146 umbilical hernia,11
MP:0009710 anhedonia,6
MP:0011395 decreased fetal cardiomyocyte proliferation,11
MP:0010123 increased bone mineral content,204
MP:0003684 abnormal inferior olivary complex morphology,7
MP:0000151 absent ribs,5
MP:0008014 increased lung tumor incidence,29
MP:0001460 abnormal olfactory discrimination memory,5
MP:0003404 absent enamel,6
MP:0009451 abnormal chromosomal synapsis,23
MP:0002329 abnormal blood gas level,6
MP:0009647 decreased fertilization frequency,24
MP:0011952 decreased cardiac stroke volume,20
MP:0010540 long stride length,7
MP:0008542 enlarged cervical lymph nodes,8
MP:0013179 wavy tail,8
MP:0002281 abnormal respiratory mucosa goblet cell morphology,8
MP:0004033 supernumerary teeth,10
MP:0003241 loss of cortex neurons,11
MP:0030013 improved central nervous system regeneration,5
MP:0004348 long femur,8
MP:0010964 increased compact bone volume,8
MP:0013631 decreased bone trabecular spacing,11
MP:0004044 aortic dissection,9
MP:0004472 broad nasal bone,6
MP:0008862 asymmetric snout,6
MP:0003246 loss of GABAergic neurons,9
MP:0014105 abnormal chondrocyte differentiation,10
MP:0012055 abnormal phrenic nerve innervation pattern to diaphragm,11
MP:0003410 abnormal artery development,9
MP:0010463 aorta stenosis,14
MP:0010439 abnormal hepatic vein morphology,12
MP:0006049 semilunar valve regurgitation,7
MP:0010476 coronary fistula,17
MP:0002570 alcohol aversion,7
MP:0003546 decreased alcohol consumption,14
MP:0005662 increased circulating adrenaline level,9
MP:0004217 salt-sensitive hypertension,9
MP:0030082 long lower incisors,5
MP:0008044 increased NK cell number,54
MP:0008647 increased circulating interleukin-12b level,15
MP:0003417 premature endochondral bone ossification,6
MP:0020861 abnormal corneal wound healing,5
MP:0010096 abnormal incisor color,18
MP:0030459 abnormal tooth attrition,6
MP:0003330 abnormal auditory tube,6
MP:0030410 middle ear effusion,6
MP:0003441 increased glycerol level,6
MP:0010484 bicuspid aortic valve,20
MP:0003444 abnormal neurotransmitter uptake,8
MP:0008682 decreased interleukin-17 secretion,26
MP:0001562 abnormal circulating calcium level,8
MP:0004721 abnormal platelet dense granule morphology,6
MP:0010149 abnormal synaptic dopamine release,7
MP:0012506 brain atrophy,6
MP:0000798 abnormal frontal lobe morphology,9
MP:0000794 abnormal parietal lobe morphology,5
MP:0003587 ureter obstruction,6
MP:0010239 decreased skeletal muscle weight,17
MP:0004967 abnormal kidney epithelium morphology,8
MP:0003325 decreased liver function,7
MP:0008884 abnormal enterocyte apoptosis,10
MP:0030160 abnormal auditory bulla morphology,5
MP:0005418 abnormal circulating hormone level,40
MP:0002987 abnormal urine osmolality,5
MP:0010213 abnormal circulating fibrinogen level,6
MP:0011230 abnormal folic acid level,5
MP:0004167 abnormal cingulate gyrus morphology,5
MP:0003582 abnormal ovary development,8
MP:0001980 abnormal chemically-elicited antinociception,6
MP:0009341 decreased splenocyte apoptosis,8
MP:0001841 decreased level of surface class I molecules,9
MP:0008178 decreased germinal center B cell number,16
MP:0013367 parotid gland inflammation,5
MP:0008648 decreased circulating interleukin-12b level,10
MP:0010961 increased compact bone mass,5
MP:0008192 abnormal germinal center B cell physiology,7
MP:0003724 increased susceptibility to induced arthritis,31
MP:0003463 abnormal single cell response,28
MP:0010995 abnormal lung alveolus development,5
MP:0008548 abnormal circulating interferon level,6
MP:0008563 decreased interferon-alpha secretion,24
MP:0008670 decreased interleukin-12b secretion,19
MP:0010738 abnormal internode morphology,6
MP:0008129 absent brain internal capsule,7
MP:0000861 disorganized barrel cortex,7
MP:0010098 abnormal retinal blood vessel pattern,11
MP:0013588 small thymus medulla,11
MP:0012739 abnormal anterior primitive streak morphology,6
MP:0010119 abnormal bone mineral density,7
MP:0003544 abnormal vascular endothelial cell migration,15
MP:0004432 abnormal cochlear hair cell physiology,7
MP:0004522 abnormal orientation of cochlear hair cell stereociliary bundles,14
MP:0004577 abnormal cochlear hair cell inter-stereocilial links morphology,7
MP:0009046 muscle twitch,5
MP:0009823 abnormal sphingomyelin level,11
MP:0004129 abnormal respiratory quotient,9
MP:0009557 decreased platelet ADP level,7
MP:0004524 short cochlear hair cell stereocilia,8
MP:0004631 abnormal auditory cortex morphology,5
MP:0020010 decreased bone mineral density of femur,10
MP:0013624 decreased femur compact bone thickness,8
MP:0012143 decreased a wave amplitude,28
MP:0012144 decreased b wave amplitude,35
MP:0008343 abnormal gamma-delta T cell morphology,7
MP:0013237 abnormal skeletal muscle regeneration,10
MP:0002473 impaired complement classical pathway,6
MP:0004317 small vestibular saccule,5
MP:0003186 abnormal redox activity,20
MP:0008119 decreased Langerhans cell number,7
MP:0004713 split notochord,8
MP:0003335 exocrine pancreatic insufficiency,5
MP:0011075 abnormal macrophage activation involved in immune response,10
MP:0020409 abnormal cardiac thrombosis,8
MP:0004946 abnormal regulatory T cell physiology,24
MP:0008493 alpha-synuclein inclusion body,7
MP:0003020 decreased circulating chloride level,36
MP:0010030 abnormal orbit morphology,6
MP:0011711 impaired osteoblast differentiation,15
MP:0003627 abnormal leukocyte tethering or rolling,6
MP:0001699 increased embryo size,7
MP:0010042 abnormal oval cell physiology,6
MP:0001697 abnormal embryo size,251
MP:0011016 increased core body temperature,13
MP:0010958 abnormal tricarboxylic acid cycle,9
MP:0009545 abnormal dermis papillary layer morphology,6
MP:0001400 hyperresponsive,7
MP:0006339 abnormal third pharyngeal arch morphology,6
MP:0030867 small thyroid cartilage,5
MP:0003550 short perineum,7
MP:0008480 absent eye pigmentation,9
MP:0003174 increased lysosomal enzyme secretion,5
MP:0004695 increased length of long bones,5
MP:0006253 clinodactyly,6
MP:0030670 increased circulating phenylalanine level,5
MP:0004880 lung cysts,6
MP:0008731 abnormal hair shaft melanin granule morphology,6
MP:0009779 enhanced behavioral response to anesthetic,5
MP:0020367 increased heart iron level,5
MP:0006375 increased circulating angiotensinogen level,5
MP:0011003 reduced AMPA-mediated synaptic currents,10
MP:0011002 enhanced AMPA-mediated synaptic currents,5
MP:0004302 abnormal Deiters cell morphology,5
MP:0003360 abnormal depression-related behavior,35
MP:0004373 bowed humerus,6
MP:0010052 increased grip strength,159
MP:0002983 increased retinal ganglion cell number,7
MP:0009787 increased susceptibility to infection induced morbidity/mortality,9
MP:0004974 decreased regulatory T cell number,37
MP:0005665 increased circulating noradrenaline level,9
MP:0008681 increased interleukin-17 secretion,34
MP:0011957 decreased compensatory feeding amount,12
MP:0008265 abnormal hippocampus CA2 region morphology,6
MP:0003838 abnormal milk ejection,6
MP:0008053 abnormal NK cell differentiation,13
MP:0004648 decreased thoracic vertebrae number,12
MP:0011451 increased susceptibility to dopaminergic neuron neurotoxicity,12
MP:0000439 enlarged cranium,14
MP:0008520 disorganized retinal outer plexiform layer,5
MP:0013818 abnormal oral cavity morphology,6
MP:0004685 calcified intervertebral disk,5
MP:0011584 increased alkaline phosphatase activity,11
MP:0011189 small embryonic epiblast,9
MP:0010996 increased aorta wall thickness,8
MP:0000228 abnormal thrombopoiesis,14
MP:0013292 embryonic lethality prior to organogenesis,234
MP:0003869 ectopic cartilage,6
MP:0003193 decreased cholesterol efflux,7
MP:0004035 abnormal sublingual gland morphology,5
MP:0010466 vascular ring,43
MP:0009877 exostosis,7
MP:0010937 increased total lung capacity,6
MP:0009917 abnormal hyoid bone body morphology,6
MP:0013486 decreased Paneth cell number,5
MP:0003422 abnormal thrombolysis,5
MP:0008039 increased NK T cell number,23
MP:0012279 wide sternum,6
MP:0030079 small incisors,5
MP:0009833 absent sperm mitochondrial sheath,10
MP:0001565 abnormal circulating phosphate level,5
MP:0010166 increased response to stress-induced hyperthermia,6
MP:0011269 increased excitatory postsynaptic current amplitude,7
MP:0006238 abnormal choriocapillaris morphology,5
MP:0008431 abnormal short term spatial reference memory,6
MP:0030937 increased mitochondrial DNA content,7
MP:0009871 abnormal aorta tunica adventitia morphology,6
MP:0011707 impaired fibroblast cell migration,7
MP:0003378 early sexual maturation,6
MP:0004043 abnormal pH regulation,6
MP:0003477 abnormal nerve fiber response,11
MP:0012359 increased partial thromboplastin time,7
MP:0012263 decreased hindbrain size,9
MP:0002997 enlarged seminal vesicle,17
MP:0003262 intestinal/bowel diverticulum,6
MP:0004008 abnormal GABA-mediated receptor currents,16
MP:0013182 increased spinal cord apoptosis,5
MP:0013639 decreased bone stiffness,5
MP:0003462 abnormal response to novel odor,8
MP:0008538 decreased zigzag hair amount,8
MP:0008672 increased interleukin-13 secretion,25
MP:0008885 increased enterocyte apoptosis,12
MP:0009378 abnormal endoplasmic reticulum morphology,20
MP:0009482 ileum inflammation,8
MP:0020354 increased endoplasmic reticulum stress,17
MP:0002367 abnormal thymus lobule morphology,9
MP:0003950 abnormal plasma membrane morphology,10
MP:0008453 decreased retinal rod cell number,6
MP:0005580 periinsulitis,5
MP:0004031 insulitis,26
MP:0012556 increased cell death,11
MP:0006207 embryonic lethality during organogenesis,17
MP:0008600 decreased circulating interleukin-2 level,5
MP:0012725 small sebaceous gland,9
MP:0014178 increased brain apoptosis,11
MP:0002327 abnormal respiratory function,12
MP:0010899 abnormal pulmonary alveolar system morphology,10
MP:0001204 decreased sensitivity to skin irradiation,5
MP:0002607 decreased basophil cell number,23
MP:0010394 decreased QRS amplitude,5
MP:0011679 abnormal vomeronasal sensory neuron morphology,5
MP:0010563 increased heart right ventricle size,8
MP:0010579 increased heart left ventricle size,21
MP:0012531 delayed limb development,5
MP:0004070 abnormal P wave,6
MP:0004495 decreased synaptic glutamate release,8
MP:0005522 increased circulating atrial natriuretic factor,5
MP:0003061 decreased aerobic running capacity,11
MP:0009770 abnormal optic chiasm morphology,11
MP:0003488 decreased channel response intensity,5
MP:0010047 axonal spheroids,14
MP:0008169 increased B-1b cell number,24
MP:0008806 increased circulating amylase level,33
MP:0008822 decreased blood uric acid level,11
MP:0005664 decreased circulating noradrenaline level,6
MP:0000362 decreased mast cell histamine storage,5
MP:0004225 patent cardiac foramen ovale,6
MP:0003213 decreased susceptibility to age related obesity,8
MP:0003965 abnormal pituitary hormone level,5
MP:0010499 abnormal ventricle myocardium morphology,12
MP:0030136 abnormal lower incisor morphology,10
MP:0004367 abnormal strial intermediate cell morphology,6
MP:0030439 decreased osteoblast proliferation,6
MP:0030017 decreased adipocyte glucose uptake,16
MP:0010209 abnormal circulating chemokine level,24
MP:0008461 left atrial isomerism,10
MP:0010668 abnormal hepatic portal vein morphology,6
MP:0011637 abnormal mitochondrial matrix morphology,5
MP:0008861 abnormal hair shedding,8
MP:0000542 left-sided isomerism,8
MP:0011250 abdominal situs ambiguus,24
MP:0000738 impaired muscle contractility,6
MP:0009392 retinal gliosis,7
MP:0010097 abnormal retinal blood vessel morphology,65
MP:0012065 increased astrocyte number,5
MP:0011999 abnormal tail length,7
MP:0005571 decreased lactate dehydrogenase level,22
MP:0010091 decreased circulating creatine kinase level,5
MP:0011891 decreased circulating ferritin level,5
MP:0009436 fragmentation of sleep/wake states,7
MP:0008308 small scala media,5
MP:0010235 abnormal retina inner limiting membrane morphology,8
MP:0011649 immotile respiratory cilia,20
MP:0005535 abnormal body temperature,7
MP:0010948 abnormal double-strand DNA break repair,53
MP:0011968 decreased threshold for auditory brainstem response,29
MP:0011437 glomerulus hemorrhage,5
MP:0005586 decreased tidal volume,7
MP:0011142 abnormal lung-associated mesenchyme development,7
MP:0004156 abnormal QT variability,7
MP:0011954 shortened PQ interval,17
MP:0003121 genetic imprinting,10
MP:0008635 increased circulating interleukin-18 level,8
MP:0003742 narrow head,5
"MP:0011659 interrupted aortic arch, type b",7
MP:0014172 decreased fatty acid oxidation,10
MP:0011572 abnormal aorta bulb morphology,5
MP:0011080 increased macrophage apoptosis,7
MP:0003942 abnormal urinary system development,5
MP:0003841 abnormal lambdoid suture morphology,6
MP:0009428 decreased tibialis anterior weight,7
MP:0010227 decreased quadriceps weight,9
MP:0011827 impaired neuron differentiation,10
MP:0020394 decreased neuronal precursor proliferation,6
MP:0013404 decreased circulating lactate level,10
MP:0003432 increased activity of parathyroid,7
MP:0009879 abnormal arcus anterior morphology,6
MP:0009874 abnormal interdigital cell death,5
MP:0008575 increased circulating interferon-beta level,7
MP:0009432 increased fetal weight,6
MP:0013945 abnormal elbow joint morphology,5
MP:0011808 abnormal myoblast differentiation,7
MP:0004226 absent Schlemm's canal,6
MP:0004223 hypoplastic trabecular meshwork,6
MP:0030567 abnormal I band morphology,5
MP:0003387 aorta coarctation,10
MP:0004971 dermal hyperplasia,5
MP:0004246 abnormal extensor digitorum longus morphology,6
MP:0003543 abnormal vascular endothelial cell differentiation,5
MP:0000805 abnormal visual cortex morphology,10
MP:0004202 pulmonary hyperplasia,5
MP:0010942 abnormal respiratory epithelium morphology,6
MP:0011045 decreased lung elastance,5
MP:0020083 decreased hippocampus volume,6
MP:0030166 increased inner canthal distance,6
MP:0006203 eye hemorrhage,8
MP:0010377 abnormal gut flora balance,14
MP:0020357 abnormal excitatory synapse morphology,8
MP:0020551 abnormal postsynaptic density morphology,16
MP:0008636 decreased circulating interleukin-18 level,9
MP:0009205 abnormal internal male genitalia morphology,6
MP:0002333 abnormal lung compliance,5
MP:0008712 decreased interleukin-9 secretion,7
MP:0020395 abnormal response to social novelty,17
MP:0008837 increased transforming growth factor level,5
MP:0008503 abnormal spinal cord grey matter morphology,6
MP:0011385 abnormal testosterone level,8
MP:0011060 abnormal kinocilium morphology,5
MP:0009108 increased pancreas weight,8
MP:0011338 abnormal mesangial matrix morphology,6
MP:0008579 abnormal Purkinje cell differentiation,7
MP:0004408 decreased cochlear hair cell number,9
MP:0009880 microstomia,7
MP:0010740 abnormal dendritic cell chemotaxis,11
MP:0008565 decreased interferon-beta secretion,23
MP:0008462 abnormal medium spiny neuron morphology,7
MP:0013601 increased testis apoptosis,11
MP:0008162 increased diameter of tibia,8
"MP:0010382 abnormal dosage compensation, by inactivation of X chromosome",7
MP:0008285 abnormal hippocampus granule cell layer,7
MP:0010965 decreased compact bone volume,7
MP:0003171 phenotypic reversion,6
MP:0011896 increased circulating unsaturated transferrin level,9
MP:0011270 decreased excitatory postsynaptic current amplitude,12
MP:0008191 abnormal follicular B cell physiology,5
MP:0011078 increased macrophage cytokine production,5
MP:0014126 increased mammary gland apoptosis,9
MP:0010887 pale lung,5
MP:0011628 increased mitochondria number,9
MP:0014046 abnormal mitophagy,7
MP:0011886 increased circulating lipase level,5
MP:0008891 decreased hepatocyte apoptosis,8
MP:0010181 decreased susceptibility to weight loss,9
MP:0020154 impaired humoral immune response,39
MP:0008573 increased circulating interferon-alpha level,9
MP:0008791 decreased NK cell degranulation,5
MP:0011971 increased circulating lactate dehydrogenase level,8
MP:0009267 abnormal cerebellum fissure morphology,6
MP:0006299 abnormal latent inhibition of conditioning behavior,6
MP:0010580 decreased heart left ventricle size,16
MP:0011698 abnormal brown adipose tissue physiology,14
MP:0011699 abnormal brown adipose tissue thermogenesis,8
MP:0012107 enhanced exercise endurance,6
MP:0006321 increased myocardial fiber number,6
MP:0003397 increased muscle weight,5
MP:0013177 abnormal tail tip morphology,6
MP:0002700 opacity of vitreous body,5
MP:0020234 decreased basal metabolism,11
MP:0006392 abnormal nucleus pulposus morphology,7
MP:0008588 abnormal circulating interleukin level,6
MP:0008614 increased circulating interleukin-17 level,15
MP:0009303 decreased renal fat pad weight,9
MP:0004250 tau protein deposits,11
MP:0010226 increased quadriceps weight,7
MP:0010933 decreased trabecular bone connectivity density,12
MP:0008581 disorganized photoreceptor inner segment,6
MP:0009299 decreased mesenteric fat pad weight,11
MP:0002869 increased anti-insulin autoantibody level,5
MP:0010031 abnormal cranium size,5
MP:0008691 decreased interleukin-23 secretion,5
MP:0002318 hypercapnia,5
MP:0009938 abnormal hippocampus granule cell morphology,15
MP:0003342 accessory spleen,8
MP:0003707 increased cell nucleus count,6
MP:0008141 decreased small intestinal microvillus size,5
MP:0009936 abnormal dendritic spine morphology,57
MP:0008580 photoreceptor inner segment degeneration,9
MP:0008599 increased circulating interleukin-2 level,8
MP:0008069 abnormal joint mobility,5
MP:0012285 misaligned sternebrae,5
MP:0014121 increased pancreatic islet cell apoptosis,6
MP:0020352 abnormal endoplasmic reticulum physiology,5
MP:0009854 impaired gastric peristalsis,6
MP:0009834 abnormal sperm annulus morphology,8
MP:0008638 increased circulating interleukin-1 alpha level,5
MP:0003060 increased aerobic running capacity,6
"MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number",30
MP:0008504 abnormal adrenal chromaffin cell morphology,5
MP:0003900 shortened QT interval,8
MP:0002800 abnormal short term object recognition memory,8
MP:0010074 stomatocytosis,5
MP:0010221 abnormal T-helper 17 cell differentiation,6
MP:0008036 abnormal NK T cell morphology,8
MP:0004019 abnormal vitamin homeostasis,5
MP:0010570 prolonged ST segment,5
MP:0008594 decreased circulating interleukin-10 level,9
MP:0012167 abnormal epigenetic regulation of gene expression,9
MP:0008576 decreased circulating interferon-beta level,11
MP:0009806 abnormal otic vesicle morphology,8
MP:0012232 abnormal ceramide level,21
MP:0008761 abnormal immunoglobulin light chain V-J recombination,8
MP:0008769 abnormal plasmacytoid dendritic cell physiology,9
MP:0011642 abnormal bone collagen fibril morphology,7
MP:0008559 abnormal interferon-gamma secretion,9
MP:0006205 embryonic lethality between implantation and somite formation,9
MP:0011254 superior-inferior ventricles,10
MP:0009049 abnormal hallux morphology,5
MP:0005133 increased luteinizing hormone level,5
MP:0008805 decreased circulating amylase level,37
MP:0012306 enhanced spatial learning,7
MP:0010742 increased Schwann cell number,6
MP:0011731 decreased myelin sheath thickness,13
MP:0030935 increased primordial germ cell apoptosis,6
MP:0008838 decreased transforming growth factor level,7
MP:0003028 alkalosis,6
MP:0002399 abnormal pluripotent precursor cell morphology,6
MP:0010167 decreased response to stress-induced hyperthermia,5
MP:0013616 decreased volumetric bone mineral density,7
MP:0010133 increased DN3 thymocyte number,8
MP:0010136 decreased DN4 thymocyte number,7
MP:0008935 decreased mean platelet volume,31
MP:0008922 abnormal cervical rib,16
MP:0008457 abnormal cortical intermediate zone morphology,7
MP:0030450 abnormal enamel mineralization,7
MP:0010924 abnormal osteoid morphology,7
MP:0010929 increased osteoid thickness,5
MP:0011165 abnormal tooth root development,6
MP:0008831 abnormal insulin-like growth factor I level,7
MP:0009222 increased uterus tumor incidence,7
MP:0004687 split vertebrae,5
MP:0009078 adrenal gland hyperplasia,5
MP:0008878 abnormal DNA methylation during gametogenesis,6
MP:0008895 abnormal intraepithelial T cell number,5
MP:0004843 abnormal Paneth cell morphology,7
MP:0011056 abnormal brain ependyma motile cilium morphology,15
MP:0011069 abnormal brain ependyma motile cilium physiology,12
MP:0011129 decreased secondary ovarian follicle number,10
MP:0009794 sebaceous gland hyperplasia,5
MP:0008964 decreased carbon dioxide production,14
MP:0008656 abnormal interleukin-1 beta secretion,5
MP:0008608 increased circulating interleukin-13 level,5
"MP:0011112 lethality during fetal growth through weaning, incomplete penetrance",13
MP:0008564 increased interferon-beta secretion,9
MP:0008896 increased IgG2c level,8
MP:0006051 brainstem hemorrhage,5
MP:0009393 abnormal resting posture,9
MP:0009121 increased white fat cell lipid droplet size,5
MP:0011168 abnormal fat cell differentiation,16
MP:0010752 impaired mucociliary clearance,11
MP:0014174 decreased fatty acid beta-oxidation,5
MP:0005632 decreased circulating aspartate transaminase level,42
MP:0009362 abnormal primary ovarian follicle morphology,7
MP:0009455 enhanced cued conditioning behavior,11
MP:0010870 absent bone trabeculae,5
MP:0011396 abnormal sleep behavior,77
MP:0009796 abnormal base-excision repair,8
MP:0010174 decreased mammary gland epithelial cell proliferation,13
MP:0010522 calcified aorta,5
MP:0011496 abnormal head size,11
MP:0011178 increased erythroblast number,15
MP:0011620 abnormal habituation to a new environment,8
MP:0011435 increased urine magnesium level,11
MP:0009829 enlarged eye anterior chamber,7
MP:0011960 abnormal eye anterior chamber depth,9
MP:0009602 abnormal keratohyalin granule morphology,5
MP:0004931 enlarged epididymis,40
MP:0010732 abnormal node of Ranvier morphology,5
MP:0009923 decreased transitional stage T1 B cell number,15
MP:0010643 absent fourth pharyngeal arch,5
MP:0010975 abnormal lung lobe morphology,16
MP:0010393 shortened QRS complex duration,5
MP:0011167 abnormal adipose tissue development,12
MP:0010220 decreased T-helper 17 cell number,8
MP:0020451 decreased sperm progressive motility,6
MP:0020254 decreased collagen level,9
MP:0013630 increased bone trabecular spacing,11
MP:0000632 abnormal pineal gland morphology,10
MP:0013842 ductus venosus stenosis,9
MP:0004848 abnormal liver size,6
MP:0010395 abnormal pharyngeal arch development,5
MP:0010639 altered tumor pathology,8
MP:0009933 abnormal tail hair pigmentation,5
MP:0010130 decreased DN1 thymic pro-T cell number,8
MP:0010219 increased T-helper 17 cell number,12
MP:0010360 decreased liver free fatty acids level,6
MP:0010769 abnormal survival,22
MP:0013852 abnormal Mullerian duct topology,14
MP:0014017 abnormal Wolffian duct connection,7
MP:0010358 abnormal free fatty acids level,5
MP:0010767 abnormal female meiosis I arrest,6
MP:0010148 abnormal exocrine pancreas physiology,5
MP:0010102 increased caudal vertebrae number,13
"MP:0010836 decreased CD4-positive, alpha-beta memory T cell number",5
MP:0005635 decreased circulating bilirubin level,24
MP:0010678 abnormal skin adnexa morphology,5
MP:0011169 abnormal white fat cell differentation,5
MP:0012269 nuchal edema,7
MP:0011275 abnormal behavioral response to light,107
MP:0013907 abnormal cerebrospinal fluid flow,5
MP:0011902 increased hematopoietic stem cell proliferation,5
"MP:0010835 increased CD4-positive, alpha-beta memory T cell number",7
MP:0010132 decreased DN2 thymocyte number,7
MP:0010134 decreased DN3 thymocyte number,6
MP:0011665 d-loop transposition of the great arteries,22
MP:0011121 decreased primordial ovarian follicle number,10
MP:0010207 abnormal telomere morphology,9
MP:0010186 increased T follicular helper cell number,5
MP:0011249 abdominal situs inversus,9
MP:0011253 situs inversus with levocardia,7
MP:0010770 preweaning lethality,6
"MP:0011666 double outlet right ventricle, ventricular defect committed to aorta",14
"MP:0011400 lethality, complete penetrance",30
MP:0009922 increased transitional stage T1 B cell number,6
MP:0011285 increased circulating erythropoietin level,7
MP:0010762 abnormal microglial cell activation,6
MP:0013203 abnormal primary cilium morphology,9
"MP:0010168 increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number",32
"MP:0010838 increased CD8-positive, alpha-beta memory T cell number",15
"MP:0010839 decreased CD8-positive, alpha-beta memory T cell number",11
MP:0006130 pulmonary valve atresia,12
MP:0010446 heart left ventricle hypoplasia,12
MP:0009759 abnormal hair follicle bulge morphology,5
MP:0011683 dual inferior vena cava,38
MP:0011661 persistent truncus arteriosus type i,9
MP:0010068 decreased red blood cell distribution width,34
"MP:0010844 increased effector memory CD4-positive, alpha-beta T cell number",57
"MP:0010850 increased effector memory CD8-positive, alpha-beta T cell number",52
MP:0013245 abnormal lipid metabolism,13
MP:0008060 abnormal podocyte slit diaphragm morphology,5
MP:0011631 decreased mitochondria size,6
MP:0010511 shortened PR interval,16
MP:0011585 decreased alkaline phosphatase activity,5
"MP:0011668 double outlet right ventricle, Taussig bing type",15
MP:0009850 embryonic lethality between implantation and placentation,7
MP:0010487 abnormal right subclavian artery morphology,8
MP:0013649 decreased CD11b-high dendritic cell number,8
MP:0003062 abnormal coping response,10
MP:0012000 abnormal limb position,6
MP:0011975 neuronal cytoplasmic inclusions,7
MP:0011751 abnormal X-Y chromosome synapsis during male meiosis,6
MP:0012075 impaired mammary gland growth during pregnancy,7
MP:0012051 spasticity,7
MP:0011436 decreased urine magnesium level,6
MP:0012315 impaired learning,5
MP:0011903 decreased hematopoietic stem cell proliferation,5
MP:0013697 decreased granulocyte monocyte progenitor cell number,5
MP:0013278 decreased fasting circulating glucose level,94
MP:0010633 myocardium hypertrophy,5
MP:0005385 cardiovascular system phenotype,44
MP:0010571 shortened ST segment,12
MP:0013513 decreased memory-marker CD4-negative NK T cell number,6
MP:0013514 increased memory-marker CD4-negative NK T cell number,6
MP:0010088 decreased circulating fructosamine level,44
MP:0013836 abnormal hypoglossal nerve topology,31
MP:0013848 subcutaneous edema,43
MP:0013968 multiple persisting craniopharyngeal ducts,15
MP:0014018 embryo tumor,18
MP:0014019 embryo cyst,12
MP:0014086 hemangioma,12
MP:0013835 absent hypoglossal nerve,18
MP:0013967 abnormal infrahyoid muscle connection,16
MP:0013971 blood in lymph vessels,45
MP:0013986 abnormal vitelline vein topology,22
MP:0014001 abnormal vertebral artery topology,33
MP:0014021 heterochrony,23
"MP:0010851 decreased effector memory CD8-positive, alpha-beta T cell number",25
MP:0013298 increased susceptibility to colitis induced morbidity/mortality,8
MP:0013293 embryonic lethality prior to tooth bud stage,204
MP:0020155 enhanced humoral immune response,7
MP:0020001 decreased response to antigen,17
MP:0013840 absent segment of posterior cerebral artery,28
MP:0013876 absent ductus venosus valve,30
MP:0013985 abnormal umbilical vein topology,11
MP:0013987 absent intrahepatic inferior vena cava segment,6
MP:0013826 absent hypoglossal canal,9
MP:0013834 thin hypoglossal nerve,17
MP:0013875 trigeminal neuroma,15
MP:0013877 abnormal ductus venosus valve morphology,30
MP:0013878 abnormal ductus venosus valve topology,13
MP:0013975 abnormal coronary sinus connection,12
MP:0013992 persistent dorsal ophthalmic artery,5
MP:0014023 abnormal intestine placement,10
MP:0010087 increased circulating fructosamine level,14
MP:0012768 decreased KLRG1-positive NK cell number,11
MP:0013427 increased memory-marker NK cell number,9
"MP:0013430 increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number",9
"MP:0013433 increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number",7
MP:0013672 decreased mature NK cell number,5
MP:0013675 decreased Ly6C-positive mature NK cell number,6
MP:0013772 increased effector memory T-helper cell number,11
MP:0013775 increased KLRG1-positive T-helper cell number,5
MP:0013969 reduced sympathetic cervical ganglion size,16
MP:0014003 additional anastomosis between intracranial vertebral arteries,9
MP:0020500 persistent trigeminal artery,14
MP:0008923 thoracoschisis,18
MP:0010496 abnormal pectinate muscle morphology,6
MP:0013830 abnormal intrathoracic topology of vagus nerve,6
MP:0013874 abnormal ductus venosus topology,5
MP:0013917 persistent right 6th pharyngeal arch artery,6
MP:0013936 abnormal thymus topology,11
MP:0013977 symmetric azygos veins,11
MP:0013982 inverse situs of great intrathoracic arteries,5
MP:0014000 anastomosis between internal carotid artery and basilar artery,6
MP:0010507 shortened RR interval,24
MP:0012121 sclerocornea,6
MP:0013855 absent celiac artery,5
MP:0013858 abnormal azygos vein topology,5
MP:0013859 abnormal vitelline vein connection,16
MP:0013873 abnormal ductus venosus morphology,5
MP:0013913 absent costovertebral joint,5
MP:0013952 retro-esophageal left subclavian artery,6
MP:0011239 abnormal skin coloration,46
MP:0013294 prenatal lethality prior to heart atrial septation,67
MP:0010490 abnormal inferior vena cava valve morphology,14
MP:0014087 retrolental blood,9
MP:0013186 abnormal basilar artery morphology,6
MP:0013970 absent connection between subcutaneous lymph vessels and lymph sac,11
MP:0013996 abnormal vertebral artery origin,7
MP:0013243 abnormal carbohydrate metabolism,5
MP:0013663 increased myeloid cell number,8
MP:0010530 cerebral arteriovenous malformation,5
MP:0012765 decreased alpha-beta T cell number,27
"MP:0010847 increased central memory CD8 positive, alpha-beta T cell number",33
"MP:0013435 decreased CD8-positive, naive alpha-beta T cell number",44
MP:0012767 increased KLRG1-positive NK cell number,15
MP:0013022 increased Ly6C high monocyte number,8
MP:0013025 increased Ly6C low monocyte number,13
MP:0013426 decreased memory-marker NK cell number,6
MP:0013522 decreased memory-marker CD4-positive NK T cell number,5
MP:0013418 increased memory-marker gamma-delta T cell number,6
MP:0013764 decreased T-helper cell number,8
MP:0012764 increased alpha-beta T cell number,24
MP:0013023 decreased Ly6C high monocyte number,5
"MP:0013436 increased CD8-positive, naive alpha-beta T cell number",5
"MP:0010845 decreased effector memory CD4-positive, alpha-beta T cell number",22
MP:0013847 retropleural edema,9
MP:0011874 enlarged urinary bladder,17
MP:0014115 cognitive inflexibility,7
MP:0012361 decreased large unstained cell number,9
MP:0013406 abnormal epidermal immune compartment,5
MP:0013272 abnormal translation,6
MP:0014040 increased cellular sensitivity to DNA damaging agents,5
MP:0013242 abnormal amino acid metabolism,11
MP:0014134 abnormal embryo morphology,12
MP:0013693 abnormal hemopoiesis,5
MP:0010101 increased sacral vertebrae number,22
MP:0013026 decreased Ly6C low monocyte number,7
MP:0014114 abnormal cognition,6
MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology,7
MP:0012362 increased large unstained cell number,6
MP:0020396 abnormal social recognition,6
MP:0020335 abnormal dentate gyrus neuron dendrite morphology,5
MP:0020421 increased freezing behavior,5
MP:0020508 decreased dendritic spine density,14
"MP:0010841 increased central memory CD4-positive, alpha-beta T cell number",24
"MP:0010842 decreased central memory CD4-positive, alpha-beta T cell number",6
"MP:0010848 decreased central memory CD8 positive, alpha-beta T cell number",8
